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“Mathematics is the door and key to the sciences”
Roger Bacon.
i Abstract
We use mathematical models to explore the evolutionary implications of health 
interventions affecting age-dependent mortality schedules in two contexts, antihelminthics 
targeting parasitic nematodes, and programs directed against malaria vectors.
We show that interventions targeting parasitic nematodes can exert selection pressure to 
either shorten or extend the time to maturity, depending on the details of worm mortality 
functions with and without the intervention. Interventions may therefore generate selection 
favouring later-maturing, larger and more fecund worms, rather than inevitably favouring 
the evolution of smaller, less fecund and hence potentially clinically less damaging worms 
as previously assumed.
The evolution of insecticide-resistant mosquitoes threatens conventional public health 
programs targeting malaria vectors. By exploiting the high mortality rates of wild 
mosquitoes and the delay between malaria infection and infectiousness in mosquito hosts, 
late-life-acting (LLA) insecticides which kill only older mosquitoes can in principle 
provide effective transmission control in combination with very low selection for 
resistance. We develop a novel mathematical model to evaluate the potential of such 
pesticides and find that theoretical LLAs which affect only mosquitoes above a specific 
age can offer transmission control comparable with conventional insecticides, combined 
with very low selection for resistance. Benefits are maximised by generating lower 
mortality in mosquitoes not infected with malaria, and contacting and killing mosquitoes 
prior to biting. We also explore the optimum virulence characteristics for a fungal LLA 
biopesticide, and find that it may offer improved transmission reduction as well as lower 
selection for resistance when compared to some insecticides in current use. Lastly we use 
our model to assess a candidate for development as a chemical LLA.
Page 6
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Finally, we explore a disparity between our model results and the conventional wisdom 
that a rare, recessive resistance allele will not spread. We find that the assumption of 
discrete, non-overlapping generations is key in this context.
PA Lynch November 2012
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“Maths is the purest science in that you don't need any test tubes or animal testing to do it. All the other sciences 
eventually boil down to maths, apart from biology, which boils down to soup. ”
Guy Browning, The Guardian, 2004.
1 General Introduction
Organisms have a wide range of life histories. For example, the African elephant 
(Loxodonta africana) has an average weight of 4.5 tonnes, a lifespan of 70 years, and 
females produce an average of one offspring every four to nine years. In contrast, the wood 
mouse (Apodemus sylvaticus) has an average weight of 23 g, lives for around 1 year, and 
females produce up to 4 litters per year, with 5 to 7 young per litter. Life history theory is a 
branch of evolutionary biology which attempts to explain this diversity by considering life 
history traits as adaptations, based on their close ties to an organism’s fitness. This 
perspective allows us to predict the direction and rate of change in such traits by 
considering trade-offs and constraints[l].
The use of drugs, vaccines, and pesticides to reduce the burden of human disease imposes 
strong selection on target organisms, as evidenced by the evolution of drug resistance in 
many microorganisms. Evolutionary biology enables us to predict the direction and rates of 
change in response to such man-made selection. Here we are concerned with the 
evolutionary consequences of age-dependent mortality, a key driver of the evolution of 
many traits. We consider its effects on age at maturity in parasitic worms, and insecticide 
resistance in mosquito vectors of malaria, with the purpose of understanding likely 
evolutionary responses and hence informing evolutionary management strategies in an 
effort to avoid undesirable outcomes.
Parasitic worms are a continuing source of morbidity and mortality, in humans and 
domestic animals across the globe, causing great suffering and generating a high economic 
cost. Human diseases caused by parasitic worm infections include onchocerciasis or “river 
blindness”, caused by infection with “Onchocerca volvulus” (see Figure 1), the second 
most important cause of infectious blindness, with approximately thirty-seven million
Page 16
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people infected worldwide [2]. Ascaris lumbricoides, the commonest helminth parasite of 
humans, grows to approximately 30cm, causes a range of symptoms, including direct 
intestinal blockage, and is estimated to infect around one billion people.
Figure 1 Lifecycle of Onchocerca volvulus
Life cycle of Onchocerca volvulus, a parasitic worm which causes Onchocerciasis in infected human 
hosts. Transmission between infected humans is via an intermediate blackfly host, which become 
infected with microfilariae when feeding on an infected human, and generates a new infection, after a 
period of development by the parasite, by transmitting parasite larvae during a subsequent feed on 
another human host.
Onchocerca volvulus
IL3 larvae enter Me wewiVJl
El lack fry takes 
a blood meas
hr.ip .'tV/wv dpd ode govikJpdx
Li larvaeV
I Microliiarrae pentrate 
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and m>grate to 
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A  = Infective Stage
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Ongesis im
Blackfly Stages
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Human Stages
©
Subcutaneous tissues
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In livestock, the annual cost of infection with gastro intestinal parasites, including 
prophylaxis, treatment and lost performance is estimated at £84 million per annum for the 
UK sheep industry alone [3].
In response to these damaging infections, a wide range of antihelminthic interventions 
have been developed and applied, including drug treatments for infected individuals, and 
prophylaxis for human and veterinary use. Antihelminthics are routinely used to maintain 
the health and productivity of livestock [4], and multiple large-scale public health
P A  Lynch November 2012
Page 17
interventions have been initiated, designed to alleviate or eliminate human disease arising 
from infection with parasitic worms [2]. These include programs which specifically target 
the elimination of specific parasites, not merely the prevention of human disease caused by 
parasites. GPELF, the Global Program to Eliminate Lymphatic Filariasis and OEPA, the 
Onchocerciasis Elimination Program for the Americas are examples of such campaigns 
and are providing regular doses of antihelminthic drugs on a huge scale, more than half a 
billion people have received treatment as part of the program spearheaded by GPELF [5]. 
Such programs inherently generate changes to parasite mortality schedules, a key life- 
history determinant. We consider in chapter 2 one possible evolutionary outcome of such 
alterations to parasite mortality, a change in the age at which worms reach maturity and 
begin to reproduce. Previous theory indicated that selection generated by increased 
mortality rates would always favour earlier maturity and hence smaller, less fecund worms 
[6]. Using a new mathematical model which generalises the existing models by taking into 
account the effects of age-related mortality we find, however, that if adult mortality rates 
vary with age at maturity, interventions which change mortality schedules could generate 
selection favouring later maturing, and hence larger and more fecund worms.
The importance of age-related mortality also informs the concept of late-life acting 
insecticides for use in the control of malaria transmission. Globally malaria continues to be 
a major cause of mortality and morbidity [7], despite a long history of public health 
campaigns, and successful eradication in many formerly endemic areas [8]. The malaria 
parasites which cause human disease, primarily Plasmodium falciparum, Plasmodium 
vivax, Plasmodium malariae and Plasmodium ovale [9], all have life histories which 
requires alternation between human and mosquito hosts (Figure 2). Although the various 
Anopheles mosquito species which can host Plasmodium are in fact the primary host, since 
sexual reproduction occurs during Plasmodium's development in the mosquito, our 
naturally anthropocentric view of the transmission process leads to definition of the
PA  Lynch November 2012
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mosquito host as a malaria ‘vector’, the means by which the disease is carried between
humans. Action to combat malaria thus has two potential modes of action, combating the
parasite directly, or targeting the means by which it is spread, the mosquito vector.
Figure 2 Life history of Plasmodium parasite
Following infection via an infected mosquito bite, the plasmodium parasite passes through a series of 
developmental stages in the human host. Onward transmission to a mosquito host can only occur when 
gametocytes are present in the bloodstream. A mosquito from a suitable vector species which ingests 
gametocytes may become infected, Plasmodium progresses through the ookinete, oocyst and sporozoite 
stages in the mosquito host over a number of days. Once sporozooites are present in the salivary 
glands, Plasmodium can be transmitted to a human host when the mosquito vector takes another 
human blood meal. Photographic images, clockwise from top left; oocyst on mosquito midgut, 
sporozooites released from ruptured oocycst, ‘ring stage’ and gametocytes, schizont.
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For vector-targeted malaria control, the biology of the Anopheles mosquito hosts is key to 
defining effective strategies. Mosquito life history follows a cyclical pattern of blood 
feeding, resting, egg-laying, host seeking, feeding again, and so on (Figure 3). For most 
malaria vectors blood feeding takes place at night, inside human habitations.
Figure 3 Generalised Anopheles lifecycle
Lifecycle of malaria vector (i) mating, (ii) blood feed on human host, (iff) rest, commonly on interior 
surface, (iv) find suitable laying site and oviposit, (v) eggs hatch, larva grow and pupate, pupae mature 
and emerging adults mate (f). ________  _______ ___
Where the physical environment and the specific biology of local vector species permit, 
removal of mosquito breeding sites, for example through drainage schemes, has proved a 
lasting and effective means of reducing mosquito numbers and hence malaria transmission.
Where such measures are impractical or uneconomic, however, the primary means of 
controlling adult mosquitoes is through the use of chemical insecticides, sprayed on the 
interior walls where mosquitoes rest after a blood meal [10] (IRS), or applied to bed nets 
(ITNS). Following long and successful use of these methods, increasing incidences of
Page 20
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vector populations resistant to commonly used insecticides threaten the long-term efficacy 
of insecticide based programs [11-15].
There is therefore a need for alternative control methods which avoid the repeated cycle of 
developing new products to replace those lost to resistance, followed in due course by the 
loss of the new compounds as resistance to them also spreads. In chapter 3 we evaluate one 
such alternative, late-life acting (LLA) insecticides which aim to achieve effective malaria 
transmission control in combination with minimal selection for resistance, by selectively 
changing age-linked mortality profiles for malaria vectors. The high mortality of wild 
mosquitoes and the relatively long period of development required before a Plasmodium 
infection in a mosquito host is transmissible, mean that older mosquitoes generate few eggs 
but are responsible for all infectious bites. Interventions which target only old mosquitoes, 
therefore, could potentially have little effect on the relative fitness of susceptible 
mosquitoes, few of whom will live long enough to be affected, whilst eliminating the 
majority of infectious bites. To explore whether the ideal of good performance for both 
criteria is theoretically possible requires a new modelling framework which captures 
mosquito survival, blood feeding and reproduction probabilities in a detailed, age- 
structured format. We therefore developed a new, two part mathematical model, the first 
part of which is a deterministic, markovian, feeding cycle based model, which tracks the 
key probabilities of age-dependent survival, infection, and reproduction for mosquitoes 
subject to a range of interventions. The results from the feeding cycle model provide data 
for the second part of our model, a population model which calculates the speed of spread 
of resistance through a population comprising a mixture of resistant and susceptible 
genotypes. We confirm that age-linked insecticides, killing on contact much like existing 
insecticides, but only affecting mosquitoes above a defined age, could meet the aims of the 
LLA concept, and provide transmission control without strong selection for resistance. We 
also consider the contexts in which the benefits of such products would be maximised.
PA Lynch November 2012
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Figure 4 Anopheles stephensi following infection with Beauveria bassiana fungus. 
Anopheles stephensi, freshly fed (top), and killed by Beauveria bassiana infection 24 hours (middle) or 
40 hours (bottom) previously, showing sporulation. Image provided by the Read Group, Penn State 
University.
Fungal biopesticides already used commercially are under development for use against 
malaria vectors (Figure 4), and their natural development pattern in infected mosquitoes, a 
period of growth prior to the onset of increased mortality, [16-18], makes them candidate 
LLA biopesticides. Multiple strains are potentially available, offering a wide range of 
virulence characteristics in Anopheles. In chapter 4 we characterise fungal virulence using 
a simple, two-parameter function, which we use with the LLA models developed in 
chapter 3 to determine the virulence characteristics which offer the best combinations of 
resistance management and disease control, providing guidance for current and future 
processes of strain selection or modification. We also compare the potential performance 
of fungal biopesticides with that of existing products, and find that, for IRS, they may offer 
better transmission control than some widely used conventional insecticides which, unlike
PA  Lynch November 2012
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fungal spore preparations [19], have high contact irritancy, and repel a proportion of 
mosquitoes before they can receive a fatal dose [20].
Serpins are biologically active protein molecules, found in all higher eukaryotes, as well as 
bacteria and viruses. In insects they control aspects of the immune system, including 
melanisation, and Serpin-2 (SRPN2) regulates melanisation in mosquitoes [21], such that 
melanisation is upregulated when SRPN2 is depleted. This process produces age-related 
changes to the mosquito mortality schedule, and a chemical LLA able to produce the same 
effect as SRPN2 depletion therefore presents as a potential target for development as an 
LLA insecticide. We were approached by the researchers working on SRPN2 and asked to 
assess the LLA potential of such a product, based on experimental data generated using 
SRPN2 depleted mosquitoes (SRPN2KD). In addition to mortality data, the experimental 
results provided information on reduced feeding propensity and fecundity in the 
SRPN2KD mosquitoes. In chapter 5 we explain how we processed the experimental data to 
provide mortality, fecundity and feeding propensity values to parameterise an amended 
version of our LLA model. Our analysis shows that the transmission reductions achievable 
by a product producing SRPN2 depletion are highly dependent on reduced feeding 
propensity. Since mosquitoes which have not blood fed do not produce eggs, reduced 
feeding propensity also directly increases the relative fitness of resistant mosquitoes, so 
that performance with respect to one criterion for a successful LLA insecticide, 
transmission reduction, comes at a direct cost to performance regarding the other criterion, 
low selection for resistance.
Finally we establish the importance of detailed life history parameters by considering an 
area of modelling where they are commonly overlooked. In analyses designed to predict 
the speed of spread of resistance alleles in a population, the conventional wisdom is that 
whilst a dominant resistance allele will spread, and the rate of spread will be substantially 
affected by the relative fitness of susceptible and resistant phenotypes, the speed of spread
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of a single-locus, rare, recessive resistance allele will be negligible, and the effect of 
relative fitness on the speed of spread will not be material. This assumption informs many 
practical resistance management strategies. The standard population genetics model which 
underpins this idea is predicated on a number of assumptions, including the premise that 
generations are discrete, the population comprising a sequential series of cohorts which 
mature, reproduce for a period and die, to be replaced by their offspring. Whilst this 
assumption is valid for many pest life-histories, it is not true for populations like Anopheles 
mosquitoes, in which the breeding population comprises a mixture of newly mature adults 
and surviving older adults of various ages, all of whom contribute to the allele proportions 
in the next generation of offspring. We show numerically that the assumption of discrete 
generations is key to the calculated rate of spread when using the standard model to predict 
the spread of initially rare, recessive resistance alleles. If the standard model is amended to 
incorporate adult survival between periods the calculated rate of spread of rare recessive 
alleles increases, it increases more when greater overlap is assumed, and the relative fitness 
benefits of resistance become increasingly material with increasing overlap. These results 
are consistent with the results generated using our detailed, age-structured mosquito 
population model. Although mathematical comparison of the rates of change with and 
without adult survivorship between generations is rendered somewhat intractable by the 
non-linear, iterative nature of population genetics calculations, in addition to our numeric 
analysis, we have also been able to show mathematically that including overlap will always 
generate a more rapid rate of growth in the proportion of resistance alleles in the 
population if given initial conditions are met.
The evolution of pathogens and disease-vectors in response to health interventions is 
occurring so fast that we can observe it happening; multiple drug resistant bacteria and 
insecticide resistant vectors emphatically remind us that evolution is not merely history, or 
theory. It has huge, immediate, practical implications, and work to understand, anticipate, 
and manage this process has enormous potential benefits. Although the complexity of the
PA Lynch November 2012
Page 24
living world at every level presents a challenge to the modelling process, the essential 
trade-offs at the heart of evolutionary biology are ideal subjects for mathematical 
modelling, and in the following chapters we develop models to answer questions about 
how efforts to combat disease may drive evolution in target organisms, and whether we 
can reduce the probability of undesirable evolutionary outcomes without compromising 
our aims in disease control.
The author has chosen to lift the quality of the prose in this document by including a few 
quotations from great minds of the past. She has additionally chosen to enliven the text 
with one bad limerick of her own. This draws on a long and well established tradition of 
bad verse in science [22-24], and should be considered above reproach.
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“I f  the people do not believe that mathematics is simple, it is only because they do not realize how
complicated life is”
(J. von Neumann)
2 Chapter 2 How might public and animal health interventions drive 
evolution of age at maturity in parasitic nematodes?
2.1 Introduction
Infections by parasitic nematodes have a large impact on the health of humans and 
domestic livestock. Two key life-history traits, fecundity and body size, are important 
determinants of nematode infectiousness and host damage [25,26]. Both are dependent on 
the age at which nematodes mature, since nematodes stop growing at or around maturity 
and begin to reproduce, and since fecundity is correlated to adult body size. A longer 
growth period permits greater size and larger worms can produce more eggs [6,25,27-29]. 
Conversely, a shorter growth period reduces the probability of dying pre-maturity and 
hence failing to reproduce at all. This trade-off means that age at maturity must be subject 
to intense natural selection. Here we ask how widespread health interventions such as 
vaccination and chemotherapy campaigns, which change mortality rates and hence affect 
this trade-off, might alter nematode life history evolution. Most previous work has shown 
that smaller, less fecund worms are the likely outcome [6,30,but see 31,32]. In this chapter 
we show that a variety of evolutionaiy outcomes are possible, some of which are likely to 
result in the evolution of larger and hence more fecund and damaging worms.
Previous theoretical work on the evolution of parasitic nematode life histories has followed 
standard life history theory [33,34] and assumed that mortality schedules are the major 
determinants of selection [6,25,29,35,36]. Where chances of survival are high, nematodes 
should delay maturity to gain the fecundity benefits of large size. However, when chances 
of survival are low, worms should mature early in order to achieve some reproduction 
before death, even if this means they mature at small size and hence have low fecundity.
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Thus, where daily survival rates are high, one might expect a life history like that of 
Ascaris lumbricoides, for example, which reaches up to 30cm in length and produces 25 
million eggs over a lifetime. In contrast, where chances of survival are low, natural 
selection should favour a life history like that of the pin worm, Enterobius vermicularis, 
which has a maximum length of 1 cm and produces no more than 10,000 eggs. A formal 
model of this idea, together with experimental data on survival rates, explains about 50 
percent of the cross-species variation in age to maturity of parasitic nematodes of 
mammals [6].
The aim of animal and human health programmes like chemotherapy and vaccination is to 
increase worm mortality. Thus, nematode life histories could evolve in response to such 
interventions [28,30-32,37]. This evolution may in principle occur in parallel with, or 
instead of, the evolution of drug- or vaccine- resistance. There is no direct evidence yet of 
such evolution, but it has not to our knowledge been looked for [for indirect evidence, see 
28]. Where it has been looked for, in other contexts, life history evolution in response to 
anthropogenic alterations in mortality schedules has been demonstrated. For instance, 
changing size-dependent mortality schedules by size-selective harvesting of populations of 
Atlantic silverside (Menidia menidia) produced rapid evolution of slow growing, smaller 
fish in large-harvested populations and fast-growing, larger fish in small-harvested 
populations [38]. Rapid evolution of life-history traits in response to non-anthropogenic 
environmental change has been observed in Rhabdias pseudosphaerocephala [39] at the 
range-edges of its toad host as it expands its geographic range.
Most previous theoretical work on the evolution of nematode age in response to medical 
and veterinary intervention has suggested that the resulting life history evolution would be 
beneficial from a disease control stand point. The argument is that intervention-induced 
increases in mortality will mean that natural selection will always favour earlier maturation 
and thus result in smaller and less fecund worms [6,30,32]. However, existing formal
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models of this make restrictive assumptions about the nature of nematode mortality 
patterns, in particular assuming that mortality rates are unaffected by age at maturity. Here 
we formally analyse earlier verbal suggestions [6,31,37] that some types of stage- or size- 
specific mortality might generate clinically-detrimental life history evolution.
It seems highly likely that mortality rates will vary with worm size. All else being equal, 
larger nematodes presumably provide more stimulus to the immune system, because they 
will secrete more antigens and have a larger surface area, and may do more damage. 
Alternatively, smaller nematodes may be more vulnerable to immune attack if they are less 
able to withstand damage from a given number of effector molecules. Immunity can also 
differentially affect the survival of different developmental stages of parasites. For 
example, in Strongyloides ratti different mortality rates are observed for larval and adult 
stages which are in different host tissues [40]. The host immune response can also alter 
worm fecundity directly and indirectly via its effects on worm size [41,42] .Here we 
consider the effects of chemotherapy and vaccination allowing for these sort of more 
complex mortality schedules. We also consider the effects both of changes in mortality 
schedules which might be continuous (eg. vaccination or, in the case of farm animals, 
artificially-selected resistant hosts) or those which would be pulsed (e.g. many 
chemotherapeutic regimes used in an agricultural context). We show that optimism 
emerging from previous models maybe misplaced: in some circumstances, health 
interventions may select for increased time to maturity, which would result in larger and 
more fecund worms.
2.2 Models
We consider two types of intervention. The first is where the entire natural lifespan of the 
worms can be expected to fall within a period where the intervention is having an effect, as 
would be the case for immunisation or enhanced resistance by selective breeding; for 
simplicity we consider this under the general heading of 'sustained interventions'. The
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second is where the intervention acts as series of brief, regularly spaced, discrete events 
against the background of the underlying mortality rates, as commonly occurs with 
chemotherapy in an agricultural context, where animals are routinely drenched at particular 
intervals. We refer to this as 'pulsed interventions'. These two situations need to be 
modelled in different ways, so we consider each in turn.
All models assume that worm births are steady over time and the population is in 
equilibrium, hence lifetime reproductive success (measured as lifetime egg production) is 
an appropriate measure of fitness. Anderson and May [43] provide evidence supporting 
this assumption. Analysis of the epidemic situation, where other fitness measures are more 
appropriate, is beyond the scope of this study.
2.3 Size-independent mortality model for sustained interventions
Here we consider the size-independent mortality model (henceforward "SIM" model) 
developed by Gemmil et al. [6], and introduce our new model, which incorporates size- 
dependent mortality (henceforward "SDM" model). We then use these models to study the 
effect of public and animal health interventions on worm life history evolution.
Throughout, symbols are as given in Table 1, and all mortality rates are instantaneous rates 
-  the probability of death at any particular point in time.
The assumptions of the SIM are as follows [6]
1. Worms grow throughout development, but growth ceases at maturity.
2. Per unit time fecundity increases with worm size and hence with maturation time a , 
according to the relationship fecundity = cap .
3. Within the host, parasites experience a constant juvenile mortality rate, M j , until 
maturation.
4. After the onset of reproduction, parasites experience a constant adult mortality rate, 
Ma.
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Table 1: Variables and Parameters for SIM, SDM and SDMP models. 
Note all ages are measured from first infection of the mammalian host.
a age at maturity
<o(a) fitness of worms maturing at a
c constant relating age at maturity to worm fecundity
P exponent of allometric relationship relating age at maturity to 
fecundity
Mf within-host mortality rate for juvenile parasites
Ma within-host mortality rate for adult parasites
m(z) mortality rate experienced by juvenile parasites at age z
d(a) mortality rate experienced by adult parasites which matured at age a
m (a) fitness of worms maturing at a  in hosts experiencing a health 
intervention
Ph allometric exponent relating fecundity to age at maturity in hosts 
experiencing a health intervention acting to reduce rate of increase of 
fecundity with age
fnh(z) mortality rate experienced by juvenile parasites at age z  in hosts 
experiencing a health intervention acting to increase juvenile parasite 
mortality
dh(oc) mortality rate experienced by adult parasites which matured at age a  
in hosts experiencing a health intervention acting to increase adult 
parasite mortality
S h ( a ) Selection gradient at a* under an intervention
The probability of survival to maturation at time a  is derived by treating the occurrence of 
death as a random variable with distribution Poisson( X ) where X is the mortality rate,
M j . Thus, the average lifetime fecundity for individuals maturing at a  is given by
B - M m  1co = caHe 1 ----
M a
( 1 )
The model comprises three elements: cap, the daily fecundity following maturity at a ; 
e~MjCC, the probability of survival to maturity with pre-patent period a ; and — , the life
M a
expectancy post-maturity (assuming survival times are exponentially distributed).
The age at maturity favoured by natural selection, a  *, corresponds to the maximum of 
co ( a ) , at which the derivative co' (a  *) = 0 , namely
(2)
The same result can be derived from an explicitly epidemiological framework. Morand and 
Poulin [36] derived an alternative model for the relationship between parasite mortality
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rate and optimal time to maturity using Ro, the basic reproductive rate, based on explicit 
epidemiology, as follows;
(a°)c PH
Ro
a { ^ + P H ) ^ -  + b + t i^ { b  + Hp)
(3)
giving
* -caa  =
(c a -\)( jiL+b)
(4)
with symbols as in Table 2, equation (4) differs from equation (2). However, we show here
that the two models give an equivalent solution for optimal age to maturity.
The derivation of equation (3) is based on a model by Anderson and May [43],
_ ks^>j3dxd2NA 
(m +Mi)(m2+Pn )
which separates the parasite mortality rate into two components, mortality of parasites 
within a living host, and parasite mortality through host death. The Anderson and May 
model also reflects a period of larval development outside the host prior to infectiousness, 
and a subsequent period of viability in the environment during which infective larvae may 
contact and infect hosts. Morand and Poulin [36] ignore aggregation and implicitly assume 
that all worms are hermaphrodite, so the parameters k, s, and <D in the Anderson and May 
model can be ignored.
Morand and Poulin [36] give the proportion of larvae infecting hosts which ultimately
become adults within the host as —- ----------— . This seems to be replicating theJ_ 1
® ML+ b+ -  
V a.
Anderson and May formula for the proportion of eggs produced which ultimately infect 
hosts, given by the probability of survival to infective stage x life expectancy of infective 
larvae in the environment x per day transmission rate. However, this is not an appropriate 
representation of the process of in-host maturity where the transition from juvenile to adult
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occurs at age a  for all larvae surviving to age a, not randomly at a given rate after age a  
has been reached. In addition, the use of Ma as the rate at which immature parasites 
become mature is inappropriate, since maturation does not happen randomly across all 
ages of immature parasites, but only to the proportion which have survived to age a , and 
this would only be Ma in the case where the in-host mortality rate among immature 
parasites was zero.
Table 2 Equivalence of parameters used in three models, ‘A and M’, from Anderson 
and May [43], ‘M and P’, from Morand and Poulin [36] and SIM, the model of 
Gemmill et al. [6]. ______________________ _______________________________
A and M Parameter Description M and P SIM
k parameter summarising aggregation of 
parasites within host population
not explicitly included n/a
s proportion of females in parasite population not explicitly included n/a
O mating function not explicitly included n/a
p transmission co-efficient between host and infective stages P
n/a
d\ proportion of parasites entering host which 
survive to maturity
not explicitly included n/a
d2 proportion of output transmission stages 
surviving to infective stage
assumed immediately infective n/a
N host density H n/a
M in-host parasite mortality rate arising from host death b part of Mj mdMa
Mi in-host parasite mortality rate arising from other causes immature fXl  
mature JUD
part of Mj 
part of M a
Mi free-living parasite mortality rate Mw n/a
X fecundity / eggs per day X=otc coP
Using the parameters of the Morand and Poulin model, the corrected formula for the 
proportion of immature parasites which survive a period of a  days from arrival in-host to
~(fiL+b)a
reach maturity is £
Incorporating this means that equation (3) becomes
a ac p H  
(,u „ + p H ) { b + n p)
  ct _____ .^(p+nL}a
giving
* caa  =
(b + ML)
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Since (jii+b) is the total mortality rate for immature parasites, equivalent to Mj in the SIM 
model, and ca is equivalent to /? in the SIM model, equations (6) and (2) are equivalent.
2.4 Size-dependent Mortality Model for sustained interventions
We now extend the size-independent model (Equation 1) to include size-dependent 
mortality before and after maturation.
To incorporate size-dependent mortality, we replace assumptions (3) and (4) above with 
the following
5. Pre-maturity mortality rate is determined by size, and so changes during larval 
development. It is given by the function m (z ) , where z is the time (age) from arrival
6. Adult parasites experience constant mortality, determined by the size at which they 
matured, and given by the function d ( a ) .
Since the size-dependent mortality model (SDM) has a mortality rate which varies with 
time, the occurrence of death is a non-homogeneous Poisson process with distribution 
Poisson(m(z)). Thus, the probability that death will not occur before age z is given by
in host.
l -F (z )  = e~M(z>
where
ju(z) -  m(u)du
Jo (z> 0)
Fitness is therefore given by
d(a) (7)
  P -Mjcc 1
which reduces to ^  — c a  e , equation (1), for constant mortality rates m(z)-Mj
a
and d(a) = Ma.
$ $The optimal value, a  , is again determined by the condition o '{ a  ) = 0. Thus,
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or d ( a )
(8)with the additional requirement that, to ensure co (<z) is maximal at a  = a  , the second 
derivative must be negative.
As illustrated in Figure 8, multiple solutions may be possible for some combinations of 
mortality functions so that the theoretical global optimum may not always be the value 
selected for.
2.5 The effects of sustained interventions on optimum time to maturity
With size-dependent mortality, there is no generalised equation for a  analogous to 
equation (2). However, an indication of the immediate direction of selection on age to 
maturity under an intervention can be determined by the sign of the selection gradient, the 
derivative of the fitness function under the intervention, in the vicinity of the pre­
intervention value of a  . This corresponds to the sign of Sh(oc) where
(9)
with one or more of /?/,, dh(a*) and mh(cc) affected by an intervention. When equation (9) 
is positive, the intervention is creating selection pressures that favour worms which grow 
for longer before reproduction; when equation (9) is negative, natural selection favours 
shorter maturation periods. Note that this selection gradient approach applies only in the 
immediate region of the pre-intervention a*. Where multiple solutions are possible the 
overall direction of evolutionary change may be different.
Inspection of equation (9) reveals the following. All else being equal, a health intervention 
which changes the pre-maturity mortality function to rtihiz), with greater mortality for a 
given size (;mh(z)>m(z), for all relevant values of z) will always favour reduced time to 
maturity. This is also true for size-independent mortality (equation (2);[6]). In both cases, 
this is because greater prematurational mortality selects for earlier reproduction, despite the 
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fecundity costs, to ensure that worms survive to reproduce at all. Similarly, an intervention 
which changes the rate of increase of fecundity with size, so that worms are less fecund for
j|t
a given size (i.e. p  to ph such that Ph < p), will make Sh{cc) < 0, so that initial selection 
pressure will always favour a reduced time to maturity. This too is true for size 
independent mortality (equation (2); [6]), and is because the intervention is reducing the 
fecundity gains which accrue through delayed reproduction. Thus, interventions which 
increase juvenile mortality or decrease the rate of increase of fecundity with worm size will 
favour the evolution of an earlier age at maturity which will result in smaller and less 
fecund worms, whether or not mortality rates are size-dependent. These effects are 
illustrated in Figure 5.
Figure 5: Illustration of the effects of interventions which increase juvenile mortality 
or reduce fecundity.
Panels (a) to (c) illustrate the effects on fitness of an intervention which increases the juvenile mortality 
rate from m(z) to mh(z) , and panels (d) to (f) show the effect of an intervention which leaves the 
mortality rates unchanged but reduces the rate at which fecundity increases with age at maturity. In 
both cases the fitness function under the intervention reaches its maximum with a shorter time to 
maturity (a/,*) than that without the intervention (ah). Continuous lines show functions without the 
intervention, dashed lines with the intervention.
Fitness of parasites maturing a t aMortality rates for immature parasites 
a t age z
Mortality rates for adult parasites 
maturing a t age a
a(a)
d(a)
a a
d(a)m(z) a  a *
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Figure 6: Illustration of the effects of interventions increasing the adult mortality rate 
for parasites maturing at age a.
Panels (a) to (c) show an intervention which increases the proportionate rate at which adult mortality 
rate changes with age at maturity, resulting in a reduction in optimum time to maturity. Panels (d) to 
(f) show an intervention which keeps the same rate of increase in mortality rate, so that, with higher 
absolute mortality, there is a reduced proportionate rate of increase and hence an increased optimum 
time to maturity. Panels (g) to (i) show an intervention with reduced rate of increase in mortality rate, 
and also reduced proportionate rate of increase in mortality, as might result if an intervention more 
easily resisted by larger worms outweighed the effects of an immune response more easily evaded by 
smaller worms, giving an increased optimum time to maturity. Continuous lines show functions 
without the intervention, and dashed lines with the intervention.
Fitness for parasites maturing a t aMortality rates for adult parasites 
maturing a t a
Mortality rates for immature parasites 
a t age z
a  (a)
d(a)
o ( tr )
d(a)
«**
< « )
m(z)
An intervention which affects mortality rates of mature worms has more complex effects 
on the optimal age to maturity. Inspection of equation (9) shows that the direction of
d ' ( a )
selection under the intervention depends upon the difference between —, * and
dice J
— ——r , the proportionate rates of change in mortality with size before and after imposing 
dh(<* )
the intervention. This difference depends in turn upon the detail of each function around 
a  . If the difference is positive, then the initial selection pressure under an intervention 
will favour earlier maturing worms (Fig. 6 a-c). If the difference is negative, as is always
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the case if the slope of dh (or) is less than or equal to that of d  (a ), then interventions to 
increase adult mortality will always favour worms which delay maturation (Figure 6 d-f 
and g-i)). If age to maturity does not affect adult mortality, then the slopes of d  (<*) and
dh (or) will be zero, and the adult mortality rate imposes no selection on age to maturity
[6].
To understand how changes in adult mortality can have these contrasting effects on age to 
maturity, it is helpful to consider the situation before the intervention is imposed. At the 
optimum age to maturity, a*, there is the highest possible product from the three 
components of fitness: (i) chance of surviving to maturity, (ii) fecundity and (iii) duration 
of reproduction (adult life expectancy). By definition, worms maturing earlier or later than 
the optimum age will not have maximum fitness, so any associated improvement in one or 
more of the fitness components must be proportionately more than offset by a reduction in 
the other component(s). For example, worms beginning reproduction after the optimum 
age will have a relative fitness benefit from increased fecundity, but this benefit must be 
outweighed by a proportionately greater reduction in the product of their chance of 
surviving to maturity and their duration of reproduction. Now consider an intervention 
which changes adult mortality rates and hence duration of reproduction, whilst the other 
two components of fitness remain unchanged. The proportionate rate of change in the 
duration of reproduction with increasing age to maturity may (i) remain unchanged, (ii) 
increase (adult life expectancy increasing more quickly, or decreasing more slowly with 
size than without the intervention), or (iii) reduce (adult life expectancy increasing more 
slowly or decreasing more rapidly with size than without the intervention). In case (i), the 
proportionate change in fitness costs and benefits for worms maturing before or after a  
will be unchanged and the optimum age at maturity will be unaffected by the intervention. 
In case (ii), worms maturing after a  , will enjoy a greater proportionate improvement in
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reproductive life than was the case with no intervention. Since the other components of
fitness are unchanged, this means that increased fitness will now be achieved by worms
maturing some time after a  , and such worms will be favoured by selection. In case (iii),
the reverse occurs and selection will therefore favour earlier maturing worms.
Figure 7 Illustration of increased adult mortality selecting for higher age at maturity 
In Panel A, graphs show survival, fecundity and life expectancy values for given mortality and 
fecundity functions. In panel B, graphs show survival, fecundity and life expectancy values for 
mortality and fecundity functions reflecting an intervention increasing adult mortality rates. Although 
adult life expectancy with the intervention is lower for all possible values of a, the reduced rate of 
change in adult life expectancy around a* means that selection favours later maturity, exploiting the 
improved combination of survival and fecundity previously offset by reductions in life-expectancy 
values for higher values of a
Adult mortality rate for worms 
maturing at a
Fitness
Adult life expectancy
Survival to maturity
Fecundity x survival to maturity
Fecundity
Adult mortality rate for worms 
maturing at a Fitness with intervention
d{ a)
Adult life expectancy with intervention
Survival to maturity
Fecundity x survival to maturity
Fecundity
As an example, consider parasites evolved to mature at the optimum age in hosts whose 
immune response increases in effectiveness with the size of adult worms. An intervention 
increasing adult mortality for adult worms of all sizes, as might chemotherapy, which had a
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more pronounced effect on smaller worms, or was size-independent, would decrease the
proportionate reduction in life expectancy for later maturing worms, whilst leaving 
unchanged the proportionate increase in fecundity, and reduction in chance of reaching 
maturity. This sort of intervention would favour worms with longer times to maturity as 
illustrated in Figure 7.
There can also be situations in which there are more than one age to maturity associated 
with fitness maxima (Figure 8).
Figure 8: Illustrations of multiple maxima for the fitness function (equation (7)). 
Mortality rates as a function of age for juveniles (left panels) and of age at maturity for adults (middle 
panels) generate the fitness functions shown in the right hand panels. The adult mortality function 
shown could arise if, for example, bigger worms are harder to kill and smaller worms are harder to 
detect. For (c), multiple local optima are found, with the global optimum falling on the later peak at a2. 
In (<e), there are also multiple local optima, but the global optimum falls at au on the first peak. In this 
case, in the absence of lower limits on the time needed to physically achieve maturity, selection would 
favour maturity at «i. If minimum achievable time to maturity is between a\ and /i, selection will 
favour maturity at the minimum achievable age, and if the minimum achievable time to maturity is 
greater than tu then selection will favour maturity at a2.
Fitness of parasites maturing a t aMortality rates for immature parasites 
a t age z
Mortality rates for adult parasites 
maturing a t age a
[(a)
{d)
The situation is further complicated because the direction of initial selection pressure as 
given by the sign of equation (9) need not indicate the overall direction of selection in 
cases where multiple local optima exist for the fitness function under an intervention, 
coh ( a ) . In such cases, one of which is illustrated in Figure 9, the slope of coh (er) close to
the original a  may not correspond to the change in a  required to give the maximum
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achievable fitness. Outcomes in such cases will be unpredictable, depending upon specifics 
of starting conditions and the details of the functions involved.
Figure 9: Illustration of the effects of an intervention changing adult mortality in an 
example with multiple optima for the fitness function.
Panel (a) shows the assumed pre-maturity mortality function, panel (b) shows the assumed post 
maturity mortality functions with and without intervention, and panel (c) shows the fitness functions 
with and without the intervention. The slope of the post maturity mortality function under the 
intervention is always less than or equal to that without the intervention, so initial selection pressure 
will favour increased time to maturity. However, the overall optimum now falls on a different peak of 
the fitness function and selection will in fact favour a lower value of a. Continuous lines show functions 
without the intervention, and dashed lines with the intervention.
Fitness for parasites maturing at aMortality rates for adult parasites 
maturing at age a
Mortality rates for immature parasites at 
age*
m(z)
d(a) <**(«)
2.6 Size-Dependent mortality function with pulsed interventions
In this section, we develop a model to study the effect of size-dependent mortality when 
there are pulsed interventions like regular drenching of farm animals with antihelminthics 
(henceforward “SDMP” model).
Drug treatments can arise as brief periodic events rather than on-going changes to 
mortality functions or fecundity parameters. Vaccine boosts (and some natural immunity 
processes) conceivably could do the same thing. The following assumptions and revised 
equations incorporate pulsed interventions, or interventions conferring transient changes in 
mortality, within the SDM model
7 Dosing is periodic at a fixed interval, I .
8 Parasites are assumed to infect hosts randomly at a constant rate, and are thus 
equally likely to arrive in host at any time point during the interval between dosing 
events.
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9 The proportion of parasites experiencing a second dose is assumed to be zero or 
very small for convenience of analysis (parameter values must be consistent with this 
assumption).
10 The effect of the intervention on any given parasite is assumed to vary only 
according to whether the parasite is immature or adult, irrespective of size or age.
11 Between dosing events, mortality rates are in accordance with those given by m (z)
and d  (a  ).
Table 3: Variables and Parameters for SDMP model. Note all ages are measured from first 
infection of the mammalian host.
a age at maturity
c constant relating age at maturity to worm fecundity
p exponent of allometric relationship relating age at maturity to 
fecundity
7w(z) mortality rate experienced by juvenile parasites at age z
d (or) mortality rate experienced by adult parasites which matured at age a
sr (“ ') Selection gradient at a* under pulsed dosing
i time interval between doses; (I > a)
H proportion of hosts dosed during dosing events
Dj probability of juvenile parasites dying if in dosed host
A, probability of adult worms dying if in dosed host
t time from start of interval between dosing events ( 0 < t < I)
a>p {a) overall average fitness of parasites maturing at age a  under pulsed 
dosing
Worms infecting a host during interval I  can be divided into the following four groups.
A Worms which die before the dosing event, without reaching maturity. These 
worms have zero fitness and thus do not contribute to the overall fitness function.
B Worms which die before the dosing event, having reached maturity. These have 
fitness in accordance with the assumptions of the SDM model, but the post-maturity life 
expectancy must be the average for worms dying before I , not the overall post-maturity 
life expectancy. Fitness for worms in this category, arriving in the host at time t, is 
modelled by function /  (t).
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Figure 10 Illustrative timeline for worms in category A
Worms arrive in-host at time /, between /=0 and t=I, and then die between time t and t + a, before 
reaching maturity
71
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t = 0
arrive in host a t time t
t = i
die before time t+ a
21
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21
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71
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Figure 11: Illustrative timeline for worms in category B
Worms arrive in-host at time t, between t = 0 and t = I -  a, mature at time t + a, and die before time /.
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C Worms which survive until the dosing event, and are mature at the time of the 
dosing event. These worms will reproduce from maturity to age I  - t , and then will either 
die in the dosing event, or will survive the dosing event and subsequently die according to 
the post-maturity mortality function. Fitness for worms in this category, arriving in the host 
at time t , is modelled by function g  (t) .
D Worms which survive until the dosing event and are immature at the time of the 
dosing event. These worms will either die in the dosing event before reproducing, or will 
survive to mature and reproduce in accordance with the SIM and SDM models. Fitness for 
worms in this category arriving in the host at time t , is modelled by function h ( t ) .
Figure 12: Illustrative timeline for worms in category C
Worms arrive in-host at time t, between t = 0 and t = I -  a, mature at time t + a ,  and survive to t = I
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Figure 13 :Illustrative timeline for worms in category D
Worms arrive in-host at time t, between t - 1 -  a and t = / ,  and survive to mature at time t + a .
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Thus, for worms in category B, for 0 <t  < ( l - a )  we have 
f ( t ) = probability of survival from t to t + a
x (1 - probability of survival from t + a  to I  )
x average life expectancy for worms dying between t + a  and I
x fecundity for worms maturing at age a
The average life expectancy post maturity for worms bom at time t which survive to time 
t + a  and die before time I , can be calculated from the definite integral on age q ,
measured from maturity, from 0 to ( i  — t - a )  of the proportion of such worms surviving
to age q less the proportion which will survive to I .
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Thus the average life expectancy post maturity, for worms bom at time t which die 
between t + a  and I  is
  -------- ( f e-dMqd q - ( 1 - t - ) = — ___ (7 1 ° ^ e ^
So
daily rate o f egg-production for w orm s  
maturing at a
f ( t )  4caje~^aM 1-e - d ( a ) ( I - a - 1
yd(a)
probability of surviving 
to maturity
a v era g e  life exp ectan cy  of w orm s dying 
betw een  a g e  a  and a g e  (/ - 1)
probability of not surviving from maturity 
to dosing event 0 < t  < (I -  a)
For worms in category C, we obtain, for 0 < t< ( j - a )
g  (7) = probability of survival from t to I
x ( (probability in undosed host + probability in dosed host but
survives)
X (average life expectancy from I  ) + I - a - t  )
x fecundity for worms maturing at age a
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giving
reproductive days pre dosing 
eventdaily rate of egg-production for 
worms maturing at a
probability in dosed host but 
survives dosing event
l - H M H  l - D
g(t) 4ca^-Kah'd(aXI-a-,)
probability of surviving to 
maturity probability host not dosed during dosing 
event
probability of surviving from maturity to 
dosing event
life expectancy of adult worms from dosing event
0 < t < ( J - a )
For worms in category D we find, with ( /  - a ) < t  <1 
h (t) = probability of survival from t to a
x (probability in undosed host + probability in dosed host but survives)
x average life expectancy from a
x fecundity for worms maturing at age a
which yields
daily rate of egg-production for worm s probability in d o sed  host but
maturing at a survives dosing event
h(t) =\ca
probability of surviving to
I
maturity
life expectan cy  of adult worm s from maturity
probability host not d osed  during dosing  
event
(I - a ) < t < I
The definite integrals of these functions over the relevant ranges for t give the following;
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f{t)dt = CaJ ^ 2 ' {{d{a)(I - a )  + 2)e-d^ - a) -  2 + d(a)(I -  a))c a ^ e ^
Jo " S ( t ) d t
f h(t)dt -
J I - a
d{a)
_ cape » ia) 
d{cc)2 
cafi+le~M(a)
( (2 - H D , > + ( d < a X a - I >  + I t D , - 2) <f )
(1 -HD,)
d(a)
These functions are then combined to give the average fitness for worms in all categories 
arriving at time t
c a ^ e - ^ i l - E D j j }  
d(a) /
rdictyl-a)
+
This can be rearranged to give
cerep  n- iAa ) (con (a)  = -----——
M '  d ( a )
1 H
V V
1 _ £-^ («)(7-«) 
d (or)
+ orD.
dj
(10)
In order to find the optimum value of or under the pulsed intervention, or*, we require
co' (or*) = 0 , which, since cav e K“p) is non-zero, is equivalent to
d{ap)
P d { a p) , . .
*p d \a p)
1 + *  
/
V
D \ e - d(ap)( l -ap)
d{ap) a PDj
J)
H  + — 
I
r  '  (  
D  ~d{a'p )(7-^)
v v
1 , d ' i a 'p) 
d « ) d \ap)
\ \
+
JJ
d '(a 'p)
d (a 'p f
-D ,
J /
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(11)
From this equation it can be seen that, in addition to the detail of the underlying mortality 
functions m (z) and d ( a ) , all the parameters associated with the pulsed intervention, the
effectiveness of the treatment [Dm, D}), the proportion of the host population treated (H  )
and the interval between doses ( / ) ,  have the potential to affect the evolution of time to 
maturity.
As for the SDM model, it is not possible to derive an explicit solution for ap for the
SDMP model. However, again, the direction of the slope of the fitness function at a  , the 
optimum value of a  without the intervention, will give the direction of the initial selection 
pressure acting on time to maturity under the intervention. Since, from equation (8),
d\ a ) and since — >o> the sign of the selection gradient at a  corresponds
a  d { a ) /
to the sign of sp( a ) , where
r r
e - d ( a ) ( I - a ) , d ' ( a ) (  . T 11 + - / - a  - 1 -
d{a ) d(a  )
d'(a*)
d(a*)2 -D ,
(12)
It is clear that the sign of sp( a )  will depend upon the detail of the mortality functions and 
the parameters of the pulsed intervention and hence that selection pressure may favour 
increased or decreased a  according to the specifics of m (z) and d (or), and the values for
the intervention parameters, Dj , Dm and I . Given this, it is also clear that increasing the 
pre-maturity mortality Dj will always act to reduce the strength of selection for increased 
time to maturity when sp (#*) > 0 , and to increase the strength of selection for reduced 
time to maturity when sp («*) < 0 .
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Figure 14: Illustration of the effects of values for dosing parameters on optimum time 
to maturity.
From a given set of starting values, the direction of initial selection, towards longer or shorter time to 
maturity can be changed by adjusting any of the three parameters, dosing interval, / ,  treatment 
mortality in immature parasites, Dj, and in mature parasites, Dm. Simple linear functions are assumed 
for m(z) and d(a), with negative slope for d(a). Continuous lines show the fitness function without 
intervention, o(a), dashed lines show the fitness function under pulsed intervention, cop(a).
a (a)
Reduce D Increase A
Fitness for parasites maturing at a
Increase I
For example, Figure 14 illustrates that the optimum age to maturity under a pulsed 
intervention may be either longer or shorter than that without intervention, depending upon 
the relative and absolute values of the parameters Dj , Dm and I . Thus, within a given
range of values for any two of these parameters, the direction of initial selection can be 
determined by the value of the third parameter. For instance, within a suitable range of
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values for /  and Dm, changing the parameter Dj alone can change the direction of initial
selection pressure. In each case, a limit may exist beyond which given values for one or 
more of these parameters fixes the direction of initial selection irrespective of the value of 
the others.
The proportion of hosts dosed, H , does not influence the direction of initial selection 
pressure. However, it does help to determine the size of the change from a  to a *p, and
can contribute to the overall direction of selection pressure in cases with multiple solutions 
as illustrated in Figure 15, where increasing H  for a particular intervention produces very 
small changes in the values of a  at which the peaks of the fitness function fall, but 
ultimately causes the optimum value of or to move from the second to the first peak. In 
practice, the outcome of such a change would depend inter alia upon there being sufficient 
variation in a  within the parasite population to allow the transition between the two optima, 
given that most intervening values of a  would be selected against.
Figure 15: Effect of H, proportion hosts dosed, on selection for time to maturity.
In this example with multiple optima for the fitness function, although the selection gradient around 
a* is positive and initial selection favours slightly increased time to maturity, sufficiently increasing the 
value of H  moves the global optimum to the earlier peak, giving overall selection in favour of a reduced 
time to maturity.
Fitness for parasites maturing at a
•a
a
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2.7 Discussion
Nematode life history traits respond readily to selection [e.g. 39,44]. Consequently, animal 
and human health programmes which alter nematode mortality schedules (almost always 
the aim of such programmes) can drive life history evolution. For nematode age at 
maturity, a key life history trait with important fitness consequences, we find that the 
resulting evolution could have variable outcomes. In some cases selection for earlier 
maturity, giving smaller, less fecund worms, is potentially clinically beneficial. In some 
cases however, selection may favour later maturity giving larger worms producing more 
eggs with potentially clinically detrimental outcomes.
The models developed here show that when adult mortality rate changes with parasite size, 
both adult and juvenile mortality rates influence the evolution of age at maturity. Critically, 
and unlike juvenile mortality, the effect of adult mortality on optimal age to maturity is not 
unidirectional. Analysis of equations (8), and (9) shows that enhanced adult mortality can 
select for earlier or later age to maturity. Thus it is possible for animal or public health 
interventions like immunisation programmes or widespread chemotherapy to promote 
either smaller less fecund worms or larger more fecund worms.
Which of these possible outcomes occurs depends upon the biology of the parasite, the 
biology of the interactions between parasite and host immune system, and on the specifics 
of the health intervention applied. Predicting the outcome for any particular case requires 
knowledge of the pre- and post-maturity mortality functions, with and without the 
intervention. These are currently not known for any worm, and indeed, they would be 
difficult to determine even where direct experimentation is possible. Furthermore, for 
pulsed interventions, the interval between doses, the proportion of hosts dosed, and 
juvenile and adult parasite mortality rates resulting from the treatment all also help to 
determine whether selection will favour earlier or later maturing worms under the 
intervention. There are no simple generalities and indeed, given current levels of
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understanding, it is not even easy to speculate on which evolutionary outcomes are more 
likely.
Nonetheless, since human interventions which change mortality schedules will exert 
selection pressure, we cannot simply ignore this issue. In many cases, the resulting 
evolution in life history traits will have little clinical significance, or will result in 
improved animal or public health outcomes. However, where, for example, the larval stage 
is much more pathogenic than the adult parasite, prolonging the time taken to reach 
adulthood may have undesirable clinical consequences. In such instances it would be 
important to take account of whether a given intervention strategy might be expected to 
select for a longer duration of larval stage, and plan accordingly.
In some instances, it may even be possible to avoid undesirable evolution. Often the 
selection pressures imposed by an intervention cannot be readily adjusted as, for example, 
with vaccine-induced immunity, although even here, the likely effects of stage or tissue- 
specific immunity could be investigated where there are several vaccine candidates being 
evaluated. However, for pulsed interventions, some elements, such as the time interval 
between doses, can readily be adjusted. Where such control is possible, rather than simply 
ameliorating selection for unwanted changes, it might be possible to specify an 
intervention to intentionally exert selection pressure in favour of a desirable change.
Detailed models developed to analyse specific cases could extend our models in a number 
of ways. For example, contrary to our assumption 11, worms which survive a dosing event 
may be damaged in some way and experience higher mortality rates, or have lower 
fecundity, than would otherwise be the case. This and other circumstances, such as 
seasonal life-cycles and dosing patterns might mean that worms are more likely to enter 
hosts early or late in the dosing cycle, contrary to our assumption 8. Certain combinations 
of dosing strategy and life-history may mean that a significant proportion of worms survive 
more than one dosing event, violating our assumption 9. Alternatively, density effects may 
mean that worms surviving a dosing event, or arriving in a host shortly after a dosing
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event, may experience lower mortality or higher fecundity than would otherwise be the 
case. We doubt that such complexities would alter our general conclusion that some 
interventions can select for clinically-detrimental worm evolution, but they might 
nonetheless be important considerations for evaluating the magnitude and direction of such 
selection pressure in particular cases.
The relationship between mortality rate and age at maturity suggests that in an 
environment where mortality rate showed variation, as would be expected within a normal 
host population, there would be benefits to the parasite in adjusting the age of maturity 
according to the mortality rate actually experienced or predicted in its individual host, 
provided the benefits of such flexibility outweighed the costs of achieving it. Such 
flexibility has been demonstrated experimentally for at least three nematode species 
[45,46]. For example, Litomosoides sigmodontis size and reproductive strategy varies 
according to host immune response [46]. This may provide a means of testing our 
conclusions, by examining whether the changes flexibly adopted by worms under different 
mortality schedules, a system which should have evolved to maximise worm fitness, are 
consistent with the responses predicted by our models.
2.8 Conclusions
Interventions like chemotherapy, vaccination and, in the case of animal diseases, enhanced 
host resistance through selective breeding could affect many of the key functions and 
variables which shape the selection pressures on nematode age to maturity. Where 
mortality rates vary with worm size, we find that selection can be influenced by 
interventions changing either juvenile or adult mortality rates, and that, whilst changes to 
either can exert selection favouring earlier maturity, changes in adult mortality rates could 
also select for later maturing worms. This is in contrast to previous finding indicating that 
only interventions which increase juvenile mortality rates could drive selection on age at 
maturity, and only to produce earlier maturity.
Page 53
PA Lynch November 2012
For intermittent interventions, the timing of treatments, the proportion of hosts treated and 
the proportion of parasites killed in treated hosts can all influence selection on age at 
maturity. This opens the possibility of structuring dosing regimes to actively exert 
selection for clinically beneficial changes to age at maturity.
The clinical effects of extending or reducing the time taken for worms to mature, and 
hence increasing or reducing their adult size and fecundity, depend upon the specifics of 
parasite life-history within the host. Whether selection favours earlier or later age at 
maturity depends critically on the details of the parasite mortality functions with and 
without the intervention. Earlier optimism that health interventions would always prompt 
the evolution of smaller, less fecund and hence potentially clinically less damaging worms 
is premature. The detail matters, and our work suggests that when planning and 
implementing large-scale anti-helminth public health programs, the possible evolutionary 
consequences, beyond simple resistance, should be carefully considered.
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For ease o f notation we must simplify, 
the mossie's a sphere that is able to fly, 
now assume a VC, 
set to infinity, 
and a cycle-length equal to pi.
3 Chapter 3 Modelling Novel Public Health Interventions for Malaria 
Vectors
3.1 Introduction
The reductions in global malaria burdens achieved by chemical insecticides against adult 
mosquitoes could be eroded by insecticide resistant mosquitoes [7,11-15,47], just as they 
were last century [48]. In principle, the evolution of insecticide resistance could be 
considerably slowed and perhaps prevented altogether by vector control aimed at killing 
only older mosquitoes (so-called ‘late-life action’, hereafter LLA) [49,50]). This exploits 
two features of the life histories of Plasmodium, the organism which causes malaria, and 
the mosquito vectors of the disease. Plasmodium parasites in a mosquito host take at least 
nine days to develop to a stage which can be transmitted to a human via an infectious bite, 
thus only older mosquitoes need to be removed to prevent disease transmission. Since 
mortality in wild mosquito populations is high, the majority of eggs are produced by young 
mosquitoes, so killing only older mosquitoes will have a relatively low impact on mosquito 
fitness, affecting the reproductive success only of the relatively few mosquitoes which 
survive to old age. Thus, a vector control treatment which kills only older mosquitoes 
could dramatically reduce transmission while exerting only weak selection for resistance 
(Figure 16).
We need to assess whether a balance is possible between useful transmission control and 
low selection for resistance and for this purpose we require a model which captures the 
detailed timings and probabilities of infection, infectiousness, reproduction and mortality 
over the mosquito lifespan. In order to encompass these elements, we have developed a 
model with two separate components, a markovian, deterministic, feeding
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cycle model (FCM) which calculates survival, egg laying and infectious bite values for 
sequential age classes during the lifetime of an adult mosquito, and a population model 
(PM) which tracks the population-level spread of resistance alleles and corresponding loss 
of transmission control.
Figure 16 Mosquito average lifetime egg production and infectious bites by age class 
A verage egg production and infectious bites from m osquitoes in age classes defined by gonotrophic 
cycle (C l , C2... CIO) , expressed as percentages o f total lifetim e values. Values calculated using FCM.
Average lifetime egg production and infectious bites
99% 100%
100%
C1 C2 C3 C4 C5 C6 C7 C8 C9 C10
B % total egg production 
B % total infectious bites
□ cumulate % egg prod.
□ cumulative % total inf.bites
We consider three types of health intervention, two kinds of LLA and a conventional 
instant-kill insecticide (CIKI). The LLAs either act as instant-kill insecticides which affect 
only mosquitoes above a given age (age-dependant insecticides, ADI), or time-delay 
insecticides (TDI), which kill according to a mortality schedule defined with respect to 
elapsed time from a mosquito’s first contact with the insecticide. TDIs may have simple 
mortality schedules comprising a delay of a fixed number of gonotrophic cycles until 
death, or more complex variable mortality schedules, such as might be generated by 
biopesticides (see chapters 4 and 5).
The model described below allows all interventions to be assessed assuming that 
mosquitoes contact them immediately following a blood meal from a human host. This 
would be consistent, for example, with indoor residual spraying (IRS), mosquitoes being
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exposed to the intervention when resting on treated internal surfaces after feeding. CIKIs 
and ADIs can also be evaluated assuming a method of application which exposes feeding 
mosquitoes to the insecticide prior to biting, consistent with delivery via treated bed nets 
(ITNs). For TDIs, since they are always assumed to have some delay between contact and 
mortality, there is no difference, from the modelling perspective, between contact assumed 
before or after biting.
3.2 The Feeding Cycle Model
The FCM calculates survival, egg laying and infectious bite values across a series of 
discrete adult age classes for a specified type of mosquito (eg. susceptible) subjected to a 
given intervention (eg. a particular LLA insecticide at a particular coverage). Each 
sequential age class is defined as lasting for the average length of one gonotrophic cycle. 
Use of the mosquito feeding cycle as the basis for age-structured analyses of mosquito 
populations is a well-established methodology [51-54].
The FCM tracks possible states and transitions through each age class (/), applying 
survival, exposure and infection probabilities (Figure 17). State changes depend on the 
preceding state, the passage of time, mortality rates and the probabilities of certain events, 
such as contacting an insecticide when resting after a human blood meal. Infection status 
for malaria, (m), or a TDI, (/), is zero for no infection, otherwise equal to the age of the 
infection.
The non-mathematical description of the model, incorporating both TDIs and ADIs, is as 
follows. Female mosquitoes are followed from successful emergence through ten 
gonotrophic cycles. In each cycle the probabilities of survival are tracked through the 
processes of host seeking, feeding, resting, finding an oviposition site and laying. For each 
cycle, the proportion of mosquitoes which acquire a malaria infection, contact a TDI, bite 
whilst infectious for malaria, and successfully lay eggs is also recorded. Specifically, the 
mosquito may die whilst searching for a host, with a probability arising from the time spent
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searching, the background mortality rate, and any incremental mortality from a previously 
contacted TDI. If she survives searching, she then attempts to feed on a human with a 
given probability, and on a non-human with one minus that probability. She may die whilst 
attacking the host immediately before or immediately after feeding, with probabilities 
calculated from the underlying risk of death when attacking a host, and the probability of 
encountering an insecticide (CIKI or ADI) which kills on contact. Of those which 
successfully feed on a human host, females carrying a mature malaria infection give an 
infectious bite, whilst those so far uninfected may become infected, with a fixed 
probability. Those which survive feeding have a fixed probability of contacting a TDI, 
after which death may occur during resting with a probability calculated from the time 
spent resting, the background mortality rate, and any previous TDI exposure. Those 
surviving resting may die whilst searching for an egg-laying site, again depending on time 
and relevant mortality rates, and survivors may then die whilst attempting to lay, either 
before or after laying, with fixed probabilities. The tracked values give the proportion of 
mosquitoes surviving, biting and laying in each cycle and the proportion of mosquitoes 
starting each cycle with each possible combination of malaria and TDI status. This 
methodology is summarised in Figure 17. For example, for a case analysing the effects of a 
TDI, a mosquito commencing its fourth cycle with an infectious, three-cycle old malaria 
infection, and no previous exposure to an insecticide, will spend a defined period of time 
searching for a host, with an associated probability of dying from background mortality 
while it does so. It will then attack a host, with a given probability that the selected host 
will be a non-infectious human, a malaria-infectious human, or non-human, and a given 
probability of being killed whilst attacking the host before biting. If it survives to bite, and 
if the host is human, this is recorded as an infectious bite. There is then a given probability 
that it is killed by the host after biting. If it is not killed, it begins a period of resting, 
during which, if the chosen host was human, it has a fixed probability of being exposed to 
a TDI, as well as a given probability of dying from background mortality before leaving to
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search for a laying site. During the search for a laying site there is a given probability that 
the mosquito may die from background mortality, or from the effects of its newly acquired 
contamination with the TDI. If it survives searching for a laying site it may die before or 
after laying with given probabilities. If still alive at the end of the cycle, it begins its fifth 
cycle with an infectious four-cycle old malaria infection, and a one-cycle old TDI 
exposure. For a case analysing the effects of an ADI or CIKI, the analysis would include a 
probability of contacting the pesticide before or after biting the host, and a probability of 
death, assumed to be instant, resulting from that contact, with zero probability of 
contacting a TDI.
The probability that a mosquito contacts and is affected (killed or infected) by a 
conventional or biological insecticide is input as a single ‘coverage’ value, incorporating 
the probabilities of being in a treated property, of contacting the pesticide, and of being 
affected by the pesticide during contact, with an appropriate adjustment for ADIs contacted 
by mosquitoes below the age at which the ADI becomes effective.
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Figure 17: FCM model structure for one feeding cycle.
Calculation of possible outcomes for feeding cycle i+1 of the model, assuming status when commencing 
cycle i+1 is age = /, malaria status = TDI status = /,, with /o=0 and m0=0. Each arrow represents a 
probability calculated by the model. If the malaria infection status (number of cycles since infection) 
of a mosquito when biting is greater than the development time of the malaria parasite in the 
mosquito, then ‘bites host’ after attacking a human host is recorded as an infectious bite.
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3.2.1 Assumptions
All model parameters are age-independent, apart from background mortality and the action 
of age-dependent pesticides. Incremental mortality from TDIs varies according to the 
number of days since acquisition of the TDI. Conventional and age-dependent insecticides 
affecting a susceptible individual are assumed to be instantly fatal. Mosquitoes choose 
human hosts at random, and the model does not capture feedback between numbers of 
infectious bites and the proportion of human hosts with infectious malaria, which is 
assumed to be constant through time for all interventions. Plasmodium infected mosquitoes 
never become uninfected. All feeding cycles are of equal duration and mosquitoes bite 
once in each cycle. The analysis assumes that malaria infection produces no effects on
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behaviour, background mortality or fecundity in infected mosquitoes, and mosquitoes 
which survive and lay eggs whilst carrying a TDI are assumed to lay as many eggs at each 
laying event as uninfected individuals.
Late-life acting (LLA) insecticides might have many patterns of effectiveness. They could, 
for example, kill on contact, but affect only mosquitoes above a certain age. They might 
contaminate mosquitoes on contact and kill later, either after a fixed period of time, 
according to given mortality schedule, or when a contaminated mosquito reaches a certain 
age. Alternatively a contaminating LLA might have no effect until multiple doses have 
been acquired. Combinations of these modes might also be possible, for example, a 
contaminant LLA killing only mosquitoes above a certain age might require a development 
period after contamination before it causes mortality. For modelling purposes we consider 
a simplified sub-set of possible LLA modes of action: (i) killing on contact only 
mosquitoes above a certain age, e.g. a 4-cycle ADI kills only mosquitoes which contact it 
after having been through four or more cycles; (ii) killing a fixed number of cycles after 
contact, eg. a 4 cycle TDI kills mosquitoes four cycles after initial contact; (iii) killing 
according to a detailed mortality schedule from time of infection, as might be the case for a 
biopesticide. With a pre-bite delivery system, (i) and (ii) are equivalent if the TDI delay is 
equal to the ADI effective age (see Box 1).
PA Lynch November 2012
Page 61
Box 1 Comparison of time-delay and age-dependant LLA insecticides
Time-dependent insecticides and age-dependent insecticides have equivalent 
effects on disease transmission and resistance evolution when ADI contact with 
the insecticide is assumed to occur pre-bite. Comparisons are made with 
mortality occurring 4 cycles after contact (TDI) or in mosquitoes aged 4 cycles 
or older (ADI).
Comparison of m ortality arising from Age-Linked f ALII and Time Delav tTDIl Insecticides
Both at 80% exposure levels, with mortality 4 cycles after contact (TDI) or in mosquitoes aged 4 cycles or older (ALI)
cycle number
1 C l 1 C2 I C3 C4 I C5 I C6 1 C7 I C8 I C9 1 CIO
Time Delav Treatm ent
No m ortality from 
treatm ent, no mosquitoes 
carrying TDI for 4 cycles
Of the mosquitoes Of the mosquitoes 
surviving to cycle 4, surviving to cycle 5,
80% were exposed to 80% were exposed to an(j so on 
TDI in cycle 1, and TDI in cycle 2, and 
will now die as a will now die as a 
result result
Mortality in cycle from LLA 0.0% 0.0% 0.0% 80% 80% 80% 80% 80% 80% 80%
Age-Linked T reatm ent
No m ortality from 
treatm ent, no mosquitoes 
4 cycles or older
Of the mosquitoes Of the mosquitoes 
surviving to cycle 4, surviving to cycle 5,
80% are now exposed 80% are now exposed
to ADI, of which all to ADI, of which all al,d so on.....
are 4 cycles of age or are 4 cycles of age or 
older, and will die as older, and will die as 
a result a result
Mortality in cycle from LLA 0.0% 0.0% 0.0% 80% 80% 80% 80% 80% 80% 80%
3.2.2 Feeding Cycle Model detail
Both CIKI and LLA pesticides offer public health benefits by reducing the numbers of 
mosquitoes that survive to give infectious bites in a treated population. Clearly the extent 
to which a reduction in infectious bites maps to reduced transmission and reduced numbers 
or severity of malaria cases in a human host population involves many complex, context- 
specific factors. For comparative purposes, however, it is assumed that in a given context, 
a given reduction in infectious bites will generate the same reduction in malaria 
transmission and hence malaria-induced morbidity and mortality, irrespective of the type 
of intervention from which it results. For generality, therefore, the comparative public 
health benefits of the insecticides considered in this analysis are all evaluated based on the 
reduction in infectious bites which they provide. This is quantified in the FCM for a given 
mosquito phenotype subject to a specific intervention by calculating RAIB, the 
proportionate reduction in the average number of infectious bites per mosquito per lifetime 
(AIB), defined as
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A , AIB with treatment RAIB = 1--
AIB without treatment
Assuming that the rate at which newly maturing adults join a population is constant 
through time, and that the size of the human host population is unaffected by the 
intervention being assessed, RAIB is equal to the proportionate reduction in the 
entomological inoculation rate (EIR), the number of infectious bites experienced per 
person per unit of time.
To evaluate mosquito fitness we use the average number of eggs produced per mosquito 
per lifetime as a proxy for lifetime reproductive success (LRS). The selection coefficient, 
the proportionate fitness benefit of resistance to a given intervention, is calculated as
Selection Coefficient = 1 f°r specified mosquito type with intervention
LRS for susceptible mosquitoes without intervention 
A selection coefficient of zero means no selection pressure in favour of resistance, with 
higher selection coefficients indicating increasingly strong selection for resistance. Where 
no cost of resistance is assumed, the LRS for resistant mosquitoes is assumed to equal that 
for susceptible mosquitoes in the absence of any intervention.
Formulating these key results in relative terms minimises the sensitivity of our conclusions 
to parameter values which are independent of the vector control treatment or mosquito 
phenotype being evaluated.
With variables as defined in Table 4 the average number of eggs laid in a given cycle by 
mosquitoes surviving to the start of that cycle, Fu is calculated as
< l-l M  >\
^ 'j ^  1 f i , m , l  
7 7  \ m = 0  1=0 J
F'= r,------
This provides the basis for the evaluation of relative fitness using a comparison of values
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A,
(o =  V  F.V.for (p, lifetime egg production, representing LRS, * / i .
/=1
Comparative levels of disease control are assessed using u , the average number of
infectious bites per mosquito lifetime
/=!
The average number of infectious bites in a given cycle per mosquito alive at the start of 
the cycle, 7; , is calculated as 
/-I  i - \
^  j ^  j tfi,m ,l,3^i,m ,l
T _  m=D 1=0______________________________
K
i> D
(13)
The average probability of survival from start of cycle i to start of cycle (i+ 1) is with
f  i—1 /—I A
s .  j v . j/  j /  j 1,171,1 i,m,l
  \m = 0  1=0 J
V:
(14)
Table 4: Feeding Cycle Model parameters and variables
Variable or Parameter
Sy
m
bo
l
Comments and 
Constraints
Time, measured in whole units equal to average length of sporogonic cycle, 
from infection of mosquito by malaria to cycle from which mosquito gives 
infectious bites
D input 
0 < D
Number of age classes included in analysis X
Cycle number (identifies specific cycle in the X cycles over which probabilities 
are tracked in the FCM)
i 0< i <X
Malaria status, the number of whole or partial cycles since infection with 
malaria
m 0< m <X 
m = 0 means not 
infected
TDI status, the number of whole or partial cycles since being exposed to and 
acquiring a TDI
I 0 <1<X 
1 = 0 means not 
contaminated
Average number of eggs laid in cycle i by mosquitoes surviving to the start of 
cycle i
Fi
Average lifetime number of eggs laid per mosquito
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Variable or Parameter
Sy
m
bo
l
Comments and 
Constraints
Average number of eggs laid in cycle i, by mosquitoes starting cycle i with 
malaria status m and TDI status /
fi,m,l m<i l<i
Average probability of survival from start of cycle i to start of cycle i+1 S i
Average probability that a mosquito starting cycle i with malaria status m and 
TDI status /, will survive to start of cycle /+1
Si,m,l m<i l<i
Average probability of a mosquito being alive at start of cycle i. Vi
Average probability of a mosquito being alive, with malaria status m and TDI 
status /, at start of period i.
Vi,m,l m<i l<i
Probability that a mosquito alive at start of cycle i with malaria status m and 
TDI status /, survives and bites host type h in cycle i
Qi,m,l,h m<i l<i
Type of host attacked h h= 1, non-human 
h=2, non- 
infectious human 
h=3, infectious 
human
Average number of infectious bites in cycle i per mosquito alive at the start of 
cycle i
It
Average lifetime number of infectious bites per mosquito u
Base instantaneous mortality rate per day for mosquito age /, during activity B rB.i input
Length of gonotrophic cycle (days) w input
Time spent host searching and feeding during a cycle (days) b input
Time spent finding oviposition site and laying during a cycle (days) d> input
Length of resting period (days) n input
Proportion human population infectious for malaria p input
Probability attacks non-human host H input
Probability killed when attacking host before biting, with malaria infection 
aged m (excluding mortality from insecticide treatments)
ai,m input
Probability killed when attacking host after biting, with malaria infection aged 
m (excluding mortality from insecticide treatments)
&2,m input
Probability contacts and acquires a TDI whilst resting after biting human host 
(TDI ‘coverage’) (0 for cases assuming no TDI)
X input
Probability acquires a Plasmodium infection when biting infectious human host M input
Probability contacts and is killed by instant-kill insecticide when attacking 
human host, before biting, in cycle i. CIKI or ADI ‘coverage’ value.
(0 for cases assuming no instant-kill intervention, or for age classes below the effective 
age of an ADI)
kht input
Probability contacts and is killed by instant-kill insecticide when attacking 
human host, after biting, in cycle i. CIKI or ADI ‘coverage’ value.
(0 for cases assuming no instant-kill intervention, or for age classes below the effective 
age of an ADI)
k2,i input
Number of eggs laid per successfully laying mosquito per cycle L input
Malaria-fecundity adjustment factor, proportionate number of eggs produced 
by mosquitoes with malaria infection age m
El,m input
TDI-fecundity adjustment factor, proportionate number of eggs produced by 
mosquitoes with TDI status /
E2,i input
Probability that a mosquito alive at start of cycle i with malaria status m and 
TDI status /, having survived to bite, then survives to lay eggs ^i.mJ
m<i 0< l<i
Probability that a mosquito alive at start of cycle i with malaria status m and no 
existing TDI, having survived to bite, will survive to lay eggs if  it acquires a 
new TDI in cycle i
z A.i9m
Probability that a mosquito alive at start of cycle / with malaria status m and no 
existing TDI, will having survived to bite, will survive to lay eggs if it does not 
acquire a new TDI in cycle i
Z B.i,m
Instantaneous daily mortality rate from TDI on xth day after infection, for 
mosquitoes with no malaria infection
& input
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Variable or Parameter
Sy
m
bo
l
Comments and 
Constraints
Instantaneous per day mortality rate from TDI on xth day after infection, for 
mosquitoes with malaria infection
Sx input
Incremental daily mortality rate with malaria infection age m Ym input
Incremental daily mortality rate assumed as cost o f resistance a input
% reduction in egg production assumed as cost of resistance 6 input
Differential mortality factor applied to TDI or ADI mortality for mosquitoes 
without a malaria infection
8 Q < 8 < \
Activity type, searching for host, resting, searching for laying site B host-seeking = 1 
resting = 2 
site-seeking = 3
Probability of dying from action of TDI before biting host in cycle i, for 
mosquito starting cycle i with malaria status m and biopesticide status /
Probability of dying from action of TDI between biting host and laying, in 
cycle z, for mosquito starting cycle i with malaria status m and biopesticide 
status /
l > 0
Probability of dying from action of TDI between biting host and laying, in 
cycle /, for mosquito starting cycle i with malaria status m and biopesticide 
status 0 and acquiring a new biopesticide infection during the cycle
Ti,m,0
For the purposes of this evaluation, mortality specifically associated with egg-laying, if 
assumed equally divided pre and post egg-laying, would have an impact on the calculations 
identical to that for pre-and post feeding mortality. It is therefore not addressed separately 
in the model.
The average number of eggs laid in cycle /, by mosquitoes starting cycle i with malaria 
status m and TDI status / is defined as
/ .  = L  \ - 6  E.
J  ijnJ , ^ 2,/
h = 1
h Z.i9mj
f  = L ( l  -  0)E  E  ( q zB + Y  q ( (l  ~ x ) z B + XzA )J i,m,0  '  ' 1 ,m 2,0 1 * i , m , 0,1 i,m  \ V  J i,m i,m J
h=1
l>0
(15)
The average probability of an adult mosquito surviving to the start of cycle /, Vt , is 1 for
cycle 1. For all subsequent cycles, V, is the sum for all possible combinations of fungus &
malaria status of the probabilities of an adult mosquito surviving to the start of cycle z.
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F 1 = l
i - i  i- 1
772=0 1=0
The various survival probabilities, vi m l are calculated as follows. The average probability
of an adult mosquito surviving to the start of cycle i, and being in the 772th cycle of malaria 
infection and the /th cycle since contamination with a TDI at the start of cycle i, vi<m>u is 
1.00 at the start of cycle 1, and thereafter calculated for each possible combination of m 
and / at the start of the preceding cycle.
The probability of surviving to the start of cycle / with no malaria or TDI, v^o, is the 
probability of surviving, uninfected, to the start of the previous cycle, and then surviving 
biting a non human host, or biting a human host without being infected by malaria or 
acquiring a TDI, and then surviving through laying.
V / A 0  “  V / - l , 0 , 0  ( # / - l , 0 ,0 ,1  + ( # / - l , 0 , 0 , 2  + # * - 1 , 0 , 0 , 3  ( l  ^ ) ) ( l  ^ 2 , 7 - 1 ^ ) ( l  ^ ) ) Z i - 1,0
i> 1
The probability of surviving to the start of cycle i with newly acquired TDI and malaria, 
V/,1,1, is the probability of surviving, uninfected, to the start of the previous cycle, and then 
surviving biting an infectious human host, becoming infected with malaria and acquiring a 
TDI, and then surviving through laying, without being killed by any rapid TDI mortality.
,0 i > 1v/,u — v i - i ,o,o# m ,o,o,3 ( l  k2 i_xS^MX  zM>
The probability of surviving to the start of cycle i with a newly-acquired malaria infection,
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and no new TDI contamination, v^o, is the probability of surviving, uninfected, to the start 
of the previous cycle, and then surviving biting an infectious human host and becoming 
infected by malaria, not acquiring a TDI, and then surviving through laying.
+ / ,1 ,0  ~  + 7 - 1 , 0 , 0 # 7 - l , 0 ,0 ,3 ^ ( l  ^ ) Z i - 1,0 7 >  1
The probability of surviving to the start of cycle i with a newly-acquired malaria infection, 
and an existing TDI, is the probability of surviving, with a TDI, but no malaria 
infection, to the start of the previous cycle, and then surviving biting an infectious human 
host and becoming infected by malaria and then surviving through laying, with survival 
probabilities reflecting additional mortality from the TDI.
Vi,lJ =  Vi-1,0,/-1#M,0,/-1,3 ( l _ Z ;-1,0,/-1 <> 1 /> 1
(16)
The probability of surviving to the start of cycle i with an existing malaria infection, and 
no TDI, Vjtnito, is the probability of surviving, with a malaria infection but no TDI, to the 
start of the previous cycle, and then surviving biting a non-human host or biting a human 
host without acquiring a TDI, and then surviving through laying.
M ,777,0 M - l ,777-1,0 (#7-1,777-1,0,1 + (# '-1 ,7 7 7 -1 ,0 ,2  + # '-1 ,7 7 7 -1 ,0 ,3
7 >  1 777 > 1
The probability of surviving to the start of cycle i with no malaria infection, and a newly 
acquired TDI, v,)0)i, is the probability of surviving, with no malaria or TDI, to the start of 
the previous cycle, and then surviving biting a human host, not acquiring a malaria 
infection and acquiring a TDI, and then surviving through laying, without being killed by 
any rapid TDI mortality.
M;o,i vH<y)($ -1,0,0,2 "*"^ -1,0,03( l i-1,0
i >  1
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The probability of surviving to the start of cycle i with an existing malaria infection, and a 
newly acquired TDI, v/)W2ji , is the probability of surviving, with a malaria infection but no 
TDI, to the start of the previous cycle, surviving biting a human host and acquiring a TDI, 
and then surviving through laying, without being killed by any rapid TDI mortality.
1,777-1,0 (#-1,7774,0,2 "^#-1,777-1,0,3) (  ^  ^2,7-1) ■^^7-1,777-1 7 >  1 772 >  1
The probability of surviving to the start of cycle i with no malaria infection, and an 
existing TDI, v/,o,/9 is the probability of surviving, with no malaria infection and an existing 
TDI, to the start of the previous cycle, and then surviving biting a human host without 
acquiring a malaria infection, then surviving through laying, with survival probabilities 
reflecting additional mortality from the TDI.
V7 ,0 ,/ V 7 - l , 0 , / - l  f  # 7 —1 ,0 ,/—1,1 +  ( # 7 - 1 , 0 , / - l , 2  +  # 7 - 1 ,0 , / - l , 3 ( l  ^ 0 )  ( l  W ) Z 7 - l , 0 , / - l
7 >  1 / >  1
(17)
The probability of surviving to the start of cycle i with existing malaria and TDI, vi>mj, is 
the probability of surviving, with existing malaria infection and TDI, to the start of the 
previous cycle, surviving biting any host, then surviving through laying, with survival 
probabilities reflecting additional mortality from the TDI.
M-Tt7t4/-4 ( #'-Tt774/-1,1 + (#-4^77-L/-f2 +#-L72-L/-f3 ) ( ^  ^z'-4) j  ^ i-Lpi4JA 7>1 tw > 1 />  1
(18)The probabilities of surviving through cycle i are calculated as follows. The average 
probability, that mosquitoes starting cycle i with any malaria status and an existing 
TDI, will survive to the start of cycle z + 1 is calculated as the probability of surviving 
biting a non-human host, plus the probability of biting a human host without being killed 
by an instant-kill insecticide, and then surviving to lay, with survival probabilities 
reflecting additional mortality from the TDI
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S i,0,l ~  [ (l 8 ^ 2 , i ) ^  Q ijnJJi + 1
h=2 
3
h=2
^i ,m, l  i  <  X I >  0
(19)
The average probability, Sj,m,o, that mosquitoes starting cycle j with any malaria status and 
no TDI, will survive to the start of cycle / + 1 is calculated as the probability of surviving 
biting a non-human host, plus the probability of biting a human host without being killed 
by an instant-kill insecticide, and then either not acquiring a TDI, or acquiring a TDI but 
not being killed by it before the end of the cycle, and surviving to lay.
Si, 0,0 — ( i + x  w L
h=2 J
i < X  1 = 0
V h=2 J
i<X  I =0 m>0
The probabilities of surviving host seeking and biting in cycle /, qi,m,i,h are calculated as 
follows. The probability, #,>,/,i,that a mosquito starting cycle i with malaria status m, and 
TDI status /, survives host seeking and biting a non-human host, is the proportion of non­
human hosts multiplied by the probability of surviving background mortality and the 
effects of any previously acquired TDI whilst host-seeking, and successfully biting without 
being killed whilst attacking host,
1 -  C T - ( 1 .
The probability, qt,0,1,2, that a mosquito starting cycle i with no malaria infection, and TDI 
status /, survives seeking and biting a human host not infectious for malaria is the 
proportion of hosts which are human and not infectious for malaria, multiplied by the 
probability of surviving background mortality and the effects of any previously acquired
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TDI whilst host-seeking, not being affected by an instant-kill insecticide before biting, and 
successfully biting without being killed whilst attacking host is
The probability, j that a mosquito starting cycle i with an existing malaria infection,
and TDI status /, survives seeking and biting a human host not infectious for malaria is the 
proportion of hosts which are human and not infectious for malaria, multiplied by the 
probability of surviving background mortality and the effects of any previously acquired 
TDI whilst host-seeking, not being affected by an instant-kill insecticide before biting, and 
successfully biting without being killed whilst attacking host is
m>  0
The probability, q*,0,1,3 ,  that a mosquito starting cycle i with no malaria infection, and TDI 
status /, survives seeking and biting a human host infectious for malaria is the proportion of 
hosts which are human and infectious for malaria, multiplied by the probability of 
surviving background mortality and the effects of any TDI whilst host-seeking, and 
successfully biting without being killed whilst attacking host is
=P{l ~H) ( ^ i ,  0, , )eK w a )  ( \ -k li5 ) { \ -a i<m) .
The probability, qi,m,i,3 , that a mosquito starting cycle i with malaria status m, and TDI 
status /, survives seeking and biting a human host infectious for malaria is the proportion of 
hosts which are human and infectious for malaria, multiplied by the probability of 
surviving background mortality and the effects of any TDI whilst host-seeking, and 
successfully biting without being killed whilst attacking host is
9 , M = P ( m > 0
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The probabilities, that a mosquito starting cycle i with status m,l, will survive
resting, site seeking and lay eggs are calculated as follows.
Probability, z fm that a mosquito starting cycle i with no previously acquired TDI, having
survived biting a host, will survive resting, site seeking and lay eggs if it acquires a new 
TDI during cycle i is
7,772 ) ( ^  7^,772,0 )
4 r3i0+r2i7]+(rm+aX0+V))
Probability, z itTn that a mosquito starting cycle i with no previously acquired TDI will 
survive resting, site seeking and lay eggs if it does not acquire a new TDI infection is
ijn \  ^,772/
The probabilities, & i,m, l , of dying from the effects of a TDI whilst host-seeking in cycle
/, for a mosquito starting cycle i with infection status / are calculated (with bd giving 
largest integer less than jc) as;
^ m .O  =  0
M  ^
(L w /-Z > J + l- (w /-Z > ))^ w/_i+1j^+  2 ,  P* + ( w / - [ w / J ) ^ w/+1j
/ > 0
C.snJ = 1 ~ e / >  0 m > 0
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The probability, ^i,m j, of dying from the action of a TDI between biting and laying during
cycle z, having started the cycle with infection status m,l is calculated for mosquitoes which 
have a previously acquired TDI at the start of cycle z, or which acquire a new TDI during 
cycle z, as follows;
r . n, = l - ei,oj
w l+1 - w l I"*"n wl+V Z fixx=|w/+lj+l
wl+0+TJ- wl+<f>+TJ ft
wl+<f)+T]+\
l>  0
v. , = l - ei,m ,l
wl+l - w l s( +^ 
wl+l
jwZ+^ +T/J
Z Sx
JC=jw/+lj+l
/ >  0 m > 0
For mosquitoes newly infected during cycle z, the probabilities, Ti m 0 , of dying from the 
effects of a TDI before the end of the cycle are,
z,0,0 - \ - e
L ^ j
Z  Px +{p+tl~ \j,+rl§)P\jj>+n+\\
w X=1
r .Z, 772,0 - \ - e
\(/>+Tl\
w X - l m > 0
For cases assessing differential TDI mortality for malaria-infected and uninfected 
mosquitoes, fix = SXS .
3.3 Modelling the spread of resistance -  the population model
The PM tracks susceptible and resistant phenotypes over a sequence of time periods for a
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population subject to a given vector control treatment. The key outputs, calculated for each 
time period, are the proportion of the population with resistant and susceptible phenotypes 
and the overall reduction in infectious bites across the population compared to a 
susceptible population with no vector control treatment.
3.3.1 Assumptions
The PM uses survival, infectious bite and reproduction data for each age class of each 
phenotype taken from the FCM, and therefore the assumptions underlying the FCM also 
apply to the PM.
The model uses the probability of survival to the start of each age class to calculate the 
initial population structure for susceptible phenotypes exposed to an intervention. By using 
survival, egg-laying and infectious bite values calculated as averages per cycle for 
mosquitoes alive at the start of each age cycle, this provides sufficient detail to generate the 
PM results. Although in some contexts mosquito population size has been observed 
fluctuating in waves, consistent with a sustained pattern of synchronised gonotrophic 
cycles, in general we must assume that the population at any point in time will comprise 
mosquitoes of all ages. The PM makes the simplifying assumption that eggs laid within a 
time period approximately equal to one gonotrophic cycle, centred around our modelled 
timepoints, can all be assumed to have the same mix of genotypes.
The model does not attempt to capture the effects of mutational processes or stochastic 
demographic effects on the origin and initial spread of very low numbers of resistance 
alleles; it is assumed that resistant alleles are already present at a low frequency in the 
population at the start of the analysis. Resistance involves a single gene and a simple 
dominant/recessive process. It is further assumed that the size and age structure of the 
population at the start of the PM analysis is that achieved after sustained use in a 
susceptible population of the insecticide being evaluated, that there is no immigration or 
emigration, and the proportion of each genotype in the new adults joining the population
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matches that in the eggs from which they originate. Density dependence is assumed to 
occur at the mosquito larval stage, with the number of newly emerged adult mosquitoes 
joining the population in each modelled time period assumed to be constant, and to be the 
same as that for an untreated susceptible population.
The genetic make up of mating males in any cycle is the same as that calculated for newly- 
hatched mosquitoes in that cycle, and males of all genotypes are equally likely to mate 
successfully. Females are assumed to mate once only, in their first cycle, as is the norm 
[55,56]. The number of eggs produced per laying female is assumed to be unaffected by 
egg paternal genotype and all eggs laid are of equal quality and viability.
The proportion of infectious humans in the population is constant for all modelled time 
periods.
The resistant allele is assumed initially to be present in heterozygotes, forming a very small 
proportion of the population. Subsequent spread of the allele reflects the age-linked 
survival probabilities for susceptible and resistant mosquitoes in the presence of the 
insecticide, as well as the age-linked fecundity of each, as calculated in the FCM.
We use an implementation of the model in Excel [57], which analyses the changing status 
of the population for five thousand sequential discrete time periods, each equivalent to the 
length of one gonotrophic cycle.
3.3.2 Population Model Details
The variables and parameters of the PM are detailed in Table 5.
The PM works in discrete time periods, each equivalent to the length of one gonotrophic 
cycle, with recruitment of newly emerged adult mosquitoes treated as occurring at the start 
of each time period. For each sequential time period, the proportion of the population 
comprised by each genotype in each age class, G , is calculated, reflecting the genotypes
of new adult recruits and the survival of adults into each age class from the preceding 
period. This is then used to calculate Rn, the proportion of the population with a resistant
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phenotype in period n, with K  = G 3,n +  G 2,nd  ■
Table 5 Variables and Parameters for Population Model
Variable or Parameter
Sy
m
bo
l
Comments &  
Constraints
Period number (periods over which the population is tracked)* n 0 <n
Dominance of resistance allele d dominant d  = 1 
recessive d = 0
Genotype (normal allele s, resistant allele r) g (s,s) g = l  
(s,r) g = 2 
M  g  = 3
Proportion of total population having genotype g  at start of period n G,,n
Proportion of the population resistant at start of period n Rn
Average number of infectious bites per mosquito in population in period n M n
Size of initial population (susceptibles in the presence of treatment) as 
proportion of base population (susceptibles without treatment)
J value from FCM
Population size in period n as proportion of initial population size Wn
Average infectious bites during one time period from an untreated 
population
q value from FCM
Number of infectious bites from treated population during time period n, 
expressed as a % of the number o f infectious bites during one time period 
from a susceptible population without treatment,
Qn Chosen measure o f  
control
Number o f periods between egg-laying and adult emergence 0 Input
Number o f mosquito age classes included in analysis X
Mosquito age (gonotrophic cycles) i 0 <i  <X
Phenotype j susceptible j =  1 
resistant j - 2
Probability of survival for mosquitoes with phenotype j, to age i+1 from age 
i 0>=1) Sj,i
values from FCM
Mosquitoes with genotype g at start of period n as percentage of initial 
population
Ygn
Allele a as proportion alleles contributed by male population in period n ■Aa,n s a =  1 
r a = 2
Proportion of mosquitoes with genotype g  which survive from start of 
period n to start o f period n+1 Rg,n
Proportion of mosquitoes with genotype g  which are age i at start of period n Gg,n,i
Average number of eggs laid by females of phenotype j ,  aged i values from FCM
Total number of eggs with genotype g  laid in period n
Proportion of all eggs laid in period n having genotype g Fg,n
Proportion of all new adults having genotype g  at start of period n K n
OII
Fitness factor for males with genotype g fg
Average number of infectious bites per mosquito of phenotype j  aged i in 
period n h i
values from FCM
New adults as % initial population K values from FCM
w
As for the FCM, the duration o f  one gonotrophic cycle is used as a unit o f time. For convenience we use 
‘cycles ’ to refer to mosquito age and ‘periods ’ to refer to the sequential time periods for which values are 
calculated in the PM.
Results from the FCM are used by the PM to calculate the average number of infectious
bites per mosquito in the population during each time period. From this Qn, the number
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of infectious bites given by the population as a whole relative to those given by an
o  -  M »W J
untreated population, can be calculated for each time period as
The proportion of the population having genotype g  at the start of period n is calculated as 
the part of the population with that genotype at the beginning of the period, expressed as a 
proportion of the initial population size, divided by the total population size at the start of 
period n, likewise expressed as a proportion of the initial population size.
Y
G  =  8,n 
8,n Wn
The part of the population having genotype g at the start of period n, Yg n, is calculated as
the part of the population with that genotype at the beginning of the previous period 
multiplied by the proportion of such mosquitoes surviving to the end of the period, plus the 
new adults recruited at the start of period n with genotype g, all expressed as a proportion
of the initial population size. Y1X and Y3l are input values, Yl t =  1 — Y2 l — Y3 x and
^ g ,n  ^ g  ,n - l^ g  ,n -l ^ ~ ^ g ,n  with «>1
The three genotypes map to the two phenotypes, resistant, j=2, and susceptible, j= 1, as 
follows;
g  =  1 - >  j  =  1 
g  = 2 ->  j  = l + d  
g  = 3 -> j  = 2
The proportion, Pg n, of mosquitoes starting period n with genotype g  which survive to the
start of period n+1, is calculated as the sum of survival probabilities for mosquitoes with 
the phenotype generated by genotype g  in each age group multiplied by the proportion of 
the mosquitoes with genotype g  which are in that age group.
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Wn, the total population size in period n, expressed as a proportion of the initial population
size, is calculated as the total of the population sizes for each genotype, also expressed as a 
proportion of the initial population size.
g=1
The proportion, Ngn, of new adults joining the population with a given phenotype in a
given period is equal to the proportion of the genotype among the eggs giving rise to the 
new adults.
The average number of bites per mosquito in the population, Mn, is calculated as the sum
of the totals for each genotype of the number of infectious bites per mosquito in each age 
category for mosquitoes with the applicable phenotype, multiplied by the proportion of 
mosquitoes with that genotype falling into each age category.
The PM starts with an age-structure for each genotype sub-population within the whole 
population, Cg l i , reflecting the survival values generated in the FCM for mosquitoes with
that genotype subject to the appropriate treatment regime, including any relevant cost-of- 
resistance parameters.
In subsequent periods, the proportion of genotype g  mosquitoes in age cycle 1 is calculated 
as the proportion of new adults with genotype g multiplied by the number of new adults
3
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expressed as a proportion of the initial population size, divided by the total mosquitoes 
with genotype g  at the start of period n, also expressed as a proportion of the initial 
population size
c  -  N *'"Kg,n, 1 n>  1
For older age classes, the proportion of genotype g  mosquitoes in each age cycle, Cg n i is
calculated as the proportion of mosquitoes with genotype g falling into the preceding age 
category in period n-1, multiplied by the relevant survival probability, divided by the total 
mosquitoes with genotype g  at the start of period n
y c
Q  _  1 g , n - l ^ g >n - \ , i - l ° j J - l
g 'n’1 A f P  1< i ri>\N  K  + Y Pi y g , n J^ ^ 1 g , n - l r g , n - l
The proportion Eg n, of eggs produced in period n which have genotype g , is calculated
as the number of eggs produced in period n with genotype g, divided by the total number 
of eggs produced in period n.
F Bg’n
g .» B, + B 0 + B,1,71 2 m  3,77
The numbers of eggs produced with each of the three possible genotypes, Bgi„, are 
calculated using the appropriate number of eggs per female for relevant phenotypes and 
ages, using the appropriate proportion of each genotype in the population to calculate the 
relevant allele contribution from the female population, multiplied by allele proportions 
appropriate to the male population in the period of mating for each female age class.
^ l , n  = J ] + ® ^ 1  + d , i ^ 2 , n , i ^ 2 , n  ) )
/=!
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,n ~  ^ l , i ^ l , n , f i l , n ^ 2 , n  + l - i  + ® ^ \ + d  2 , n , f i  2,n + ^ 2  3 ,n 3 ,n ^ l , n  + l - i  )
i=l
^ 3  ,n ~  X ( ( ^ 2 , i Q , n , i ^ 3 , B  +  0 * ^ ^ W ,i^ 2 ,n , i^ 2 ,» i ) ^ ,n + l - i  )
/=1
The proportions, A1 n and Aln of susceptible and resistant alleles available from the male
population in period n is calculated based on the proportion of newly hatched males with 
each genotype, and any relative fitness adjustments applied to different phenotypes. Male 
genotypes for matings prior to the start of the modelled time period are assumed to be 
consistent with those in the population in the first modelled period, so AJn = Aj X n < 1
= ( 0 . 5 / 2a ^  + f 2N %„
4 , „  = ( 0 . 5 / ^  + f 2N 2jt + / A » >
3.4 Parameter Values for LLA Analysis
The formulation of key results in comparative terms reduces sensitivity of conclusions to 
specific parameter values. Sensitivity analysis (see section 3.6) confirms that variation in 
specific, non-intervention-related parameter values changes quantitative results but does 
not change our qualitative results and conclusions.
Variable or Parameter Symbol Value units
Background instantaneous mortality rate for mosquito age i t'B.i 11.75% 1 per day
Length o f gonotrophic cycle W 2.851 days
Time spent host searching and feeding during a cycle b 1.26 5 days
Time spent finding oviposition site and laying during a cycle 1.26 s days
Length o f resting period (days) r\ 0.32 s days
Proportion human population infectious for malaria4 P 4.28%1
Probability attacks non-human host H 0.171
Probability killed when attacking host before biting ai .05 6
Probability killed when attacking host after biting (excluding 
mortality from insecticide treatments)
a 2 .05 6
Probability becomes infected with malaria when biting 
infectious human host4
M 1
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Variable or Parameter Symbol Value units
Number of eggs laid per successfully laying mosquito per cycle L 100 2 eggs
Time, measured in whole units equal to length of gonotrophic 
cycle, from infection o f mosquito to cycle from which 
mosquito gives infectious bites
D 3 3
Based on 10.78 1 
days
cycles
Probability contacts and is killed by instant-kill insecticide 
when attacking human host, before biting, in cycle i
0 for cases not 
assessing use o f  
CIKI or for ages 
below effective age 
o f ADI
Otherwise 0.8
Number of age classes included in analysis X 10 cycles
1.Based on data from four geographic locations [51].
2.Since we are only interested in comparative values, the absolute value for the number o f eggs per lay is 
immaterial, 1 0 0  has been used as a convenient normalised value.
5. The number o f cycles assumed for sporogonic development is calculated from the average number o f  
days for sporogonic development and the average number o f days per gonotrophic cycle, rounded down to 
give a whole number o f cycles. This is a conservative assumption with respect to the amount o f E1R 
reduction calculated for given LLA parameters.
4.The data set used provides a total probability o f acquiring a malaria infection when biting a human host. 
This has been used as the value for parameter p, with M=1.00, to give the appropriate combined 
probability, Mp
5. Assumes c.11.1% o f every cycle is spent resting (8  hours in a 72 hour cycle), with the rest o f  the 
gonotrophic cycle divided equally between laying andfeeding
6 . Estimated 10% mortality per feeding attempt [58], divided equally between pre- and post-bite.
Because the purpose of this analysis is to ‘test’ the potential of LLAs, where a choice 
arises, our intention has been to use conservative assumptions which will tend to understate 
rather than overstate the benefits (reduction in infectious bites and resistance management) 
of LLAs, so that any results generated in support of LLAs can be viewed as robust.
Table 7 Values used in the PM for this analysis
Time periods are equal in length to gonotrophic cycles, but we here use cycles to refer to units of 
mosquito age and periods to refer to units of time.
Variable or Parameter Symbol Value
Proportion of total population having genotype g at start of period 1 Gg,i Gij =  I-G2J
G2,i = 10'9
G 3J  =  0
Dominance of resistance allele (0=recessive, 1 =dominant) d d=  1
Number of periods between egg-laying and adult emergence 3
Fitness factor for males with genotype g fg f l= f 2 =f3 =  1.00
All other input values use results calculated by the FCM
3.5 Results
Using the FCM we calculate survival, egg-laying and infectious bite values for each age 
class for mosquitoes experiencing no intervention, a conventional instant-kill
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intervention, and age-dependent instant-kill interventions effective in mosquitoes aged at 
least 2, 3, 4, 5 or 6 cycles old, assuming that all interventions are applied at 80% coverage 
using a pre-bite delivery method. Given our assumption of constant recruitment to age 
class 1, i.e. the number of new adults joining the population per unit of time is constant 
through time and for all interventions, the values we calculate per lifetime also give 
proportionate population-level values per unit of time. For example, the probability of 
mosquitoes surviving to the start of age class 3 under a given intervention, as a proportion 
of the total probabilities of survival to the start of all age classes, is also the proportion of 
mosquitoes joining that age class in the population as a whole.
From Table 8 it can be seen that the probability of survival through any given age class is 
reduced from 65% to 22% for ages affected by an insecticide. The way in which this 
changes population structure is summarised in Table 9.
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Table 8 : Summary of FCM survival results by age cycle
Percentage probability of survival to the start and end of each age cycle, and the probability of 
surviving through each age cycle for mosquitoes in populations subject to no public health 
intervention, to a conventional instant-kill intervention, or to one of five age dependent insecticides.
Survival Cycle 1 Cycle 2 Cycle 3 Cycle 4 Cycle 5 Cycle 6 Cycle 7 Cycle 8 Cycle 9 Cycle 10
No Intervention
Survival to start o f  cycle 100% 64.6% 41.7% 26.9% 17.4% 11.2% 7.2% 4.7% 3.0% 2.0%
Survival to end o f  cycle 64.6% 41.7% 26.9% 17.4% 11.2% 7.2% 4.7% 3.0% 2.0% 1.3%
Survival through cycle 64.6% 64.6% 64.6% 64.6% 64.6% 64.6% 64.6% 64.6% 64.6% 64.6%
CIK
Survival to start of cycle 100% 21.7% 4.7% 1.0% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0%
Survival to end of cycle 21.7% 4.7% 1.0% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Survival through cycle 21.7% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7%
2-Cycle ADI
Survival to start of cycle 100% 64.6% 14.0% 3.0% 0.7% 0.1% 0.0% 0.0% 0.0% 0.0%
Survival to end of cycle 64.6% 14.0% 3.0% 0.7% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0%
Survival through cycle 64.6% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7%
3-Cycle ADI
Survival to start of cycle 100% 64.6% 41.7% 9.0% 2.0% 0.4% 0.1% 0.0% 0.0% 0.0%
Survival to end of cycle 64.6% 41.7% 9.0% 2.0% 0.4% 0.1% 0.0% 0.0% 0.0% 0.0%
Survival through cycle 64.6% 64.6% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7%
4-Cycle ADI
Survival to start of cycle 100% 64.6% 41.7% 26.9% 5.8% 1.3% 0.3% 0.1% 0.0% 0.0%
Survival to end of cycle 64.6% 41.7% 26.9% 5.8% 1.3% 0.3% 0.1% 0.0% 0.0% 0.0%
Survival through cycle 64.6% 64.6% 64.6% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7%
5 cycle ADI
Survival to start of cycle 100% 64.6% 41.7% 26.9% 17.4% 3.8% 0.8% 0.2% 0.0% 0.0%
Survival to end of cycle 64.6% 41.7% 26.9% 17.4% 3.8% 0.8% 0.2% 0.0% 0.0% 0.0%
Survival through cycle 64.6% 64.6% 64.6% 64.6% 21.7% 21.7% 21.7% 21.7% 21.7% 21.7%
6 cycle ADI
Survival to start of cycle 100% 64.6% 41.7% 26.9% 17.4% 11.2% 2.4% 0.5% 0.1% 0.0%
Survival to end of cycle 64.6% 41.7% 26.9% 17.4% 11.2% 2.4% 0.5% 0.1% 0.0% 0.0%
Survival through cycle 64.6% 64.6% 64.6% 64.6% 64.6% 21.7% 21.7% 21.7% 21.7% 21.7%
Table 9 : Population Profile
Population structure of mosquitoes at start of an age class. Percentage of total commencing each age 
class.
Population Profile1 Cycle 1 Cycle 2 Cycle 3 Cycle 4 Cycle 5 Cycle 6 Cycle 7 Cycle 8 Cycle 9 Cycle 10
No Intervention 36% 23% 15% 10% 6% 4% 3% 2% 1% 1%
CIK Insecticide 78% 17% 4% 1% 0% 0% 0% 0% 0% 0%
2-Cycle ADI 55% 35% 8% 2% 0% 0% 0% 0% 0% 0%
3-Cycle ADI 46% 30% 19% 4% 1% 0% 0% 0% 0% 0%
4-Cycle ADI 42% 27% 17% 11% 2% 1% 0% 0% 0% 0%
5-Cycle ADI 39% 25% 16% 11% 7% 1% 0% 0% 0% 0%
6-Cycle ADI 38% 24% 16% 10% 7% 4% 1% 0% 0% 0%
1.Assuming that the number o f  new adults joining the population per unit o f  time remains constant through time andfor all 
interventions
Infectious bite values are affected by survival within, as well as between age classes (Table 
10). No infectious bites are given by mosquitoes younger than the malaria development
Page 83
P A Lynch November 2012
period, in this case, 3 cycles. Thereafter the proportion of infectious bites per mosquito in a 
given age class increases with age, as previously acquired malaria infections mature and 
reach an infectious stage. For the total number of infectious bites given by mosquitoes in 
each age class this effect is counterbalanced, and ultimately outweighed, by the decreasing 
numbers of mosquitoes surviving into each age class. Thus, in the absence of an 
intervention, age class 5 generates the most infectious bites per cycle, more than age class 
4, since more malaria infections have matured by cycle 5, more than age class 6, since 
mortality outweighs the increase in infectiousness between cycles 5 and 6. With 
interventions the picture is more complex, and for all but the 6-cycle effective age ADI, 
mortality effects outweigh the increasing proportion of mature infections, and the number 
of infectious bites per age class decreases from the 1st infectious cycle.
Table 10 Summary of FCM infectious bite results by age cycle
Average number of infectious bites (x 1,000) given during a mosquito lifetime, broken down by age 
class, and the average number of infectious bites given by mosquitoes surviving to the start of each age
Infectious B ites
(x 1,000) Cycle 1 Cycle 2 Cycle 3 Cycle 4 Cycle 5 Cycle 6 Cycle 7 Cycle 8 Cycle 9 Cycle 10
Total per 
lifetime
No Intervention
During cycle 0.00 0.00 0.00 6.49 8.23 7.83 6.63 5.26 4.00 2.96 41.41
Per mosquito starting cycle 0.00 0.00 0.00 24.12 47.38 69.82 91.46 112.33 132.46 151.88
CIK Insecticide
During cycle 0.00 0.00 0.00 0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.05
Per mosquito starting cycle 0.00 0.00 0.00 2.87 5.68 8.43 11.13 13.76 16.34 18.87
2-Cycle ADI
During cycle 0.00 0.00 0.00 0.15 0.05 0.01 0.00 0.00 0.00 0.00 0.22
Per mosquito starting cycle 0.00 0.00 0.00 4.82 7.59 10.30 12.96 15.55 18.10 20.59
3-Cycle ADI
During cycle 0.00 0.00 0.00 0.44 0.19 0.05 0.01 0.00 0.00 0.00 0.69
Per mosquito starting cycle 0.00 0.00 0.00 4.82 9.48 12.15 14.76 17.32 19.83 22.28
4-Cycle ADI
During cycle 0.00 0.00 0.00 1.30 0.55 0.18 0.05 0.01 0.00 0.00 2.09
Per mosquito starting cycle 0.00 0.00 0.00 4.82 9.48 13.96 16.54 19.06 21.53 23.95
5 cycle ADI
During cycle 0.00 0.00 0.00 6.49 1.65 0.53 0.15 0.04 0.01 0.00 8.86
Per mosquito starting cycle 0.00 0.00 0.00 24.12 9.48 13.96 18.29 20.78 23.21 25.59
6 cycle ADI
During cycle 0.00 0.00 0.00 6.49 8.23 1.57 0.45 0.12 0.03 0.01 16.89
Per mosquito starting cycle 0.00 0.00 0.00 24.12 47.38 13.96 18.29 22.47 24.86 27.21
The relative number of eggs laid per lifetime is our measure of fitness. As can be seen from 
Table 11, even the 2-cycle ADI offers a substantial fitness benefit compared to a CIKI, and 
this increases with the effective ages of ADIs.
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Comparative fitness values and EIR reduction values are summarised in Table 12. The 
selection coefficient indicates the strength of selection in favour of resistance, so high 
selection coefficients indicate a high strength of selection for resistance. Predictably, whilst 
resistance management benefits increase with increasing ADI effective ages, the 
transmission reduction opportunities indicated by the reduction in EIR are maximised with 
lower ADI effective ages.
Table 11 Summary of FCM reproduction results by age cycle
Average number of eggs laid during a mosquito lifetime, broken down by age class, and the average
R eproduction1 Cycle 1 Cycle 2 Cycle 3 Cycle 4 Cycle 5 Cycle 6 Cycle 7 Cycle 8 Cycle 9 CyclelO
Total per 
lifetime
No Intervention
Average in cycle 64.6 41.7 26.9 17.4 11.2 7.2 4.7 3.0 2.0 1.3 179.93
per mosquito starting cycle 64.6 64.6 64.6 64.6 64.6 64.6 64.6 64.6 64.6 64.6
number in cycle as % total 36% 23% 15% 10% 6% 4% 3% 2% 1% 1%
CIK Insecticide
Average in cycle 21.7 4.7 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 27.71
per mosquito starting cycle 21.7 21.7 21.7 21.7 21.7 21.7 21.7 21.7 21.7 21.7
2-Cycle ADI
Average in cycle 64.6 14.0 3.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 82.46
per mosquito starting cycle 64.6 21.7 21.7 21.7 21.7 21.7 21.7 21.7 21.7 21.7
3-Cyde ADI
Average in cycle 64.6 41.7 9.0 2.0 0.4 0.1 0.0 0.0 0.0 0.0 117.81
per mosquito starting cycle 64.6 64.6 21.7 21.7 21.7 21.7 21.7 21.7 21.7 21.7
4-Cycle ADI
Average in cycle 64.6 41.7 26.9 5.8 1.3 0.3 0.1 0.0 0.0 0.0 140.63
per mosquito starting cycle 64.6 64.6 64.6 21.7 21.7 21.7 21.7 21.7 21.7 21.7
5 cycle ADI
Average in cycle 64.6 41.7 26.9 17.4 3.8 0.8 0.2 0.0 0.0 0.0 155.37
per mosquito starting cycle 64.6 64.6 64.6 64.6 21.7 21.7 21.7 21.7 21.7 21.7
6 cycle ADI
Average in cycle 64.6 41.7 26.9 17.4 11.2 2.4 0.5 0.1 0.0 0.0 164.88
per mosquito starting cycle 64.6 64.6 64.6 64.6 64.6 21.7 21.7 21.7 21.7 21.7
1. Calculated using a normalised value of 100 eggs per lay for mosquitoes of all ages and status
The PM allows the relative fitness values calculated in the FCM to be translated into 
comparative times to loss of efficacy as resistance spreads. From Figure 18 it can be seen 
that ADIs with higher effective ages offer lower reductions in EIR before the spread of 
resistance, but that these reductions are maintained for longer, as spreading resistance 
erodes the population-level EIR reductions achieved by CIKIs and earlier effective age 
ADIs. Even with a 2-cycle ADI resistance takes between 2 and 3 times as long to spread as 
with a CIKI.
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Table 12 : Selection coefficient and RAIB values for CIKI and ADIs 
Summary of results for conventional and age-dependent insecticides. The selection coefficients are the 
proportionate reduction in lifetime reproductive success for mosquitoes susceptible to each 
intervention. Higher selection coefficients indicate stronger selection pressure in favour of resistance. 
The reduction in EIR is the proportionate reduction in population-level infectious bites.__________
Selection
Co-efficient
Relative 
fitness of 
resistant 
mosquitoes 
when 
intervention 
applied
Reduction 
in EIR
Conventional Instant-Kill Insecticide 0.85 6.5 99.9%
2-Cycle ADI 0.54 2.2 99.5%
3-Cycle ADI 0.35 1.5 98.3%
4-Cycle ADI 0.22 1.3 95.0%
5-Cycle ADI 0.14 1.2 78.6%
6-Cycle ADI 0.08 1.1 59.2%
Figure 18: Results from the PM showing the spread of resistance over time, and the 
consequent loss of reduction in EIR.
Changing values over time for resistant phenotypes as a proportion of the population (bottom panel) 
and consequent loss of reduction in population level infectious bites (top panel) for a CIKI and ADIS 
with effective ages of 2, 3, 4, 5 and 6 cycles. All insecticides assumed delivered pre-bite with 80% 
coverage.
( i )  CIK insecticide
( ii)  2-cycle ADI 
(i/7) 3-cycle ADI 
(iv ) 4-cycle ADI
( v ) 5-cycle ADI
(v i)  6-cycle ADI
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3.5.1 Coverage
The probability that a mosquito contacts and is affected (killed or contaminated) by an 
insecticide, which we here refer to as ‘coverage’, affects EIR reduction and selection 
coefficient values for all insecticide types. However, as can be seen from Figure 19 the 
magnitude of these effects varies for the CIKIs and ADIs we evaluated. It can be seen 
(Figure 19 left hand panels) that coverage levels have a proportionately greater impact on 
both LRS and reduction in EIR for CIKIs and lower effective age ADIs. From the right 
hand panels of Figure 19, which show LRS and reduction in EIR for all insecticides as 
proportions of those for a CIKI, it can be seen that, when compared to the best existing 
alternative, the relative performance of ADIs is maximised for both transmission control 
and resistance management, at high coverage values.
Comparison of Figure 18 and Figure 20 shows the improvement in time to speed of spread 
of resistance for all insecticides assuming 40% rather than 80% coverage. However, the 
relative time for spread of resistance to ADIs is reduced compared to that for CIKIs and in 
all cases, initial reduction in EIR is reduced. This is also illustrated in the plots in Figure 
21, which shows the speed of spread of resistance and loss in EIR reduction for a 4-cycle 
effective age ADI assuming 80%, 60%, 40% and 20% coverage.
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Figure 19 : Comparison of conventional instant-kill chemical insecticide and ADIs 
across a range of coverage values
Lifetime reproductive success with interventions as a proportion of LRS for untreated mosquitoes (top 
left panel) and as a proportion of LRS for mosquitoes treated with an instant-kill insecticide (top right 
panel). Reduction in average infectious bites per mosquito lifetime with interventions, compared to the 
value for untreated mosquitoes (bottom left panel), 0 = no reduction in infectious bites, 1.00 = no 
infectious bites. Reduction in infectious bites with interventions vs untreated mosquitoes, compared to 
the reduction achieved using a conventional instant kill insecticide (bottom right panel), 1.00 means a 
reduction equal to that achieved by instant-kill insecticide.
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With CIK insecticide
LOOT
it .................  .n.nnn.. ...........
15
10
5-
0.00
1
High
(i) CIK
(ii) 2-C ADI
(iii) 3-C ADI
(iv) 4-CADI
(v) 5-CADI
(vi) 6-CADI
Low
0
100% 100%coverage coverage
PA  Lynch November 2012
Page 88
Figure 20 Results from the PM showing the spread of resistance over time, and the 
consequent loss of reduction in EIR, with 40% insecticide coverage.
Changing values over time for resistant phenotypes as a proportion of the population (bottom panel) 
and consequent loss of reduction in population level infectious bites (top panel) for a CIKI and ADIS 
with effective ages of 2 ,3 ,4 ,5  and 6 cycles assumed delivered pre-bite with 40% coverage.
(/) CIK insecticide
(ii) 2-cycle ADI
(iii) 3-cycle ADI 
(z'v) 4-cycle ADI 
(v) 5-cycle ADI 
(vz) 6-cycle ADI
100%
0%
100%
0%
time periods0 1000 2000
Figure 21 : Results from the PM showing the spread of resistance over time, and the 
consequent loss of reduction in EIR, for a range of insecticide coverage values. 
Changing values over time for resistant phenotypes as a proportion of the population (bottom panel) 
and consequent loss of reduction in population level infectious bites (top panel) for a 4-cycle ADI, 
assumed delivered pre-bite with 80%, 60%, 40% and 20% coverage.
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3.5.2 Delivery method for CIKIs and ADIs
The two most commonly adopted delivery methods for the control of adult mosquitoes are 
insecticide treated bed nets (ITNs) and indoor residual spraying (IRS). Both deliver 
insecticides to indoor-biting mosquitoes immediately prior to a feeding attempt (ITNs) or 
shortly after feeding (ITNs and IRS). We here consider the significance of these two 
different delivery methods for LLA insecticides.
For instant-kill insecticides, CIKIs and ADIs, the difference between pre-bite or post-bite 
exposure does not affect the likelihood of surviving to the end of an age class, nor of 
surviving to oviposit. It is only the probability of biting in a given cycle which is affected 
by the choice between these two delivery methods. This in turn affects two key 
probabilities, the probability of a mosquito becoming infected with malaria, and the 
probability of a mosquito giving an infectious bite. A mosquito which dies immediately 
prior to biting, and one which survives to bite and acquires a new malaria infection, then 
dies immediately, have the same zero probability of giving an infectious bite, and so are 
identical for all our key metrics. This is not the case, however, for an infectious mosquito, 
which gives an infectious bite if killed post-bite, but is prevented from doing so if killed 
pre-bite.
For TDIs, which kill some time after contacting and contaminating a mosquito, the timing 
of mortality is not inevitably linked to whether initial contact occurs prior to or after 
feeding, being determined by the characteristics of the TDI after contact. We therefore 
explore the impact on RAIB of a post, rather than pre-bite delivery method for CIKIs and 
ADIs only.
It can be seen from Figure 22 that in all cases, use of a post-bite delivery method reduces 
the RAIB to a level below that available with a one cycle higher effective age ADI 
delivered pre-bite. From Figure 23 it can be seen that the difference between the two 
delivery methods is greater for higher effective ages, and for lower coverage values.
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Since the LRS values are unaffected by this issue, the reduction in RAIB with post-bite 
delivery is not offset by any improvement in the LRS. Choice of delivery method may 
therefore be key to accessing the best possible combination of transmission control and 
resistance management using ADIs.
Figure 22 : Comparison of pre-bite and post-bite delivery systems
Plotted values are the reduction in EIR for conventional and age-dependent instant-kill insecticides 
applied using delivery methods which result in contact either immediately before or immediately after 
biting a human host. ADI values are shown for ADIs which are effective for mosquitoes aged 2, 3, 4, 5 
or 6 cycles or above. Panel A assumes 80%, and panel B 40% coverage. All results assume 3 cycles 
between infection and infectiousness of malaria in mosquito host.
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Figure 23 : Proportionate difference between pre- and post-bite delivery methods 
Plotted values are the proportionate difference in RAIB between pre and post-bite delivery systems, 
for conventional and age-dependent instant-kill insecticides at 80% or 40% coverage. ADI values are 
shown for ADIs which are effective for mosquitoes aged 2, 3, 4, 5 or 6 cycles or above. All results 
assume 3 cycles between infection and infectiousness of malaria in mosquito host.
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3.5.3 Relationship between ADI effective age and malaria pre-patent 
period
It is clear from Figure 22 that, with a pre-bite delivery method, reduction in EIR falls away 
steeply for ADIs with effective ages of 4 cycles or more. In order to test how far this 
profile is dependent on the assumed period of malaria development in the mosquito host, 
we calculated results using our base assumptions, with pre-bite delivery for all insecticides 
at 80% coverage, assuming malaria pre-patent periods equivalent to 2, 3, 4, 5 and 6 
gonotrophic cycles.
Table 13 Summary of LRS and AIB values without interventions, relative to base case 
values, for various malaria development periods__________________
Results for untreated populations relative to base case values
EIR LRS
2-cycle malaria development period 1.63 1.00
4-cycle malaria development period 0.60 1.00
5-cycle malaria development period 0.35 1.00
6-cycle malaria development period 0.19 1.00
As can be seen from Table 13, the malaria development period has a substantial impact on 
the EIR in the absence of any intervention, relative to our base case assumption of 3 
development cycles.
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The results with interventions indicate a clear relationship between the malaria 
development period and the ADI effective ages with which the highest transmission 
control can be achieved (Figure 24). ADIs effective for ages up to 1 cycle more than the 
malaria pre-patent period offer similar levels of EIR reduction, with efficacy falling away 
steeply for effective ages above this. Within this group ADIs with effective ages 1 cycle 
greater than the malaria pre-patent period offer lower EIR reductions than ADIs with 
earlier effective ages, and ADIs with effective ages one cycle less than the malaria pre­
patent period offer EIR reductions comparable to those for CIKIs.
Assuming no impact from malaria infection on mosquito survival and fecundity, resistance
management benefits are not affected by the malaria development period and so are
maximised with higher ADI effective ages. For high coverage with pre-bite delivery
methods, ADIs with effective ages equal to the malaria period of development ±1 cycle
therefore offer the best range of options, depending upon context, from which to select the
optimum combination of transmission reduction and resistance management.
Figure 24: Conventional and age-dependent instant-kill insecticide effectiveness for 
various malaria development periods
Plotted values are the proportionate reduction in EIR for conventional and age dependent instant-kill 
insecticides assuming malaria development periods equivalent to 3, 4, 5 or 6 mosquito gonotrophic 
cycles. All results assume 80% coverage and a pre-bite delivery method
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The same evaluation assuming a post-bite delivery system does not simply show a one- 
cycle reduction in the useful ADI effective ages, as might be expected. EIR reductions for 
ADIs with effective ages equal to or greater than the malaria development period, are 
consistently lower than those offered by ADIs with an effective age 1 cycle higher using a 
pre-bite delivery method (Figure 25). For a post-bite delivery method used with high 
coverage, the useful range of ADIs appears to be those with effective ages up to 1 cycle 
less than the malaria pre-patent period.
With low (40%) coverage the reduction in EIR is more sensitive to the speed of malaria 
development for CIKI and low effective-age ADIs (Figure 26). There is no clear dividing 
line between ADI effective ages offering reasonable and poor transmission control, and no 
clear relationship between malaria time to maturity and useful ADI effective age.
Figure 25: Instant-kill insecticide effectiveness for various malaria development 
periods with post-bite delivery method
Plotted values are the proportionate reduction in EIR for conventional and age dependent instant-kill 
insecticides assuming malaria development periods equivalent to 3, 4, 5 or 6 mosquito gonotrophic 
cycles. All results assume 80% coverage and a post-bite delivery method
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Figure 26 Instant-kill insecticide effectiveness for various malaria development 
periods with 40% coverage
Plotted values are the proportionate reduction in EIR for conventional and age dependent instant-kill 
insecticides assuming malaria development periods equivalent to 3, 4, 5 or 6 mosquito gonotrophic 
cycles. All results assume 40% coverage and a pre-bite delivery method
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3.5.4 Differential insecticide mortality in mosquitoes with malaria 
infection
Since our purpose is to control malaria, not to control mosquitoes, interventions which 
preferentially target malaria-infected mosquitoes may offer the ultimate opportunity to 
achieve high transmission control with very low selection for resistance. From Figure 27 it 
can be seen that, with high coverage, insecticides which have a mortality differential 
between malaria-infected and uninfected mosquitoes offer substantially improved 
resistance management (lower selection coefficient, left hand panel) with no loss of 
transmission control (reduction in infectious bites, right hand panel). The differential 
mortality percentages are the mortality produced by an ADI in malaria-free mosquitoes as 
a percentage of that produced in malaria-infected mosquitoes. Malaria-infected mosquitoes 
experience the full mortality associated with each insecticide at 80% coverage.
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Figure 27 Selection Coefficient for ADIs with differential mortality in malaria 
infected and uninfected mosquitoes.
ADI mortality in malaria uninfected mosquitoes is the specified percentage of the mortality in malaria- 
infected mosquitoes. Inset shows the corresponding reductions in infectious bites for all differential 
mortality assumptions. All results assume 3-cycle malaria pre-patent period and 80% coverage.
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A similar pattern is seen at 40% coverage (Figure 28) with regard to resistance 
management, however, there is also a cost in terms of lost EIR reduction, particularly for 
CIKI and early effective age ADIs. This is presumably a consequence of additional 
survivors amongst malaria uninfected mosquitoes which become infected and bite, an 
effect more significant for additional survivors in early age classes, and hence for CIKI and 
early effective age ADIs.
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Figure 28 Selection Coefficient and reduction in infectious bites for ADIs with 
differential mortality in malaria infected and uninfected mosquitoes at 40% coverage. 
ADI mortality in malaria uninfected mosquitoes is the specified percentage of the mortality in malaria- 
infected mosquitoes. Results assume 3-cycle malaria pre-patent period and 40% coverage.
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3.5.5 Costs of resistance
Complete evolution-proofing can be achieved if there are high enough costs of resistance
(COR). The actual magnitude of the costs of insecticide resistance in Anopheles are
unclear. A figure has, however, been calculated for the fitness cost of resistance in the
non-malaria vector Culex pipiens. The fitness of Culex pipiens organophosphorous (OP)
resistant homozygotes relative to susceptible homozygotes, following 40 years of OP
insecticide spraying in Southern France, was calculated as between 0.63-0.72 [59,60]. We
calculate that resistant mosquitoes are less fit than susceptibles for costs of
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resistance > 3.43% additional daily mortality. This gives a relative fitness value for
resistant mosquitoes of 0.78, a lower COR than that observed in Culex pipiens, so we know
that evolution proofing is possible with biologically plausible costs of resistance.
Figure 29 Results from the PM showing the spread of resistance over time, and the 
consequent loss of reduction in EIR with various costs of resistance.
Resistant phenotypes as a proportion of the population (bottom panel) and consequent loss of 
reduction in population level infectious bites (top panel) with range of assumed costs of resistance. Cost 
of resistance is applied as an addition to daily mortality rates at the percentages shown. All results are 
for a 4 cycle ADI at 80% coverage.
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Figure 29 summarises results from the PM for a 4-cycle ADI at 80% pre-bite coverage
with a range of COR. All plots have the same initial EIR reduction. It can be seen that
increasing COR predictably extends the time taken for resistance to spread. For a COR of
+3.0% daily mortality, even when the population is wholly comprised of resistant
phenotypes, the increased mortality of resistant mosquitoes means that EIR reduction
remains at around 30% compared to an untreated susceptible population. With 3.5% COR,
resistance does not spread during the 5,000 modelled time periods. This is consistent with
the <1.0 relative fitness calculated for resistants with this COR in the FCM. If COR is
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realised as a direct fecundity reduction, with no additional mortality, a 22% reduction in 
fecundity produces evolution proofing for a 4-cycle effective age ADI, at 80% coverage 
delivered pre-bite, with our base case assumptions. With no survival costs, COR only 
affects the selection coefficient, transmission reductions are the same as those assuming no 
COR.
3.5.6 Combination of cost of resistance and differential mortality in 
malaria-infected mosquitoes -  evolution proofing
Figure 30. Fitness of resistant mosquitoes relative to susceptibles for a late-life acting 
insecticide for various costs of resistance and differential efficacy against malaria- 
infected mosquitoes.
When relative fitness >1, resistance spreads, when relative fitness is <1, resistance will not spread, even 
when present in a population (complete evolution-proofing). Plotted values are for an ADI insecticide 
which kills mosquitoes on contact during or after their 4th gonotrophic cycle, reducing infectious bites 
by 95% in susceptible populations. Differential mortality is the proportionate mortality produced by 
the ADI in malaria uninfected mosquitoes compared to that in malaria-infected mosquitoes. Costs of 
resistance accrue as additional daily mortality rates.
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The results summarised in Figure 30 are the fitness values for resistant mosquitoes relative
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to susceptibles in a population subject to a 4-cycle ADI with pre-bite delivery at 80% 
coverage. The results assume a range of values for differential mortality in malaria- 
infected mosquitoes, combined with various costs of resistance. It can be seen that very 
low COR can result in relative fitness values for resistant mosquitoes below 1.00, meaning 
that resistant mosquitoes are less fit than susceptibles and resistance cannot spread. When 
COR is combined with differential mortality in malaria-infected and uninfected 
mosquitoes, a COR as low as 0.43% can give evolution proofing.
3.6 Sensitivity Analysis
To explore the significance of the parameters used in our evaluation we conducted a 
sensitivity analysis. In most cases this gave results differing quantitatively from our base 
case, but in all cases results are qualitatively consistent with our conclusions.
3.6.1 Proportion non-human feeds
In a given gonotrophic cycle, a mosquito which feeds on a non-human host cannot catch 
malaria nor give an infectious bite to a human. We also assume that insecticides are 
delivered using methods which mean mosquitoes are only exposed to them when attacking 
human hosts.
Table 14 Summary of LRS and AIB values without interventions, relative to base case
Results for untreated populations relative to base case values
AIB LRS
0% probability feeds on non human host 1.44 1.00
10% probability feeds on non human host 1.17 1.00
20% probability feeds on non human host 0.93 1.00
30% probability feeds on non human host 0.72 1.00
As can be seen from Table 14, the probability of feeding on a non-human host can make a 
substantial difference to EIR. For example, a species feeding entirely on humans would 
generate 44% more infectious bites per mosquito per unit of time than a species which has 
a 17% probability of feeding on a non-human host, our base case assumption. Without
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intervention, there is no effect on fitness. However, since we assume that mosquitoes are 
only exposed to insecticides when choosing to feed on a human host, the probability of 
feeding on a non-human host does affect fitness values when considering the effects of 
interventions.
Figure 31 Non-human feeding propensity
Reduction in EIR and selection coefficient for CIKI and range of ADIs, assuming 0%, 10%, 20% or 
30% probability of choosing a non-human host for any given feeding attempt.
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Although non-human feeding propensity has no material effect on comparative reductions 
in EIR (Figure 31, top panel), it can be seen (Figure 31, bottom panel), that it does affect 
resistance management, higher non-human feeding propensity giving lower selection 
coefficients and hence better resistance management. This effect is more significant for 
CIKI and low effective age ADIs.
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3.6.2 Natural mortality rates
We assume that mosquitoes are subject to a daily background mortality rate, plus
additional mortality related to feeding and/or egg laying of 10% per attempted bite, half
pre-bite, and half post bite. It can be seen from Figure 32 that, for the present analysis, the
division of mortality per cycle between the daily background mortality rate and the
feeding-related figure has no effect on our results when the per-cycle mortality is
maintained at a constant level. From Figure 33 and Figure 34 however, it is clear that
changing either mortality assumption independently, so that the overall mortality per cycle
changes , does affect our results for both EIR reduction and resistance management.
Figure 32 Constant per cycle mortality with varying mixture of background and bite- 
related mortality
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Figure 33 Background mortality rate sensitivity
Reduction in EIR and selection coefficient for CIKI and range of ADIs, assuming 5%, 10%, 15% or 
20% daily background mortality rates
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Table 15 Summary of LRS and AIB values without interventions, relative to base case 
values for various natural mortality assumptions_______________________
Results for untreated populations relative to base case values
EIR LRS
Constant per cycle mortality with 0% bite mortality 1.01 1.00
Constant per cycle mortality with 20% bite mortality 0.99 1.00
5% per day background mortality rate 3.33 1.83
10% per day background mortality rate 1.35 1.15
15% per day background mortality rate 0.59 0.79
20% per day background mortality rate 0.27 0.58
0% feeding mortality rate 1.88 1.35
20% feeding mortality rate 0.53 0.76
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EIR and LRS are both sensitive to daily background mortality and blood-feeding related 
mortality rates (Table 15). Higher values for either mortality rate result in a reduction in 
RAIB, and a decrease in the selection co-efficient (Figure 33 and Figure 34). The loss of 
EIR reduction is minimal for CIKIs and ADIs with effective ages in the most useful range, 
increasing markedly with higher ADI effective ages. There is a reduction in selection 
coefficients with higher mortality for all evaluated insecticides, with a proportionately 
larger effect for later effective age ADIs.
Figure 34 Blood-feeding mortality sensitivity
Reduction in EIR and selection coefficient for CIKI and range of ADIs, assuming 0%, 10% or 20% 
bite-related mortality rates.
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If a constant per cycle mortality is maintained, it can be seen that varying the proportion of 
mortality contributed from blood-feeding versus daily background mortality rates has little
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effect on EIR or LRS (Table 15) and no impact on reduction in EIR nor selection 
coefficient (Figure 32). It is thus the overall mortality per cycle, determined by daily 
background mortality, feeding-related mortality and days per cycle, rather than the 
allocation of mortality between daily and feeding-associated mortality which affects our 
key outcomes. The optimum combinations of transmission control and resistance 
management would seem to be achievable in contexts with high natural mortality per 
feeding cycle, which offer improved selection coefficients at little or no cost in terms of 
EIR reduction, for ADIs with effective ages in the most useful range.
3.6.3 Mosquito senescence
We have followed the example of many previous analysts [51,61,62] in using a simple 
assumption of constant natural background mortalities. Increasingly, however, arguments 
are being made for the importance of understanding mosquito life-tables and reflecting 
them in vector-control models [63-65]. Since our study specifically considers differential 
induced mortality in different mosquito age-classes, it seems appropriate to consider 
whether age-linked changes in background mortality rates might affect our results.
For this analysis, however, we cannot simply use mortality rates generated from laboratory 
data. Mortality in laboratory mosquitoes is generally much lower than that observed in the 
field [51,63] and the resistance management benefit of the LLA principle is predicated on 
the high mortalities experienced by the target populations of wild vectors. Figure 33 and 
Figure 34, for example, illustrate the importance of natural mortality for the selection 
coefficients achievable with ADIs. Although a number of mark and recapture experiments 
are in the literature, there is not yet any clear consensus regarding the range of age-linked 
variation in mortalities experienced by wild mosquitoes. We therefore chose to use a model 
generated by Styer et al [64], based on large scale laboratory studies, and providing a fully- 
specified model, adjusting the values of some parameters to reflect field rather than 
laboratory overall mortalities.
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Using the logistic model fitted by Styer et al for mortality rates in female mosquitoes, we 
changed the model parameters to give per cycle mortality across the population matching 
our base case value, by adjusting either the initial age-linked mortality rate (parameter a in 
the Styer model), the incremental age-independent mortality rate (parameter ‘c ’ in the 
Styer model) or both the initial age-linked mortality and the exponential rate of increase in 
the mortality rate (parameter ‘b ’ in the Styer model). The mortality rates generated by 
adjusting each parameter are plotted in panel A of Figure 35. Using parameter V  
maintains the curve produced by the original model, but displaces it upwards, as would be 
expected. Increasing the initial age-dependent mortality rate, parameter ‘a \  to achieve the 
same overall mortality produces a different mortality pattern. Adjusting the initial mortality 
rate by half the amount needed to achieve our required per-cycle mortality, and then 
achieving the required total mortality by adjusting the exponential rate of change, 
parameter ‘b’ gives a much steeper s-shaped survival curve, and can probably be 
considered an extreme case. It can be seen that, given the relatively low numbers of older 
mosquitoes, later high mortality rates can only offset a relatively small early-life reduction 
in mortality versus a constant age-independent rate, if the same overall mortality rate per 
cycle is to be achieved.
These cases represent various possible ways that the senescence values observed in the 
laboratory might inform age-linked mortality in the field. Age-independent mortality could 
include mortality from external sources such as predation, starvation, dehydration, contact 
with sticky surfaces etc. The general stresses of life in a fluctuating heterogeneous 
environment might increase the level of inherent mortality and/or the rate at which it 
increases with age.
Table 16 Summary of LRS and AIB values without interventions, relative to base case
Results for untreated populations relative to base case values
EIR LRS
senescence using adjusted parameter ‘c’ 1.03 1.04
senescence using adjusted parameter ‘a’ 0.90 1.00
senescence using adjusted parameter ‘a+b’ 0.50 1.01
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It can be seen from Table 16 that the senescence mortality profiles considered, although all
resulting in the same average mortality per cycle across the whole population, nonetheless 
produced variation of more than 50% in the calculated EIRs for untreated populations. 
Figure 35 : Mosquito senescence scenarios
Plots in panel A show the daily mortality rates assumed for constant mortality, laboratory mortality, 
and three senescence scenarios based on the logistic model fitted by Styer et al to laboratory mortality 
rates [64], and using mortalities calculated by adjusting either parameter ‘a ’, initial age-dependent 
mortality rate, parameter ‘c % age-independent mortality rate, or parameter ‘Z>’, the exponential rate of 
increase for age dependent mortality, to give the same overall mortality per cycle (35%) as our 
constant base case mortality assumption, in an untreated susceptible population. Reduction in EIR 
(panel B) and selection coefficients (panel C) for CIKI and ADIs with effective ages of 2 ,3 ,4, 5 and 6 
cycles using constant mortality and three senescence scenarios.
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It can be seen from Figure 35 (panels B and C) however, that because we use comparative 
values for key metrics, the EIR reductions and selection coefficient results for all but the 
most extreme of the senescence profiles tested are not materially different to those 
calculated with a constant mortality rate. For the more extreme case, EIR reductions are 
lower with higher ADI effective ages, but little affected for the more useful ADIs, whilst 
selection coefficients are improved compared to those calculated using a constant mortality 
rate. In assessing the importance of age-linked mortality effects, they clearly have a 
potentially large impact on EIR, but there is perhaps a balance to be achieved between 
ignoring them inappropriately, and over-emphasising them whilst ignoring the more 
significant differences between mortality rates in the field and the laboratory, which in turn 
serve to reduce the impact of detailed mortality profiles with respect to older mosquitoes.
3.6.4 Probability feed on human host results in P l a s m o d i u m  infection of 
mosquito
It can be seen from Table 17 that the assumed probability of a mosquito acquiring a 
Plasmodium infection when biting a human host has a substantial impact on EIR. From 
Figure 36, however, it can be seen that the relative reductions in EIR achievable with a 
given intervention are essentially unaffected by this parameter.
Table 17 Summary of LRS and AIB values without interventions, relative to base case 
values for various probabilities of a mosquito acquiring a Plasmodium infection when 
feeding on a human host.______________________________________________
Results for untreated populations relative to base case values
EIR LRS
1% probability of catching malaria when feeding on human host 0.24 1.00
5% probability of catching malaria when feeding on human host 1.16 1.00
10% probability of catching malaria when feeding on human host 2.21 1.00
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Figure 36 Malaria prevalence sensitivity
Reduction in EIR and selection coefficient for CIKI and range of ADIs, assuming 1%, 5%, or 10% 
probability of mosquito acquiring a Plasmodium infection when feeding on a human host.
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3.6.5 Mosquito mortality and fecundity effects of P l a s m o d i u m  infection
Although there is still debate around this issue [66], it is increasingly clear that 
Plasmodium has pronounced effects on mosquito fitness, by affecting both survival and 
fecundity [67,68]. We here consider the extent to which such effects might alter our 
conclusions with respect to LLA insecticides.
Table 18 Summary of LRS and AIB values without interventions, relative to base case 
values with various assumptions for the effects of Plasmodium infection on mosquito 
mortality and fecundity____________________________________________________
Results for untreated populations relative to base case values
EIR LRS
37.5% increase in bite mort for malaria infectious mosquitoes 0.93 1.00
37.5% increase in 20% bite mort for malaria infectious mosquitoes 0.47 0.76
reduced mortality and fecundity in infected mosquitoes 1.98 1.00
reduced mortality and fecundity +35% bite-related mort in infected mosquitoes 1.82 0.99
3 x base mortality in oocyst stage infection 0.28 0.96
Anderson et al [67] found an increase in feeding associated mortality of 37.5% in 
sporozooite positive (infectious) mosquitoes in the field. Using this estimate in
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combination with our base 10% bite-related mortality assumption we did not find any 
material change in our calculated values for EIR reduction or selection coefficient (Figure 
37, plots i and zz). As a proportionate adjustment, this effect would be expected to be more 
significant in combination with higher bite-related mortalities; we therefore also 
considered a 37.5% increase in bite-related mortality for malaria infectious mosquitoes 
using baseline bite-related mortality of 20%. This reduced the EIR relative to our base case 
by 53% (Table 18) compared to a reduction of 47% for a 20% feeding-related mortality 
case without incremental malaria-associated mortality (Table 15), whilst showing little 
effect on EIR reduction and selection coefficient values (Figure 37 plots in and /v).
Vezilier et al [68], working with a natural mosquito-malaria system, found enhanced 
survival linked with reduced egg-production in Plasmodium infected mosquitoes. Taking 
the survival figure for the mosquito strain showing the strongest survival effect (55% 
reduction in background daily mortality), and the average fecundity reduction (30%), we 
find that, whilst EIR under these assumptions is approximately double that for our base 
case (Table 18), they produce a slight improvement in the transmission reduction potential 
of later effective age ADIs, without increasing the selection coefficient for a given 
insecticide (Figure 38).
Much work seeking to establish the effects of Plasmodium infection on mosquitoes has 
been done using Plasmodium!mosquito combinations not found in the wild, under idealised 
laboratory conditions. Aboagye-Antwi et al [69] used wild-caught blood fed Anopheles 
gambiae s.s. subject to restricted water access to explore the effects of natural infections 
with Plasmodium falciparum on females experiencing stress associated with sub-optimal 
conditions. They found that females subject to hydric stress and carrying Plasmodium 
oocysts showed substantially higher mortality than those uninfected or carrying 
sporozooites. Based on their results we consider a three-fold increase in daily background 
mortality for infected oocyst-stage females and find that this assumption gives an EIR 
approximately 70% below our base case value (Table 18). The proportionate reductions in
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EIR with conventional and ADI insecticides are completely unchanged by this assumption, 
however, and selection coefficients show only a very slight improvement (Figure 39).
Figure 37 Effect of differential bite-related mortality in malaria infectious mosquitoes 
Plotted values are the proportionate reduction in EIR (top panel) and selection coefficient (bottom 
panel) for conventional and age-dependent instant-kill insecticides at 80% coverage with pre-bite 
delivery. Plots are for 10% (/) and 20% (»*) bite-related mortality for all mosquitoes, and 10% (iff) and 
20% (iv) bite-related mortality assuming 37.5% higher bite-related mortality in mosquitoes with an 
infectious malaria infection.
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Figure 38 Effect of reduced mortality and fecundity in Plasmodium infected 
mosquitoes
Plotted values are the proportionate reduction in EIR (top panel) and selection coefficient (bottom 
panel) for conventional and age-dependent instant-kill insecticides at 80% coverage with pre-bite 
delivery. Plots are for (i) base case and (ii) 55% reduction in background mortality with 30% 
reduction in fecundity for Plasmodium infected mosquitoes and (Hi) 55% reduction in background 
mortality with 30% reduction in fecundity for Plasmodium infected mosquitoes plus 35% additional 
bite-related mortality for all malaria infectious mosquitoes.
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Our conclusions seem to be robust to a range of assumptions about the effect of 
Plasmodium infection in mosquitoes, although such effects can have a substantial impact 
on the calculated EIR values, and may be very important to many aspects of malaria 
epidemiology, the efficacy of some other types of control measure, and to calculated 
thresholds for eradication strategies.
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Figure 39 Effect of increased mortality in pre-infectious Plasmodium infected 
mosquitoes
Plotted values are the proportionate reduction in EIR (top panel) and selection coefficient (bottom 
panel) for conventional and age-dependent instant-kill insecticides at 80% coverage with pre-bite 
delivery. Plots are for (/) base case and (ii) assumed 3-fold increase in background mortality for pre- 
infectious malaria infected mosquitoes.
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3.6.6 Constant population size v e r s u s  constant recruitment
Our analysis assumes that the rate at which new adults join the population remains constant 
with and without insecticide use, and through all modelled time periods. This would be 
consistent with complete density dependence at the juvenile stage, so that reduced egg 
production from a population treated with a CIKI or ADI would not result in a material 
change in the numbers of emerging adults. From a modelling perspective this gives a
PA Lynch November 2012
Page 113
population size which varies with post-emergence adult mortality only.
To test the sensitivity of our results to this assumption we ran a version of the PM model 
amended to maintain a constant adult population size.
Figure 40 Results from the PM showing the spread of resistance over time, and the 
consequent loss of reduction in EIR assuming constant adult population size.
Resistant phenotypes as a proportion of the population (bottom panel) and consequent loss of 
reduction in population level infectious bites (top panel) for a CIKI and ADIs with 2 ,3 ,4 , 5 and 6 cycle 
effective age, assuming constant population size at the start of all time periods.
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Comparison between the base case results in Figure 18, with constant adult recruitment, 
and the results in Figure 40 confirms that our assumption of constant rate of recruitment to 
the adult population is not key to our conclusions.
3.6.7 Dominant/recessive resistance alleles
See Chapter 6 for additional discussion of this issue.
3.6.7.1 Recessive resistance
Our analysis assumes that, for all insecticides, resistance is controlled by a single, 
dominant allele. Both dominant and recessive modes of action have been identified for
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resistance to existing insecticides [70,71], so we here examine whether the assumption of
dominance is key to our conclusions.
It can be seen from Figure 41 that, assuming resistance is controlled by a recessive allele 
for all insecticides predictably gives slower rates of spread of resistance, but does not 
change our fundamental conclusions regarding the relationship between transmission 
control and resistance management.
Figure 41 Results from the PM showing the spread of resistance over time, and the 
consequent loss of reduction in EIR assuming resistance allele is recessive.
Resistant phenotypes as a proportion of the population (bottom panel) and consequent loss of 
reduction in population level infectious bites (top panel) assuming recessive resistance allele, for a 
conventional instant-kill insecticide and ADIs with effective ages of 2 ,3 ,4 ,5  and 6 cycles.
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3.6.7.2 Recessive resistance for conventional insecticides, dominant
for LLAs
In the absence of knowledge regarding resistance mechanisms for theoretical LLA 
insecticides, we have compared the spread of resistance assuming equivalent mechanisms 
for conventional and LLA insecticides. Clearly the situation which would minimise 
relative resistance management benefits for LLAs would be dominant resistance for the 
LLA, with recessive resistance for conventional instant-kill insecticides. Making this 
comparison (Figure 42) shows that all but the earliest-acting LLAs would continue to offer 
resistance management benefits compared to CIKIs.
Figure 42 Comparison of speed of spread of resistance over time with dominant LLA 
resistance allele and recessive CIKI resistance allele
Resistant phenotypes as a proportion of the population (bottom panel) and consequent loss of 
reduction in population level infectious bites (top panel) assuming dominant resistance allele for ADIs 
with effective ages of 2, 3, and 4 cycles, and dominant or recessive resistance allele for conventional 
instant-kill insecticide.
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3.6.8 Assumed starting level of resistants in the population
It is not possible to predict how long resistance will take to arise in a population, and all 
our results compare the speed of spread once resistance alleles are present. Our base case 
assumption is that resistance alleles are initially present as rare heterozygotes, comprising 
one per billion of the mosquito population. We here assess whether the start point 
materially affects the comparative rates of spread for CIKIs and ADIs, given that the 
analysis is primarily interested in the process of resistance spreading from an initially low 
level in the population.
Figure 43 Comparison of speed of spread of resistance for CIKI and ADIs assuming 
10‘6 initial prevalence of heterozygotes in population
Resistant phenotypes as a proportion of the population (bottom panel) and consequent loss of 
reduction in population level infectious bites (top panel) assuming initial population has 10'6 
heterozygotes. Plots are for CIKI and ADIs with effective ages of 2 ,3 ,4 ,5  and 6 cycles.
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Comparison between Figure 18 and Figure 43 shows that a 1,000-fold increase in the
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assumed initial level of heterozygotes in the population, to 1 per million, does not 
materially change the relative useful lives of a CIKI and ADIs with effective ages of 2, 3, 
4, 5 and 6, before the spread of resistance eliminates transmission control. Absolute times 
between the start of the evaluation and any given proportion of resistants in the population 
are predictably shorter for all insecticides.
Figure 44 Comparison of speed of spread of resistance for CIKI and ADIs assuming 
1% initial prevalence of heterozygotes in population
Resistant phenotypes as a proportion of the population (bottom panel) and consequent loss of 
reduction in population level infectious bites (top panel) assuming initial population has 1% 
heterozygotes. Plots are for CIKI and ADIs with effective ages of 2 ,3 ,4 ,5  and 6 cycles.
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When the proportion of heterozygotes is increased to 1%, the profile of the spread of 
resistance changes (Figure 44), but, again, the relative times to loss of effectiveness, 
defined as any given level of resistance in the population, still show a relationship between 
the CIKI and ADIs consistent with our conclusions.
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We have assumed that rare alleles will primarily be present in heterozygotes. However, it 
can be seen from Figure 45 that changing this assumption and assuming instead that the 
resistants initially present in the population are all homozygotes, does not affect our 
conclusions.
Figure 45 Comparison of speed of spread of resistance for CIKI and ADIs assuming 
10'9 initial prevalence of homozygotes in the population
Resistant phenotypes as a proportion of the population (bottom panel) and consequent loss of 
reduction in population level infectious bites (top panel) assuming initial population has 10~9 
heterozygotes. Plots are for CIKI and ADIs with effective ages of 2 ,3 ,4 , 5 and 6 cycles
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3.6.9 Male population matches genotype of new adults or of females
We have assumed that females mate once, shortly after emerging as adults, and that they 
primarily mate with males emerging at around the same time. The validity of this 
assumption depends on males having a short reproductive life. If instead males survive and 
continue to mate with new females over an extended period, the allele frequencies among
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mating males will be different to that which we have assumed. To explore the significance 
of this, we adjusted the model and repeated our analysis assuming that, at the time of 
mating, the male population has the same allele frequencies as the total adult female 
population, rather than that of newly-emerged adults only.
Figure 46 Comparison of speed of spread of resistance for CIKI and ADIs assuming 
males have same allele frequencies as adult female population
Resistant phenotypes as a proportion of the population (bottom panel) and consequent loss of 
reduction in population level infectious bites (top panel) assuming that mating males have the same 
genetic mix as the adult female population. Plots are for CIKI and ADIs with effective ages of 2 ,3 , 4, 5 
and 6 cycles
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It can be seen from comparison between Figure 46 and Figure 18 that resistance spreads 
faster with male genotype proportions matching those of adult females rather those of 
newly emerged adults, but, again, the relative times to spread of resistance remain 
consistent with our conclusions.
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3.6.10 Geographic data sets
We have used a data set based on averages of field data from four geographic locations, 
which vary by climate, vector species etc. Here we assess whether the average values 
provide a reasonable basis for our evaluation, or whether the geographic data sets 
considered individually produce results inconsistent with those generated using the average 
values.
Table 19 Geographic data sets
Kankiya Kaduna Namawala Butelgut Average
Probability of acquiring malaria 
infection when biting a human host
2% 6% 2% 7% 4%
Length of feeding cycle / days 3.00 2.00 2.70 3.70 2.85
Instantaneous daily mortality rate 6% 10% 17% 14% 12%
Per feeding cycle mortality 17% 19% 40% 43% 28%
Probability attacks non-human host 0.25 0.10 0.05 0.28 0.17
Number of cycles from malaria 
infection to infectious bite
3 5 4 2 3
Table 20 Summary of LRS and AIB values without interventions, relative to base case 
values, using individual geographic data sets
Results for untreated 
populations
relative to base 
case values
AIB LRS
Kankiya 1.18 1.57
Kaduna 1.30 1.44
Namawala 0.11 0.67
Butelgut 0.73 0.59
It can be seen from Table 20 that AIB and LRS results vary widely between the four 
geographic data sets. The absolute values of AIB and LRS do not, however give an 
indication of the relative reductions in EIR and selection coefficients associated with 
insecticide use for a given data set, as can be seen in Figure 47, where the two locations 
offering the highest EIR reductions are Namawala and Kaduna, which have respectively, 
the lowest and highest absolute values for AIB.
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The reductions in infectious bites across the different ADI effective ages (Figure 47, top 
panel), are consistent with the results in Figure 24 for all four locations, indicating that 
optimum disease control and resistance management combinations are offered at ±1 cycle 
compared to the malaria development period. A steep loss of EIR reduction occurs for 
ADIs with effective age above 4 for Kankiya, which has a 3 cycle malaria development 
period, and above five for Namawala which has a four-cycle malaria development period. 
For Kaduna, reduction in EIR is well-maintained for ADIs with effective ages up to 6, 
consistent with its malaria development period of 5 gonotrophic cycles. For Butelgut, steep 
loss of EIR reduction occurs for ADIs with effective ages above 3, consistent with a 
malaria development period equivalent to 2 gonotrophic cycles, and with high per cycle 
mortality (Figure 33 and Figure 34). Comparing results for Kankiya with those for the 
average data set, the profiles are almost identical for ADIs with effective ages up to four, 
consistent with the results in Figure 24 for a malaria development period equivalent to 3 
gonotrophic cycles. Thereafter, EIR reduction is lost less quickly with increasing ADI 
effective age for Kankiya than for the average data. This profile is consistent with 
Kankiya’s lower per cycle mortality rate compared to the average value (Figure 33 and 
Figure 34).
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Figure 47 Geographic sensitivity
Comparison of reduction in infectious bites and selection coefficients for CIKI and ADIs using an 
average data set and the four geographic data sets [51] from which it is calculated.
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For the selection coefficient, the primary drivers appear to be the natural mortality (Figure 
33 and Figure 34) and human feeding propensity (Figure 31). For both these parameters, 
higher assumed values give lower selection coefficients and hence better resistance 
management. Background mortality has more impact for higher ADI effective ages, whilst 
human feeding propensity has more impact on selection coefficients with CIKI and lower 
ADI effective ages. The geographic sensitivities are consistent with these results. Butelgut 
with the highest non-human feeding propensity and the highest per-cycle background 
mortality has the lowest selection coefficient for all insecticides. Namawala has low non­
human feeding propensity, which is most significant for CIKI and low ADI-effective ages,
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giving a higher than average selection coefficient for CIKIs, falling with increasing ADI- 
effective age as the impact of high background mortality increases. Kankiya and Kaduna 
have very similar background mortality, and very similar selection coefficients for ADI 
effective ages above 2-cycles. Kankiya has much higher human feeding propensity, and 
consistent with this, has lower selection coefficient for CIKI and the lowest effective-age 
ADIs, where this difference has most effect.
Analysis of the individual data sets thus generates results consistent with our analysis using 
the average data set. Use of the average values therefore appears to be an appropriate 
simplification for the purpose of generating generalisable results.
3.7 Discussion
Our results predictably show a trade-off between the levels of transmission reduction 
accessible in a susceptible population, and the speed of spread of resistance. In general, 
earlier-acting insecticides give the greatest reduction in EIR, but also exert the strongest 
selection for resistance. Early gains are therefore paid for by shortening the useful life of 
the product (Figure 48). The importance of the initial level of transmission reduction 
depends on many factors, such as the EIR before treatment, the prevalence of malaria 
infection in the human population, other interventions used in conjunction with the LLA, 
budgetary constraints, and availability of alternative interventions when a product is lost to 
resistance. We therefore cannot offer a simple mathematical optimum for the trade-off 
between initial EIR reduction and long term resistance management, however, for any 
given context there are clearly substantial benefits to employing insecticide action, 
coverage and delivery methods designed to maximise the resistance management benefits 
achievable in combination with a given level of EIR reduction.
In general, it seems that for instant-kill, age-dependent, LLA insecticides, the best 
combinations of EIR reduction and low selection for resistance can be accessed at high 
coverage levels (Figure 19). Provided the same effective coverage values can be achieved
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in each case, a pre-bite delivery method offers better transmission reductions than does
post-bite, and allows better resistance management for a given level of transmission 
reduction (Figure 22).
Figure 48 Trade off between initial levels of control and product useful life
The natural mortality rate per cycle has a significant effect on EIR in the absence of any 
intervention, but makes little difference to the proportionate reduction in EIR possible 
using ADIs with effective ages in the most useful range. Selection coefficients are however 
reduced by higher background mortality per cycle, for all insecticides. Contexts with high 
natural mortality per cycle therefore offer good opportunities to access good resistance 
management in combination with good transmission control. High per cycle mortality can 
be the result of high per day mortality rates and/or long gonotrophic cycle lengths.
With high coverage and pre-bite delivery, comparable transmission control is offered by all 
ADIs with effective ages up to one cycle higher than the number of cycles required for a 
Plasmodium infection in a mosquito to develop to infectiousness (Figure 24). ADIs with 
effective ages 1 cycle less than the Plasmodium development period may offer 
transmission reduction almost equal to that provided by a conventional instant-kill 
insecticide. Resistance management improves with increasing effective age, so optimum 
combinations of transmission reduction and resistance management are in general offered 
by ADIs with effective ages between one cycle less and one cycle more than the 
Plasmodium development period. Locations with longer Plasmodium development periods 
offer scope to achieve high reductions in EIR using higher effective age ADIs
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and hence generating low selection for resistance, and therefore offer opportunities to 
maximise the resistance management benefits of ADIs. This is particularly the case if a 
long Plasmodium development period is combined with high natural per cycle mortality, as 
is the case for the Namawala geographic data set (Figure 47).
Costs of resistance less than those observed in a natural system [59] can make resistant 
mosquitoes less fit than susceptible mosquitoes exposed to a 4 cycle effective age ADI at 
80% pre-bite coverage, an intervention offering a 95% reduction in EIR in a susceptible 
population.
LLAs which generate lower or zero mortality in mosquitoes without a Plasmodium 
infection can greatly reduce selection for resistance, without compromising transmission 
reduction (Figure 27). Such products have the potential to be evolution proof if resistant 
phenotypes incur even very small costs of resistance (Figure 30) and should comprise a 
target for LLA product development.
The PM model indicates a very rapid spread of resistance in populations subject to high 
coverage of a conventional instant-kill insecticide, with >90% resistant phenotypes within 
a year. Our primary interest is the comparative timing of spread of resistance for different 
insecticides, but it is worth considering whether the values generated for CIKIs are 
plausible. Firstly it is important to remember that we are comparing the spread of 
resistance once a resistance allele is present in the population. Observed time to spread of 
resistance in the field necessarily includes any time required for resistance to arise. 
Nonetheless, dieldrin resistance has been observed in some field locations at >90% of the 
population after just two years of spraying [72]. Dieldrin is a particularly relevant example, 
because it is unusual in having virtually no spatial or contact repellancy [20]. Standard 
measures of resistance do not capture behavioral avoidance such as outdoor resting or 
feeding, or simply moving away from treated surfaces before acquiring a fatal dose, 
whereas the PM reflects the spread of all heritable resistance mechanisms. The most 
widely used conventional insecticides, DDT and pyrethroids all have varying levels of
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spatial and contact repellancy, the lower selection pressure generated as a result (see 
section 4.5.2) compared to our assumptions, and the failure to monitor resistance expressed 
as avoidance behaviors would both lead to a lower observed rate of spread of resistance 
than that presented by our model.
Our models do not attempt to capture feedback between EIR reduction and the prevalence 
of malaria in the human population. This relationship is complex and location specific, and 
beyond the scope and requirements of this analysis. Even with an initial EIR below 1 in an 
untreated population, for example, reduction in EIR would not be expected to map directly 
to a proportionate reduction in malaria prevalence. Assuming that the probability of a 
susceptible individual becoming infected in a given period of time varies proportionately 
with the reduction in EIR, the proportion of susceptible individuals in the population would 
be expected to change, so that the number of infections per infectious bite might increase 
as the number of infectious bites declined. Our sensitivity analysis (Figure 36) shows that 
variance in the absolute value for the prevalence of infectious human hosts does not 
materially affect the proportionate reduction in EIR compared to an untreated population. 
However, if the value changed over time (which is, after all, the purpose of the 
intervention), the relevant comparison would be between EIR with an intervention and the 
reduced malaria prevalence and the EIR with the original malaria prevalence and no 
treatment. So for example, if sustained use of an intervention resulted in a 30% reduction 
in the prevalence of malaria in human population, our chosen measure of control, RAIB, 
would change by -0.3(1-RAIB). Clearly the effect of such a change would be limited for 
CIKIs and early effective age ADIs which offer large reductions in EIR and consequently 
have RAIB values close to 1.
Our sensitivity analysis indicates that the values chosen as our measures for transmission 
reduction and resistance management give results which are robust to variation in 
parameters not directly involved in the interactions being assessed, consistent with our
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expectations when choosing to formulate our key results as comparative rather than 
absolute values.
3.8 Conclusions
Our results indicate that LLA insecticides do offer good potential for achieving useful 
transmission reductions comparable with those available using conventional instant kill 
insecticides, whilst exerting much lower selection pressure in favour of the spread of 
resistance.
The optimum combinations of transmission reduction and resistance management can be 
accessed using delivery methods which provide high coverage, and, for instant-kill ADIs, a 
pre-bite delivery method. Given this, the most useful ADIs are those with effective ages 
within 1 cycle of the time required for Plasmodium to mature and become infectious in a 
mosquito host.
Locations best suited to maximising the benefits of ADIs are those with mosquito 
populations with high per cycle natural mortality and long Plasmodium development 
cycles. Vector species with higher propensities to feed on non human hosts also offer 
better resistance management in combination with a given level of transmission reduction. 
In all contexts, differential mortality between Plasmodium infected and uninfected 
mosquitoes, with uninfected mosquitoes experiencing reduced or absent mortality, gives 
better resistance management for a given level of transmission reduction and, at high 
coverage values, this is achieved at minimal cost in terms of transmission reduction. Very 
small costs of resistance can make ADIs with this characteristic completely evolution 
proof.
Our results indicate that LLA insecticides offer great potential for transmission control 
using products which will not rapidly lose their utility to the spread of resistance.
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“Mathematics in general is fundamentally the science of self-evident things. ”
________________________________________ (Felix Klein, 'Anwendung der Differential- und Integralrechnung auf Geometric', 1902)
4 Chapter 4 Fungal biopesticide LLAs
4.1 Introduction
Entomopathogenic fungi have a characteristic pattern of infection followed by an initial 
period of growth before generating mortality in an insect host. This delayed mortality 
means that such fungi offer potential to exploit the LLA concept [73]. Here we assess 
which of the wide range of possible virulence characteristics for fungal biopesticides can 
best realise this potential.
Naturally occurring strains of two fungi, Beauveria bassiana and Metarhizium anisopliae, 
are already in commercial use for agricultural applications and have been shown to infect 
and kill mosquitoes in laboratory and field settings. Fungal spores can be picked up by 
mosquitoes following contact with treated surfaces, and so could be used against 
mosquitoes in indoor residual spray (IRS) programmes, or delivered via traps, curtains or 
netting [16,18,74-77].
A wide variety of mortality schedules can be induced in Anopheles by entomopathogenic 
fungi [17]. In some cases, all mosquitoes can be killed within a few days; in others, 
background mortality rates can be barely altered. This virulence variation depends on 
isolate [18], dose [78] and malaria-infection status [16,78], see also [79]. Lethality can 
also be increased by genetically modifying fungal isolates [80-82].
If fungal entomopathogens are to realize the potential of the LLA approach to sustainable 
malaria control, candidate biopesticides need to be chosen which balance reductions in 
parasite transmission (maximized by high fungal virulence) with resistance management 
(maximized by low fungal virulence). Here we use our LLA model to ask which virulence 
phenotypes best achieve this balance. The intention is to guide the development of target 
product profiles. The possible efficacy of fungal biopesticides in IRS campaigns is 
compared with that of pyrethroid-based insecticides now in widespread use. Pyrethroids
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are highly lethal if contacted by a mosquito, but they also have a strong excito-repellency 
effect, which can drive away mosquitoes before they receive a lethal dose [20,83,84]. 
There is evidence that fungal spores do not repel mosquitoes [19], raising the prospect that, 
for IRS, fungal biopesticides might more effectively reduce transmission than pyrethroid- 
based technologies currently in use.
Our results show that fungal biopesticides which generate high rates of mortality at around 
the time mosquitoes first become able to transmit the malaria parasite offer potential for 
large reductions in transmission while imposing low fitness costs. Strains which have high 
virulence in malaria-infected mosquitoes but lower virulence in malaria-free mosquitoes, 
offer the ultimate benefit in terms of minimising selection pressure whilst maximising 
impact on transmission. Exploiting this phenotype should be a target for product 
development. For indoor residual spray programmes, biopesticides may offer substantial 
advantages over the widely used pyrethroid-based insecticides, not only offering 
substantial resistance management gains in the long term, but also providing greater 
reductions in transmission before resistance has evolved. This is because fungal spores do 
not have contact irritancy, reducing the chances that a blood-fed mosquito can survive an 
encounter and thus live long enough to transmit malaria.
4.2 Model Assumptions
We use the FCM and PM developed for analysis of LLA insecticides and detailed in 
sections 3.2 and 3.3. The assumptions underpinning the FCM and PM therefore apply to 
this analysis, with the following amendments and additions.
All model parameters are age-independent, apart from incremental mortality from fungal 
biopesticide infection which varies according to the number of days since infection. 
Mosquitoes are assumed to contact the CIKI or biopesticide when resting after biting a 
human host, reflecting an application method essentially consistent with IRS. Avoidance
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behaviour such as outdoor feeding and outdoor resting is not reflected in the coverage 
values for susceptible mosquitoes since it comprises a method of resistance.
4.3 Parameter Values
The baseline values used in the analysis are summarized in Table 6 and Table 7 (Section 
3.4)
4.4 Analysis
A number of fungal strains have now been tested in laboratory mosquito populations, and a 
wide range of mortality characteristics have been observed around the basic pattern of 
initial fungal growth and development followed by an increase in observable mosquito 
mortality [16,18,77,78,85]. This suggests that most virulence profiles are potentially 
available, and in a search for generalisable results we therefore use highly simplified 
fungal virulence characteristics, defined by two parameters, ‘initiation day’, the time from 
infection to the onset of fungus-induced mortality, and the daily mortality rate from that 
point. A number of illustrative survival curves generated from these parameters are shown 
in Figure 49.
Fungal biopesticides can also impact mosquito feeding propensity and flight capacity in the 
days before mosquito death [18]. A mosquito which no longer attempts to feed or to lay 
eggs is effectively dead from the perspectives of fitness and disease transmission. For the 
purpose of the model therefore, ‘mortality’ encompasses cessation of feeding and 
reproduction, as well as actual death.
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Figure 49 Illustrative survival curves for a range of simple virulence mortality 
assumptions
Survival curves illustrating mortalities defined by two simple virulence parameters.
For each illustrated pair of values, mortality is zero until the specified initiation day, and is thereafter 
maintained at the indicated fixed daily mortality rate. Initiation day and mortality rate are the two 
parameters used to define the assumed incremental mortality generated by a given biopesticide 
infection, and referred to here as ‘simple virulence’.
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4.5 Results
4.5.1 Coverage and Virulence
The proportionate reduction in EIR generated by use of a biopesticide is affected by fungal 
virulence and coverage (Figure 50). For a given level of coverage, similar levels of EIR 
reduction are achieved by various combinations of the two parameters used to summarize 
virulence (initiation day and mortality rate, Figure 49).
Unsurprisingly, the longer a fungus takes to initiate mortality, the greater the subsequent 
mortality rate has to be to maintain a given level of reduction in EIR. There are limits to 
the EIR reductions that can be achieved at low virulence and/or low coverage.
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Figure 50: Comparison of virulence characteristics and fitness costs associated with 
given reductions in EIR.
axis) which achieve the denoted reductions in EIR (RAIB). The mortality rate required to achieve a 
given RAIB increases for later initiation days, up to an initiation day beyond which the target RAIB 
cannot be achieved, at which point the plots stop. With 50% biopesticide coverage, no virulence 
parameter combinations achieve 99% RAIB. Bottom panels show the selection coefficients 
corresponding to the same set of virulence parameter values, eg, the 99% RAIB value plotted for 
initiation day 2 gives the fitness cost for susceptibility to a biopesticide with initiation day 2 combined 
with the mortality rate required to achieve a 99% RAIB. Higher selection coefficients indicate stronger 
selection pressure for resistance.
selection coefficient associated with a 90% RAIB at 80% coverage is 21%, with day 9 
initiation and a 91% mortality rate. At 50% coverage the lowest selection coefficient 
available in combination with 90% RAIB is 40%.
The temporal dynamics of EIR reduction and resistance evolution are shown in Figure 51. 
Predictably, more virulent biopesticides give better population-level reductions in EIR to 
begin with, but they then drive the evolution of resistance more rapidly. The speed of 
resistance evolution is more sensitive to the timing of mortality onset than to the 
incremental mortality rate.
The evolutionary dynamics and resulting pattern of control failure differ markedly for
Top panels show different combinations of values for initiation day (x-axis) and daily mortality rate (y-
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For equivalent reductions in EIR, selection for resistance is best minimized by high
coverage with late initiation day, high mortality rate biopesticides. For example, the lowest
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different insecticides even when they give identical reductions in EIR for susceptible 
populations (Figure 52). Conventional instant-kill chemical insecticide (with coverage 
adjusted to achieve the same initial control as the biopesticides) fails first. The longest time 
to product failure is offered by a fungal biopesticide with relatively late mortality initiation, 
which then kills at a very high rate (Figure 52).
Figure 51: Population level infectious bite rate and proportion resistant for 
populations exposed to different biopesticides
Top panels show the population reduction in infectious bites per unit of time for each of five different 
virulence combinations, and the change in this value over time with the spread of resistance to the 
treatments, shown in bottom panels. 80% coverage assumed throughout.
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Clearly, the probability that a mosquito contacts and is affected by a vector-control 
treatment has a significant impact on both the reduction in EIR and reproductive success.
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Figure 52: Comparison of four interventions providing a 90% initial reduction in 
infectious bites
Plots show the change over time in the proportion of resistant individuals (bottom panel) and the 
percentage reduction in population level infectious bites (top panel) for a mosquito population 
consistently exposed to one of four vector control treatments, all chosen to give the same 90% initial 
reduction in EER.
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Reductions in EIR improve as coverage is increased, but the strength of selection for 
resistance also increases (Figure 53, left panels). This illustrates the predictable trade-off 
between the best transmission control, obtained at high coverage, and the best resistance 
management, obtained at low coverage. When compared to the currently available 
alternative, a conventional instant-kill chemical insecticide, however, the relative values 
for EIR reduction and resistance management with the biopesticides are maximized at the 
high coverage values which correspond to the best transmission control and the strongest 
selection pressures for resistance (Figure 53, right panels). Even a biopesticide with 
sufficiently high virulence to match the initial EIR reduction of instant-kill insecticides at 
the same coverage levels offers some benefit in terms of useful life (Figure 54). This is
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because fungus-infected mosquitoes are still able to achieve some reproduction before
being killed, thus somewhat reducing the selection for resistance.
Figure 53 Comparison of conventional instant-kill chemical insecticide and four 
biopesticides across a range of coverage values
Lifetime reproductive success with interventions as a proportion of LRS for untreated mosquitoes (top 
left panel) and as a proportion of LRS for mosquitoes treated with an instant-kill insecticide (top right 
panel). Reduction in average infectious bites per mosquito lifetime with interventions, compared to the 
value for untreated mosquitoes (bottom left panel), 0 = no reduction in infectious bites, 1.00 = no 
infectious bites. Reduction in infectious bites with interventions vs untreated mosquitoes, compared to 
the reduction achieved using a conventional instant kill insecticide (bottom right panel), 1.00 means a 
reduction equal to that achieved by instant-kill insecticide.
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Figure 54: Comparison of resistance spread and consequent increases in infectious 
bites with instant-kill and fungal biopesticides
Biopesticide virulence selected to give pre-resistance EIR reduction matching instant-kill pesticides at 
80% or 30% coverage. Plots show the proportion of the population with resistant phenotypes, and the 
corresponding values for population-level reduction in infectious bites per unit of time compared to an 
untreated population.
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4.5.2 Repellancy
One of the most commonly used classes of conventional insecticides, pyrethroids, have 
high contact irritancy (also called excito-repellency), causing approximately 50% of 
mosquitoes contacting treated surfaces to be repelled without acquiring a harmful dose 
[20,83,84,86]. There is no indication of any repellency effects for the fungal biopesticides 
[19]. For IRS, if 50% of mosquitoes contacting the instant-kill insecticide are unaffected 
by it, then, for equivalent spray coverage, fungal biopesticides offer better reductions in 
EIR at all coverage levels, whilst maintaining selection benefits for all but the most 
virulent strain at the lowest coverage (Figure 55).
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Figure 55: Comparison between biopesticides and instant-kill insecticide with 50% 
contact irritancy, across range of coverage values
Lifetime reproductive success with interventions as a proportion of LRS for untreated mosquitoes (top 
left panel) and as a proportion of LRS for mosquitoes treated with an instant-kill insecticide with 50% 
contact irritancy (top right panel). Reduction in average infectious bites per mosquito lifetime with 
interventions, compared to the value for untreated mosquitoes (bottom left panel), 0 = no reduction in 
infectious bites, 1.00 = no infectious bites. Reduction in infectious bites with interventions vs untreated 
mosquitoes, compared to the reduction achieved using a conventional instant kill insecticide with 50% 
contact irritancy (bottom right panel), 1.00 means reduction in AIB equal to that achieved by instant- 
kill insecticide with 50% contact irritancy.
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4.5.3 Malaria interactions
Some fungal strains have been shown to have higher virulence in malaria-infected 
mosquitoes than in those without malaria infection [16]. The trade-off between reducing 
EIR and resistance management is greatly reduced where fungal virulence is lower in 
malaria-free mosquitoes, with selection for resistance virtually eliminated if the fungus 
induces mortality exclusively in malaria-infected mosquitoes (Figure 56).
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Figure 56 Differential mortality in malaria-infected and malaria-free mosquitoes 
Comparison of speed of spread of resistance and consequent loss of transmission control for 
populations treated with one of five fungal biopesticides with differential mortality rates in malaria- 
infected mosquitoes. Plots show the proportion of the population with resistant phenotypes, and the 
corresponding values for population-level reductions in infectious bites per unit of time compared to 
an untreated population. The biopesticides all have day 3 initiation of a 72% daily mortality rate for 
malaria infected mosquitoes, giving an initial 99% reduction in infectious bites per time period.
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Variation in the virulence characteristics of potential biopesticides offers scope for 
selecting strains targeted to provide desirable combinations of reduced transmission and 
resistance management. A number of virulence phenotypes can provide equivalent levels 
of EIR reduction (Figure 50), and in general high biopesticide-induced mortality rates 
commencing as late as possible offer better resistance management for a given level of pre­
resistance EIR reduction (Figure 50 and Figure 52). There is nonetheless a trade-off 
between extending the time taken for resistance evolution to undermine efficacy of a 
pesticide, and the initial reductions in transmission (Figure 51). In general terms, and
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consistent with our results in Section 3, more virulent fungal strains better reduce 
transmission initially, but at the cost of stronger selection for resistance, and consequently 
a shorter useful life.
Although high coverage offers scope to use less virulent fungal strains to reduce EIR, for 
given virulence parameters, higher levels of coverage also generate stronger selection for 
resistance, for both conventional and biopesticide interventions. Remembering that the 
biopesticides must be considered in relation to the best currently used approaches, it is 
interesting to note that in relative terms, the benefits of biopesticides versus conventional 
instant-kill insecticides are maximized at high coverage for both transmission control and 
resistance management (Figure 53).
The relative importance of initial control versus product lifespan depends on a large 
number of factors, including the availability of alternative replacement treatments, the 
meaning in terms of human morbidity and mortality of a smaller reduction in EIR at the 
outset, and the realities of public health budgets and other resources. The relative costs and 
benefits also change if the biopesticide is being considered for use as part of a combination 
treatment with other interventions [54,87,88]. There is, therefore, no simple mathematical 
optimum for the many possible virulence schedules; the many possibilities need to be 
considered in context. In so far as it can be done without compromising transmission 
control, however, it is clearly beneficial to choose the biopesticide that generates the 
lowest selection for resistance in a particular context. For resistance management, the aim 
should be to achieve high levels of coverage, allowing less virulent fungal strains to 
achieve a given level of control, and maximizing their resistance management benefits 
over instant-kill insecticides.
Even strains sufficiently virulent to match the transmission reducing characteristics of 
conventional instant-kill chemical insecticides at the same coverage levels still offer a 
small benefit in terms of the rate of spread of resistance (Figure 54). Such a resistance
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management gain would be enhanced by any fitness costs associated with resistance [49] 
(see Section 3.5.5).
The conclusions presented here are independent of the method of resistance (e.g. metabolic 
or behavioural), provided it is genetically determined. It is assumed however that 
resistance is a binary quality, with mosquitoes either experiencing the full effects of a 
control measure, or remaining completely unaffected by it. The analysis of the speed of 
spread of resistance here thus assumes that susceptible mosquitoes experience infections 
with the specified virulence characteristics, and that resistant mosquitoes have no fungal 
mortality. In reality, it is more probable that a resistance/tolerance process would operate, 
with resistant mosquitoes still becoming infected, but experiencing a lower mortality rate 
than fully susceptible individuals. The spread of resistance would therefore effectively 
comprise a reduction in fungal virulence, rather than a complete loss of control. 
Considering the results presented in Figure 51, for example, this would mean that the 
spread of resistance to the highest virulence biopesticides, rather than comprising a steep 
function to complete resistance and total loss of transmission control, would move to the 
curves calculated for sequentially less virulent strains, as resistance converts high virulence 
strains to low virulence strains, offering even more beneficial resistance management 
possibilities. Future analyses could explore the impact of hypothetical resistance 
mechanisms that might operate with respect to conventional and fungal pesticides. The 
analysis presented here could also be extended to evaluate the impact of malaria infection 
on mosquito survival, fecundity and behaviour and variation in fecundity with mosquito 
age.
Certain widely used pyrethroid insecticides have high contact repellency, with studies 
suggesting that around 50% of mosquitoes landing on treated surfaces may leave before 
acquiring a fatal dose [20,83,84,86]. Whilst this potentially enhances the impact of 
pyrethroid-treated bed nets on transmission by deflecting mosquitoes away from protected
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humans before they bite, for IRS it results in mosquitoes surviving to potentially transmit 
malaria in later feeding cycles [20]. Thus, for this group of conventional insecticides, the 
composite ‘coverage’ value at a given level of spray cover would be half that for 
biopesticides, and could never be greater than 50%. Comparing biopesticide results with a 
conventional insecticide, and assuming 50% contact repellency (Figure 55) across a full 
range of coverage values, fungi better reduce transmission than pyrethroid IRS, while still 
maintaining some resistance management benefits. This suggests that, for all spray 
coverage values, suitably virulent fungal strains might provide a better option for IRS- 
based vector interventions than contact-repellent pyrethroids. If only low levels of spray 
coverage are achievable, replacing repellent pyrethroids with high-virulence fungal 
treatments could significantly improve the achievable EIR reduction, without significantly 
increasing selection for resistance, which is in any case relatively weak at low coverage 
(Figure 55). Where high spray coverage is achievable, replacing pyrethroids with relatively 
low-virulence fungal treatments could give improvements in both transmission control and 
resistance management, since the relative fitness of susceptible mosquitoes would be 
potentially doubled.
The analysis shows that in all cases, having higher fungal-induced mortality in malaria- 
infected mosquitoes than in uninfected mosquitoes minimizes the fitness costs associated 
with a given reduction in transmission (Figure 56). The ideal biopesticide from the 
resistance management perspective would be one that had little or no impact on 
mosquitoes not infected with malaria, but was strongly virulent in malaria-infected 
individuals. This might be possible since malaria infection can impose significant 
metabolic and immunological challenges to mosquitoes [89-92]. There is only a minimal 
trade-off between transmission control and resistance management in malaria-linked 
incremental biopesticide mortality. By changing the fitness cost to the mosquito of malaria 
infection, pesticides working in this way might also exert selection in favour of vector 
resistance to malaria, further enhancing the transmission-control benefits from the
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intervention. Strain selection or genetic modification should ideally target this trait. A 
further development of this principle would be fungal strains which specifically block 
development of the malaria parasite in the mosquito, or simply act as a delivery 
mechanism for anti-malaria interventions in the mosquito host (‘paratransgenesis’ [73,85]), 
with minimum survival or fecundity costs to the mosquito. It must be noted, however, that 
this potentially moves selection for resistance from the mosquito to the malaria parasite, 
which has so far proved extraordinarily adept at evolving its way out of trouble.
4.7 Conclusions
This analysis shows that fungal biopesticides have the potential to significantly reduce EIR 
while imposing only weak selection for resistance. There is always a trade-off between the 
magnitude of the initial reductions in transmission and maintaining those reductions in the 
longer term. Given the severe human and economic consequences of malaria transmission, 
choosing an intervention which does not maximally reduce transmission at the outset 
requires very careful justification. However, the analyses presented here show that fungal 
biopesticides can offer equivalent or better reductions in transmission than existing 
interventions in both the short and long term. This is especially true where existing 
conventional chemical pesticides have high contact irritancy or resistance to them has 
already begun to spread. The theoretical analyses presented here should help define the 
vector mortality profiles required to maximize the sustained malaria control potential of 
fungal biopesticides, or indeed other novel biological or chemical insecticides.
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“If a healthy minded person takes an interest in science, he gets busy with his mathematics and haunts 
the laboratory. ”
W.S. Franklin.
5 Chapter 5 Case study, potential target for TDI development 
5.1 Introduction
Molecular entomologist Kristen Michel, with Karajo Sprigg and others working in the 
Michel laboratory at Kansas State University, have identified a serpin, SRPN2, which 
negatively regulates the process of melanisation in the mosquito [21]. Melanisation is one 
arm of invertebrate immunity [93]. Using injection with dsRNA to deplete SRPN2, their 
experiments have revealed that the consequent upregulation of melanisation produces a 
time-delayed mortality schedule in affected mosquitoes, as well as reducing feeding 
propensity and fecundity. A chemical formulation achieving the same effect in a more 
easily delivered format therefore presents as a potential target for TDI development. We 
were asked to help investigate the disease control potential and resistance management 
characteristics of such a product.
Using experimental data provided by Michel et al, with an adapted version of our FCM 
model (chapter 3.2) we calculate values for the reduction in EIR and selection coefficient 
associated with use of a TDI producing effects equivalent to SRPN2 depletion, and 
compare these with values for theoretical LLAs and conventional instant-kill chemical 
insecticides.
5.2 Methods
We were provided with survival, blood feeding, egg laying and hatch-rate data generated 
from a number of experiments using mosquitoes injected with dsRNA to produce SRPN2 
depletion (hereafter “SRPN2KD”), alongside untreated controls and controls injected with 
green fluorescent protein (hereafter “injected controls”).
In order to evaluate the transmission reduction potential of SRPN2 depletion we need to 
identify the additional mortality experienced by SRPN2KD mosquitoes compared to that
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experienced by control mosquitoes. We can then use these incremental mortalities in our 
FCM model in combination with background mortalities derived from field data. We need 
to do this rather than simply using the total laboratory SRPN2KD mortality figures because 
the LLA concept is predicated on the high mortality rates experienced by wild mosquitoes 
[49], and these are not reflected in laboratory mortality rates, where survival is generally 
much higher. The daily incremental SRPN2KD mortalities are the values required for px 
and sx in our FCM model (Table 4, p.30). Since we model 10 cycles of less than three days 
duration, we are not concerned with values beyond day 30.
We were provided with survival data for four replicate experiments for each of two feeding 
regimes. Mosquitoes were either offered daily opportunities to blood feed and oviposit, or 
were offered a blood meal only every fifth day. Since we are interested in the effect that a 
potential TDI would have in the field, we use the results from the daily bloodfeed 
experiments as these more closely resemble the natural situation than the five day blood 
feed experiments. Sensitivity analysis confirms (below) that this choice is not critical to 
our conclusions.
The SRPN2KD mosquitoes were injected with dsRNA to engender SRPN2 depletion. 
Since we are interested in the mortality arising from the effects of SRPN2 depletion but not 
those arising from the injection process, we make comparisons with the control mosquitoes 
injected with double-stranded green fluorescent protein, a neutral substance for this 
purpose. The differences between the daily mortality rates in the SRPNKD and injected 
control mosquitoes showed high variability between experiments, and rapid daily 
fluctuations within experiments (Figure 57). This was also the case for daily average 
values across all experiments within each feeding regime. Simple linear trend lines did not 
give a good visual match to the pattern of data.
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Figure 57 Difference between daily mortality of SRPN2KD mosquitoes and that 
experienced by injected controls.
Mortality differences calculated using the results from Michel et al, for daily blood fed (panel A) and 5 
day blood fed (panel B) experiments, and corresponding average values. Experiment identification 
numbers are from the source data.
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In order to capture time-related changes in incremental SRPN2KD mortality, therefore, 
whilst reducing arbitrary daily fluctuation, we process the data in the following way. For 
each experiment, for SRPN2KD and injected controls, we group the daily mortalities into 
three-day averages, for example we calculate the average values for SRPN2KD mortalities 
over days 1 to 3, days 4 to 5, and so on. Using the grouped averages as daily rates, so that 
the average for days 1 to 3 is used as the value in days 1 to 3, and so on, we subtract the 
grouped average mortalities for injected controls from those for SRPN2KD, giving 
grouped SRPN2KD incremental daily mortalities for each experiment. We use these results 
to calculate average daily values across all four experiments (hereafter “3 day averages”).
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The averaging calculation ignores experiments which have no survivors (so when only 
three experiments still have survivors, averages are divided by three rather than four). As 
can be seen from Figure 58 this gives figures which appear to follow the pattern of the 
data, but with reduced fluctuation.
Figure 58 Simple and grouped averages for SRPN2KD incremental mortality
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To check that these calculated incremental mortality values are an appropriate 
representation of the data, we add the 3 day averages to the unprocessed mortalities for 
injected controls in each experiment, and compare survival curves calculated using these 
values with the observed SRPN2KD survival curves. As can be seen from Figure 59 the 
results give a good visual fit in all cases, although predictably better with the daily blood 
feed experimental results on which they are based, than with the five day blood feed 
results.
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Figure 59 Survival curves using experimental data and calculated mortalities 
Each panel shows the survival curves for injected controls and SRPN2KD mosquitoes in a single 
experiment. The top four panels use data from experiments where daily blood feeds were offered, the 
bottom four use data from experiments which gave a blood feed on every fifth day. The SRPN2KD 
calculated plots show survival values produced using the injected control mortalities for each 
experiment plus the 3 day average incremental mortalities calculated from the daily blood feed 
experimental results. Panels are labelled with the experiment identification numbers provided with the 
original data sets. All experimental data provided ny Michel et al.
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In addition to incremental mortalities, we also need a value for the proportionate reduction 
in feeding propensity for SRPN2KD mosquitoes. Experimental data for the percentage of 
surviving mosquitoes which blood feed on any given day (Figure 60) is available for five 
experiments, including those used to calculate the 3 day average incremental mortality 
values. Simple comparison of the daily blood fed percentages is not adequate for definition 
of our required parameter value however, for a number of reasons. Firstly, the different
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number of survivors on different days means that the daily blood feeding percentages
should not be equally weighted, for example, periods in which only a small proportion of
mosquitoes are still alive, and the percentage attempting to feed is an extreme high or low
value will distort average values. Secondly, the daily results are very sensitive to the timing
of feeding attempts. For example, consider a two-day period in which all surviving
SRPN2KD and injected control mosquitoes attempt to blood feed exactly once. If feeding
attempts for both categories of mosquito are similarly distributed in time, the daily blood
feeding propensities will be the same for both groups of mosquitoes, indicating no
difference in feeding propensity. However, if feeding attempts by SRPN2KD mosquitoes
are 99% made on day 1, and by injected controls, 99% on day 2, the difference between the
daily blood feeding propensities would be 98% on both days.
Figure 60 Daily blood feeding propensities for SRPN2KD and injected controls.
Results from experiments (Michel et at) with blood feeds and ovipositing opportunities offered daily. 
Plots are the proportion of surviving SRPN2KD (top panel) and injected control (bottom panel) 
mosquitoes taking a blood meal each day.
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To deal with these issues, instead of using the daily blood feeding propensities we consider 
the number of blood feeds per mosquito day. For example, if 100% of mosquitoes survive 
to day 1, with 60% of them feeding, and 50% survive to day 2, of which 30% feed, for an 
initial population size of N, over the two days we have Nx(l+0.5) mosquito days, during 
which there were Nx(lx0.6+0.5x0.3) blood feeds, giving Nx0.75 blood feeds in Nxl.5 
mosquito days, an average of 0.5 blood feeds per mosquito day.
We calculate the average number of blood feeds per mosquito day for SRPN2KD and 
injected controls over the first 30 days of each experiment (i.e. over the period of interest 
for our model). For each experiment we then calculate the difference between these values 
for SRPN2KD and injected controls as a proportion of the injected control values, giving 
the proportionate difference in blood feeding propensity for SRPN2KD versus injected 
controls. The average of these values across all 5 experiments is 24%, and we use this as 
our base reduction in feeding propensity for TDI contaminated mosquitoes in our model.
The feeding propensity values vary substantially between experiments, however, and we 
cannot know which set of experimental results correspond most meaningfully to conditions 
in the field, nor whether field conditions would simply produce all the possible outcomes 
at different times, we therefore bracket this average value with evaluations using the 
smallest (7.5%) and largest (59%) single experiment values for reductions in feeding 
propensity.
The FCM model (chapter 3.2) assumes that all mosquitoes which survive long enough to 
do so will attempt to feed, and then go on to lay eggs, in each gonotrophic cycle during a 
lifetime. We therefore have to amend the model to incorporate the possibility of 
mosquitoes missing a feed during a given sporogonic cycle.
We create a new parameter, A/, feeding propensity for mosquitoes with a TDI status of /, 
with / = 0 for mosquitoes uncontaminated with a TDI, and otherwise / is equal to the 
number of cycles since contamination with the TDI, as defined in Table 4, p30. 
Mosquitoes with no TDI continue to attempt to feed in every cycle so Ao=l. We then
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adjust the probabilities of survival, giving an infectious bite and egg-laying to reflect the 
possibility that a given proportion of mosquitoes will not feed or lay. It is assumed that 
mosquitoes which do not feed or lay in a given cycle will still experience the daily 
background mortality associated with a period of time equal to the length of one 
gonotrophic cycle.
The number of infectious bites given in cycle i by mosquitoes with TDI status /, will be 
reduced in direct proportion to the reduction in feeding propensity. Equation (13), p.64, is 
therefore revised to 
i-l i-l
J  _  m = D  /= 0_________________________________________________
K i> D
The probability that a mosquito starting cycle i with malaria status m and TDI status I will 
not attempt to bite any host, nor to lay eggs, and will survive to the start of cycle i+1 is the 
probability that a mosquito with TDI status / will not attempt to feed, multiplied by the 
probabilities of surviving a number of days equivalent to the time spent host seeking, 
resting and searching for a laying site. Since this model adaptation is specifically for the 
evaluation of a TDI we can assume that the probability of contacting a conventional 
instant-kill insecticide is zero, so k\j = 0 and kzj = 0. The probability of surviving a cycle 
without feeding or laying is therefore equal to the probability of surviving the cycle with 
feeding and laying, adjusted to remove the specific feeding-related mortalities, a\ and #2- 
The probability of surviving to the start of cycle i, with an existing malaria infection, given 
by equation (18), p.69, is therefore reformulated as
V*
A !-A -4
v V -v y
i >1 m > 1 / > 1
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Non-feeding mosquitoes cannot acquire a new malaria infection, so equation (17), p.69, 
can be amended to
( # / - ! , 0 ,/-l,l ^  ^ ;- l ,0 ,/- l ,2  # /-l,0 ,/- l,3  )  Z i-\ ,0 ,l- \ A. +■
1-A.
/ > 1 / > 1
and equation (16), p.68, to
V i , l , /  =  V / - l , 0 , / - l # / - l , 0 , / - l , 3  ( l  —  A )  M  Z M > 0 j M
/>  1 />  1.
The probability of surviving through cycle i with an existing TDI infection, given by
equation (19), p.70, is revised to
f  3
^i,m,l ^  j Qi,m,l,l 
\ h =1
Z ,i,m,l A/ +
1-A,
V
/ > 0.
Only mosquitoes which blood-feed are assumed to lay eggs in any given cycle. The 
average number of eggs laid in cycle i by mosquitoes starting cycle / with malaria status m 
and TDI status 1, equation (15), p.66, is thus revised to
(  3
\ h=1
l> 0
We need an empirical estimate of fecundity for SRPN2KD to use for parameter E ^ i, the 
proportion of eggs laid per oviposition by mosquitoes contaminated with a TDI / cycles 
ago, compared to those laid by mosquitoes with no TDI contamination (Table 4, p.64). The 
experimental results include the number of eggs laid per bloodfed female and the 
subsequent hatch rates, for SRPN2KD bloodfed females and injected controls, for four 
feeding cycles (Table 21).
We use the number of hatching eggs per bloodfed female as a basis for comparing 
fecundity of SRPN2KD and injected controls. We calculate the relative numbers of 
hatching eggs per SRPN2KD female as a proportion of those laid by injected controls for 
each cycle, and use the average of these results, 0.40, as our fecundity adjustment factor.
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We also produce sensitivity cases using the highest and lowest per cycle values, 0.53 and 
0.32.
Table 21 Summary of experimental reproduction data and calculation of relative 
SRPN2KD fecundity
SRPN2KD injected controls
Eggs
/bloodfed
female hatch rate
eggsx
hatch
rate
Eggs
/bloodfed
female hatch rate
eggsx
hatch
rate
SRPN2KD
relative
fecundity
Cycle 1 31.57 52% 16.33 67.11 75% 50.45 0.32
Cycle 2 18.68 60% 11.12 46.89 72% 33.99 0.33
Cycle 3 20.54 76% 15.52 49.64 71% 35.04 0.44
Cycle 4 23.54 56% 13.29 37.87 67% 25.30 0.53
average 0.40
5.3 Results
Using the amended FCM model we calculate the reduction in infectious bites and the 
selection coefficient for a TDI with equivalent effects to SRPN2 depletion (hereafter 
“SRPN2 TDI”), assuming 80% coverage and other parameter values as defined above and 
in Table 6, p.80. Our results, summarised in Table 22, indicate that RAIB is very 
dependent on the SRPN2 TDI’s effect on blood feeding propensity. A TDI producing the 
same mortality effects as SRPN2 depletion, but no changes in fecundity or feeding 
propensity, offers a reduction in infectious bites of only 54%, unlikely to be sufficient as a 
stand-alone intervention. When reduced blood feeding propensity is considered in addition 
to increased mortality, however, infectious bite reductions range from 68% to 94%, the 
maximum value approaching the infectious bite reductions calculated for a conventional 
instant-kill insecticide at the same coverage levels. Reduced blood feeding propensity, 
however, also increases the selection coefficient because mosquitoes which do not feed do 
not lay eggs, increasing the relative fitness of resistant phenotypes, and this is exacerbated 
by the reduction in fecundity for those females which do produce eggs, so that an 
infectious bite reduction of 94% is associated with a selection coefficient of 0.49, and even 
the lowest reduction in feeding propensity, offering a 68% reduction in infectious bites,
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generates a selection coefficient of 0.41, compared to 0.35 for a conventional instant kill 
insecticide at coverage levels providing the same infectious bite reduction.
With average feeding propensity, an 84% reduction in infectious bites is achievable, but 
with a selection coefficient of 0.46, almost as high as that for a CIKI giving the same 
transmission reduction.
Table 22 Results summary for effects of SRPN2 depletion on malaria transmission 
and mosquito fitness
Figures calculated using incremental mortality figures for SRPN2KD based on 3 day averages from 
daily blood feed data. Sensitivity results (a) using incremental mortality figures for SRPN 2KD based 
on 5-day averages from 5 day blood-feed data (b) using base case incremental mortalities with 
minimum and maximum values for relative fecundity
R esults Summary SRPN 2KD
Using incremental mortality schedule derived 
from 3-day grouped averages from daily 
bloodfeed experiments
Assum ptions Results
Relative 
Feeding 
Propensity 
per cycle 
when 
'infected'
Relative 
Fecundity 
per lay when 
'infected'
Transmission 
reduction 
(proportionate 
reduction in 
infectious bites 
per mosquito 
lifetime)
Selection
Coefficient
Selection 
Coefficient for 
conventional 
instant-kill 
insecticide 
giving same 
reduction in 
infectious 
bites
No fecundity or feeding propensity adjustment 1.00 1.00 54% 0.13
Minimum reduction in feeding propensity 0.925 1.00 68% 0.21 0.35
Average reduction in feeding propensity 0.76 1.00 84% 0.32 0.49
Maximum reduction in feeding propensity 0.41 1.00 94% 0.40 0.65
Min. reduction in feeding propensity + fecundity reduction 0.925 0.40 68% 0.41 0.35
Av'ge reduction in feeding prop. + fecundity reduction 0.76 0.40 84% 0.46 0.49
Max. reduction in feeding propensity + fecundity reduction 0.41 0.40 94% 0.49 0.65
Sum m ary sensitiv ity  resu lts SRPN 2KD
5 day grouped average mortalities (a)
Minimum reduction in feeding propensity 0.925 0.40 64% 0.42
Average reduction in feeding propensity 0.76 0.40 83% 0.46
Maximum reduction in feeding propensity 0.41 0.40 93% 0.49
Base case  mortalities, fecundity sensitivies (b)
Av'ge reduction in feeding prop. + fecundity reduction 0.76 0.32 84% 0.47
Av'ge reduction in feeding prop. + fecundity reduction 0.76 0.53 84% 0.43
Sensitivity analysis confirms that these results are robust to our choice of data. It can be 
seen from Table 22 that using incremental mortalities derived from the five-day blood feed 
experimental results, rather than from the daily blood feed data, does not materially change 
the results for either EIR reduction or selection coefficient. Using the maximum and 
minimum relative fecundity values for individual experiments also gives results consistent 
with our base case.
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5.4 Discussion
The mortality produced by SRPN2 depletion offers levels of transmission control 
considerably lower than those available with CIKIs at the same coverage levels, but when 
reductions in feeding propensity are also taken into account, levels of transmission control 
comparable to those achieved using current CIKIs may be achievable. The potential for a 
SRPN2 TDI to be developed into a practical transmission control intervention is therefore 
dependent on its impact on feeding propensity in the field. A high degree of variation in 
the feeding propensity values was apparent in the experimental data, however, making this 
hard to predict. It may be that the stresses which increase background mortality in the field 
interact with the effects of SRPN2 depletion to give a consistently high reduction in 
feeding propensity. Alternatively, however, field conditions might minimise the effect of 
SRPN2 depletion on feeding propensity, limiting the transmission reductions achievable. 
Reduced feeding propensity also reduces the fitness of susceptible mosquitoes, so the 
transmission control benefits it provides come at the cost of higher selection for resistance. 
Reduced fecundity in SRPN2KD mosquitoes further increases the strength of selection for 
resistance to a SRPN2 TDI and the results summarised in Table 22 indicate that a SRPN2 
TDI would not achieve a combination of transmission reduction and low selection for 
resistance equivalent to those calculated in previous chapters for theoretical LLA 
insecticides. For example, we calculate (Figure 50, p. 133) that an appropriately virulent 
fungal biopesticide could offer a 90% reduction in infectious bites combined with a 
selection coefficient of 0.21, and (Table 12, p.86) that a 4-cycle ADI could offer a 95% 
reduction in infectious bites combined with a 0.22 selection coefficient, whereas for a 
SRPN2 TDI we calculate selection coefficients between 0.41 and 0.49 for infectious bite 
reductions between 68% and 94%.
If its potential as an LLA is limited, then the performance of a SRPN2 depletion TDI needs 
to be compared to that of existing conventional insecticides simply as a potential new
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transmission reduction tool. As discussed above, this is highly dependent on the reduction 
in feeding propensity produced by the TDI. If the largest feeding propensity reduction we 
consider was achieved in the field, a SRPN2 TDI could offer a 93% reduction in infectious 
bites, lower than the 99% calculated for a conventional instant-kill insecticide applied at 
the same coverage levels (Table 12, p.86), but better than the 87% calculated for an instant 
kill insecticide with 50% contact irritancy (Figure 55, p. 138), assuming no contact irritancy 
for the new TDI. If the average or the lowest single-experiment feeding propensity 
reductions of 24% or 7.5% were achieved in the field, we calculate transmission reductions 
of 84% or 68% respectively, both lower than the transmission reductions offered by 
conventional instant-kill insecticides assuming the same (80%) coverage levels, and some 
very specific benefit, for example low cost, high persistence, high specificity or low 
toxicity, would presumably be required to make a SRPN2 TDI a candidate for commercial 
development in such case.
With the current data, we would conclude that a SRPN2 TDI would not offer the necessary 
combination of transmission reduction and resistance management benefits to make it a 
promising candidate for development as an LLA insecticide. It is not clear that it could 
offer consistently good transmission control in the field, but if it could, it would not be in 
combination with good resistance management.
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The problem with simple arguments is that they may be difficult to explain. 
_______________________________________________________________________________(Karin Erdmann)
6 Chapter 6 Modelling the spread of resistance -  generation overlap 
matters
6.1 Introduction
Results from the sensitivity analysis of our LLA model (Section 3.6.7) show that an 
assumption of recessivity versus dominance for resistance alleles is important, but has 
much less influence on the speed of spread of resistance than the differences in selection 
coefficient between the various insecticides we evaluate (Figure 42). This is inconsistent 
with conventional wisdom in resistance management however, which assumes that, if 
resistance alleles are recessive, resistance will not spread, or will spread extremely slowly 
(eg. [94-96]), and that this effect outweighs that of selection pressure in determining the 
speed of spread of resistance. We here explore the cause of this disparity, and identify a 
key assumption which determines which paradigm applies in specific contexts.
Review of the literature reveals that the assumption of little or no spread for recessive 
resistance alleles is generally based on the use of a standard population genetics model 
(hereafter the ‘replacement model’ or ‘RM’), as described by John Maynard Smith in his 
classic text book “Evolutionary Genetics” [97]. The RM considers discrete time-periods 
during which generations are produced, develop to maturity, reproduce once and die. 
These assumptions match the realities of a semeloparous life history with seasonal 
reproduction, like that of the mayfly [98]. The breeding adults in populations of 
Anopheline mosquitoes comprise a mixture of ages and generations, with surviving adults 
which have previously reproduced, as well as newly mature adults, all contributing to the 
genotypes of new offspring. Hereafter we refer to this mixing of surviving adults from one
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cohort with newly mature adults of a later cohort, as generation overlap. We show below, 
using comparison with our PM model, algebraic manipulation and numeric analysis, that 
for iteroparous populations with overlapping generations, such as anopheline mosquitoes, 
the RM significantly underestimates the speed of spread of initially rare recessive 
resistance alleles. Use of the RM in this context will therefore lead to misguided optimism 
about the predicted spread of resistance when resistance is recessive, and misplaced 
anxiety about the consequences of switching from functionally recessive to functionally 
dominant systems [95,99,100], as further discussed below..
6.2 Analysis
The RM is a standard population genetics model, [97] which tracks the spread of resistance 
alleles within a population through sequential discrete time periods. The model calculates 
the proportion of resistance alleles in the population at the beginning of each modelled 
time period. Offspring produced by the population in one period constitute the population 
at the beginning of the following time period, with proportions adjusted to reflect 
differential survival for resistant and susceptible phenotypes, and so on. Thus reproductive 
adults in one modelled time period are assumed to be entirely replaced by their offspring in 
the following modelled time period. This assumption is clearly appropriate for many 
combinations of life-history and time period. For many species however, including major 
disease vectors such as Anopheles mosquitoes, populations comprise multiple generations, 
all contributing to the genetics of the next generation of offspring. Although there are 
many details of such populations which the RM does not capture, for example population 
age-structure, we show here that, for initially rare recessive resistance alleles a primary 
source of the inconsistency between the RM and more detailed models is the RM’s failure 
to capture simple adult survivorship between modelled time periods.
Our analysis, calculated using the PM (chapter 3), of interventions using a conventional 
instant-kill insecticide (CIKI) provides a helpful basis for comparison with the results of
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the RM, as the mortality and reproduction values are the same for all mosquito ages, 
minimising the effects of age-structuring in the PM. It can be seen from Table 8 and Table 
11 that resistance to a CIKI (assuming no cost of resistance) gives 3 times the probability 
of surviving through a gonotrophic cycle, and hence the opportunity to produce 3 times as 
many eggs per cycle. If we take account of survival between feeding cycles, the lifetime 
fitness of resistant phenotypes is 6.5 times that of susceptibles. Whereas it is easy to 
interpret the parameters of the RM with respect to populations which follow seasonal 
breeding patterns in which adults reproduce once and then die, it is difficult to define 
biologically meaningful data sets for the RM when considering populations in which 
multiple adult generations overlap and adults reproduce repeatedly. It is in essence the 
failure of the RM to properly capture this situation which lies at the heart of this analysis. 
We find however, that, as can be seen in Figure 61, whether we assume that the RM time 
periods equate to a feeding cycle, and use relative fitness for resistants of 3, so s = 2, or that 
the RM time periods somehow equate to an adult lifetime, and use relative fitness for 
resistants of 6.5, so s = 5.5, our conclusions are unchanged and, compared to the PM, the 
RM substantially understates the speed of spread of rare recessive resistance alleles. For 
both s = 2 and s = 5.5, resistance has not spread after 10,500 modelled periods using the 
RM, whereas resistance alleles are close to 100% after 150 periods in the PM results. This 
is not the case if resistance is assumed to be dominant, the RM results in such cases 
actually showing somewhat faster spread of resistance than the PM. Note that the profiles 
of the results plotted from the PM shown in Figure 61 differ from those shown in chapters 
3 and 4 primarily because they are the proportion of resistance alleles rather than the 
proportion of resistant phenotypes.
A number of assumptions in the PM would be expected to contribute to differences in 
results when compared to the RM. The PM captures age-structuring in the population, 
delay between the timing of reproduction and the time when adult offspring join the
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population, mismatch between male and female genotypes, single mating at maturity, adult 
but not juvenile mortality and adult survival between modelled time-periods. The use of 
CIKI data eliminates age structure with respect to survival and reproductive success within 
a modelled time period and, for better comparability, the PM results presented in Figure 61 
also assume that the population of males has the same genetic makeup as that of females, 
and that the development period between reproduction and maturity of new offspring is 
one cycle.
Figure 61 Spread of resistance alleles over time, comparison of RM and PM results 
Spread of resistance alleles calculated using the PM model for a CIKI insecticide, assuming 1 cycle 
between egg production and resultant adults joining the population and that the male population has 
the same genotype as the female population (panel A), and using the RM model with the fitness benefit 
of resistance, set to S.5 (panel B) and 2 (panel C). The plots in each panel show results assuming 
recessive and dominant resistance. All calculations assume p 0 = 0.000000001.
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If the PM inputs are further adjusted to assume no adult survival between modelled time 
periods, the results become qualitatively much more like those from the RM, whether we 
maintain the same overall reproductive success per modelled time period, or use per 
lifetime reproductive figures in each modelled time period, as can be seen in Figure 62. 
The recessive allele does not spread in these examples within the 5,000 periods modelled 
by the PM.
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Figure 62 Spread of resistance alleles over time using the PM model with no adult 
survival between modelled periods
Using relative reproductive success values in each modelled time period equal to those per cycle (left 
hand panel), resistants produce 3x as many eggs as susceptibles, or per lifetime (right hand panel), 
resistants produce 6.5x as many eggs as susceptibles
— recessive
— recessive
—  dominant
—  dominant
per cycle relative fitness lifetime relative fitness
o.oo.o —t
300 5000 100 400200 3000 100 200
modelled time periods modelled time periods
Allowing new adults to survive and breed in a second time period is the simplest possible 
way to include overlap of part of the adult population between modelled time periods in 
the PM. We use per cycle resistant (65%) and susceptible (22%) survival probabilities 
between cycles 1 and 2 (Table 8), whilst either maintaining the per cycle reproductive 
value, or adjusting values to maintain the average per lifetime reproductive value across 
two cycles, and either assumption produces results much more consistent with the original 
PM results than with the RM results (Figure 63).
Figure 63 Spread of resistance alleles over time using the PM model with 1 period 
survival of new adults between modelled periods
Using relative reproductive success values in each modelled time period equal to that per cycle (left 
hand panel), resistants produce 3x as many eggs as susceptibles, or giving the original per lifetime 
value taking account of survival and reproduction in 2 periods (right hand panel), resistants produce 
6.5x as many eggs as susceptibles per lifetime, equal to 4.8x as many per cycle
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This suggests that population overlap may be a key assumption driving the difference 
between RM and PM results in cases with initially rare, recessive resistance alleles. To 
explore this further, eliminating any of the other possible differences between the PM and 
the RM, we add a generation overlap calculation to the RM model.
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6.2.1 Overlap Model
The ‘replacement model’ (RM) calculates sequential values forp t as
_ p] (1 + x) + P,q, (1 + hs)
l + s{p f + 2hpiqi)
Variables in the model are defined as follows; p t is the proportion of resistance alleles in
associated with a homozygous resistant genotype, and h is the proportion of that fitness 
benefit applicable to heterozygotes. If no direct fecundity effects of resistance are assumed, 
relative fitness is the same as the relative probabilities of resistant and susceptible 
phenotypes surviving through one modelled time period and hence forming part of the 
adult population at the start of the next period.
This is a representation of an iterative calculation based on proportions in the population of 
the three genotypes, homozygous susceptible, heterozygous and homozygous resistant. 
With the proportion of susceptible homozygotes in the population in modelled period i 
represented by at , of heterozygotes by bt and resistant homozygotes by c., the proportions
of each genotype in the population are calculated under the assumptions of the RM as 
follows (using superscript R to indicate values generated using the RM);
Seeking to avoid introducing ambiguity through unnecessary complexity, we use a simple 
development of the RM to explore the effects of including overlap of generations.
the population at start of time period i, s is the fitness benefit of the resistant phenotype
(cf +0.5 )2 (l + s)
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We assume that a proportion, m , ( 0 < m < 1), of the population in each period comprises 
new offspring, and(l -/w)is the proportion of the population in each period comprised of
surviving adults from previous periods, which we characterise as ‘overlap’. When m - 1, 
the revised model simplifies to the original RM model.
If we maintain the RM assumption that reproduction is periodic rather than continuous, and 
assume that modelled time periods equate to one reproductive cycle, the RM and the 
overlap model (hereafter “OM”) can use the same survival differential between resistant 
and susceptible phenotypes per reproductive period. The RM calculations ignore adults 
which survive from one period to the next, considering only the genotypes and resistance 
phenotypes of the offspring generated in each period. On this basis, the two models as 
formulated can have the same values for s , the fitness benefit accruing to the phenotype of 
a homozygous resistant genotype during a single modelled period, and results can be 
compared directly. Since for the RM, the fitness benefit of resistance can be equated to the 
differential survival of resistants through a period, from ‘birth’ to reproduction, we also use 
s as the value for differential survival from one modelled period to the next.
For the OM, genotype and allele proportions are calculated as follows, (using superscript 
V to indicate values generated using the OM);
,  ___________ (c:+ o .5b :)\\+s)_____________  <  (i+ s)
q  = i y i -------------------------------------     b l l ____ 771) ______   -____ ______
(l + (cf +0.52>f)2s + 2(c,’' + 0.5ft,r ) ( l-(c f  +0.5ftf))ftsj {\ + cvt s + t f  hs)
t VbM =m
2 (<  +0.5ft;)(l-(c,’' + 0.5*;))(l + fc)
( i + ( < + o.5ft;)2« + 2 ( c f + 0.5ft;) ( ! - « + o.5a; ) ) as) v ' ( i + c;.s+ a»
+ ( l -m)- bvt ( l  + hs)
+ cs s + 1
a = \ - h v - c v7+1 1 Ui+1 S + l
pl 1= 0 .5^ + ^
Graphical comparison of results calculated with the RM and OM, indicates (Figure 64) that
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qualitatively similar results are calculated by the two models when heterozygotes are
assumed to be largely or wholly resistant (resistance is dominant). In fact, if the proportion 
of resistant phenotypes is plotted rather than the proportion of resistant alleles, the OM and 
RM results with dominant resistance are effectively identical.
Figure 64 Spread of dominant resistance allele calculated using the RM model and 
the OM model with a range of fitness benefits for resistance.
Panels present results for values of 5=0.2 , 2, 5.5 and 100. Plots are for spread of dominant resistance 
alleles calculated using the RM, and using the OM assuming 10%, 20%, 40%, 60% and 90% overlap. 
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We therefore focus on comparison of the models when resistance is assumed to be 
recessive, (h  = 0). Under this assumption heterozygotes have no fitness or survival 
benefits, hence, spread of the resistance allele will depend on values of c , the proportion 
of resistant homozygotes.
Given h -  Owe can restate the models as follows;
r (cf + 0.56* )2 (1 + .S') 
(l + (c*+0.56*)2.y)
C i+1
2 (c* + 0.56*) (l -  (cf + 0.56*)) 
l + (c* + 0.56*)%j
K i =
_ (c* + 0.56*) (c*i + 0.56*s+ 1) 
PM 1 + (c*+0.56*)%
PA  Lynch November 2012
Page 164
and
CM=m
(qT+ O jy ) , (l + f ) c f  (1 + 5)
(i+(cr+o.5*r)2i) (i+c^ )
iYbM =m
2(c: + 0 .56;)(l-(cT  +O.Sy)) 
l + (cr+0.54,,')2i
(l — 7/2)
„ (cf + 0.56f )(l + cfs + 0.56^) ,0 .» r+ c T ( l  + *)
P w = n ,i--------------- ~ i --------L+ (\~m )-  -J—  v 7
l+ (c f + 0.56f) s 1 + cfs
For any given non-zero initial values of bt and c,. therefore, the rate of spread of the
P vresistance allele calculated using the OM model -^ 7-will be faster than that calculated
Pt
pR (0.5 t f ) 2
using the RM model, , if c, > -------*—r (note this is a sufficient but not necessary
p f  (l -  0.56, )
condition).
Initial values of c0 may, however be expected to be very low or zero, in which case the 
OM will give a lower value for c\ than the RM’s value, c f . We can nonetheless show
numerically that the RM understates the speed of spread of rare, recessive resistance alleles 
for overlapping generations even when a resistance allele is initially present only in 
heterozygotes and hence c q = 0 .
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Figure 65 The spread of resistance alleles assuming a range of values for generation 
overlap, /?o=0 .0 0 0 0 0 0 0 0 1
Spread of resistance alleles calculated with RM and OM models assuming fitness benefits of resistance 
of 100, 5.5 and 2. Panels are for (top to bottom) RM, OM assuming that 10%, 20% or 40% of the 
population in each time period comprises adult survivors from the preceding time period. In all cases 
resistance alleles are initially assumed to be present in heterozygotes only, and to comprise IE-9 of the 
population. Note that x-axis values differ between panels.
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It can be seen from the results shown in Figure 65 that for a given fitness benefit of 
resistance, 5, the calculated value of p  increases more slowly using the RM than using the 
OM with any of the tested values for generation overlap, (1-m), between model periods. It 
can further be seen from Figure 65 that p  increases more rapidly with higher values for 
overlap, and that the effect of overlap is greater with higher values of 5, the relative fitness 
benefit of resistance.
If the initial proportion of resistance alleles po, is increased, the times to spread of 
resistance are predictably compressed, as the long, differential periods of slow initial 
spread are removed, Figure 66. As can be seen from comparison with Figure 65, the effect 
of overlap is greater with a smaller initial value of po . For example, for 5=5.5, with p o = 1 0 '9, 
modelling a 20% overlap between generations reduces the time to spread of resistance 
from approximately 2xl08 to 100, a factor of about 2xl06, the equivalent reduction with 
/?o=10‘4 is from 2,000 to 40, a factor of approximately 50.
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Figure 6 6  The spread of resistance alleles assuming a range of values for generation 
overlap, with /?0=O.OOO1
Spread of resistance alleles calculated with RM and OM models assuming fitness benefits of resistance 
of 100, 5.5 and 2. Panels are for (top to bottom) RM, OM assuming that 10%, 20% or 40% of the 
population in each time period comprises adult survivors from the preceding time period. Note that x- 
axis values differ between panels.
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6.3 Discussion
Our results show that generation overlap is one of the key determinants of the speed of 
spread of resistance for initially rare recessive resistance alleles. In all cases resistance is 
predicted to spread more rapidly when population overlap is assumed. The practical 
importance of this effect is at least partly determined by context rather than just by 
magnitude. For example, for a 5.5 fitness benefit of resistance, with /?o= 1 0 '9, modelling a 
1 0 %  overlap indicates a time to resistance approximately 1 0 0  fold less than that indicated 
by the RM. Depending on the actual period of time represented by the modelled periods, 
however, the difference between 1.8x10s and 1.7xl05 may be immaterial, both timescales 
effectively representing ‘never’. The same comparison assuming j9o= 0 . 0 0 0 1 ,  calculates 
resistance spreading in around 1,900 periods using the RM, reducing to less than 740 
periods when 10% overlap is modelled. If modelled periods equate to a year, this 
difference is also of little practical importance, but if the modelled time period is some 
smaller unit, halving the expected time to spread of resistance may be a very important 
issue. The difference in expected time to spread of resistance for a fitness benefit of 100 
with />o= 1 0 ' 9, from around 1 0  million periods, modelled assuming no overlap of 
generations, to around 10, modelled with just 10% overlap, would almost certainly be seen 
as having very serious practical implications in any context, however.
In assessing the significance of these results it is helpful to consider that 5=100 is the order 
of magnitude of fitness benefits of resistance for pests feeding on crops genetically 
modified to express Bt toxins [94,101], our FCM model (Table 12) calculates the per cycle 
fitness benefit of resistance to a conventional insecticide as 5=2, and of resistance to a 4- 
cycle ADI as 5=0.2 . Also, based on an assumption that a constant number of newly mature 
offspring join the population in each modelled feeding cycle, the PM model calculates 
values for m of approximately 78% (i.e. 22% overlap) for a susceptible population, 
increasing as the proportion of resistant phenotypes grows, up to 64% (36% overlap) for a
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wholly resistant population. The values tested in our analysis are therefore within a 
biologically meaningful range.
In some circumstances the dominance of an allele is context-sensitive. For example, a 
resistance allele giving heterozygotes resistance to a given insecticide only for 
concentrations below a given threshold, would produce resistant heterozygotes in a context 
where the insecticide was present in low concentrations, and susceptible heterozygotes in a 
context where the insecticide was present in high concentrations^ 00]. Based on this it has 
been suggested that some resistance management strategies would actually result in an 
increase in the speed of spread of resistance if they generated a switch from functional 
recessivity to functional dominance for resistance alleles [102]. It is clear that such 
concerns are in part predicated on the assumption that rare recessive resistance alleles will, 
in practical terms, not spread. This assumption rests on the use of models equivalent to the 
RM, and whilst there is no reason to question its validity for life histories complying with 
the assumption of discrete non-overlapping generations, our work suggests it should be 
questioned when this is not the case.
The results we generate using the OM model all assume a constant value for the proportion 
of the population in each model period which is comprised of new offspring rather than 
surviving adults (m). Many factors can affect this value, including numbers of offspring 
produced per breeding adult, juvenile and adult survival, any adult or juvenile density 
dependence effects, et cetera. It cannot be derived directly from the parameters of the OM 
model without making additional explicit assumptions, such as the assumption of constant 
recruitment used for the analyses in chapters 3 and 4. In most circumstances, however, one 
might expect that changes to average adult survival probabilities, as arise when resistant 
phenotypes replace susceptibles in a population, will produce changes in the relative 
proportions of new offspring and surviving adults at the start of each modelled period.
Since the value of m directly affects the speed of spread of resistance (Figure 65 and Figure 
66) variations in this value as resistance spreads might alter the profile of p  over time, but
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for the purposes of comparison with results from RM, this should not affect our 
conclusions since the value of m during the crucial early periods, when spread of the allele 
accelerates, will be relatively stable, as susceptibles consistently form the vast majority of 
the population during this period.
6.4 Conclusions
It can be seen from our numeric analysis that the assumption of discrete, non-overlapping 
generations is key to the applicability of simple, single-allele, population genetics models 
when evaluating the spread of rare, recessive resistance alleles. Applying such models to 
organisms with life histories which violate this assumption is likely to generate highly 
misleading results, particularly when the fitness benefit of resistance is high and/or the 
proportion of the breeding population comprised of adult survivors rather than newly 
mature offspring is high. In such instances, the conventional wisdom, that rare, recessive 
resistance alleles will never spread, is wrong.
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‘7 have had my results for a long time: but I do not yet know how /  am to arrive at them. ” 
_________________________________________________________________ Carl Friedrich Gauss (1777-1855)
7 Chapter 7 General Discussion and Conclusions
In the preceding chapters we have explored a number of very specific questions under the 
general title “Mathematical modelling of the effects of health interventions on the 
evolution of life history in disease-causing organisms” and drawn particular conclusions 
with respect to each. Are any general conclusions possible for this group of topics? One 
consistent theme, perhaps, is the idea that detail matters. For worm evolution under health 
interventions, the precise details of worm mortalities will determine the direction of 
selection. For LLA insecticides, it is the detail of mortality schedules which opens the 
opportunity to combine transmission reduction with minimal selection for resistance, and 
for the standard popgen model, details of population structure prove critical to its results. 
Many biological parameter values are currently unknown and may be impossible to 
determine, so if detail matters, does this preclude any meaningful modelling of biological 
systems? Does all the work detailed in this text simply serve to highlight the futility of 
such undertakings? To paraphrase the Guy Browning quote heading chapter 1, how do we 
model soup?
If they collectively serve to pose this question, do the chapters above also offer a collective 
answer? On reflection, we would suggest that they do, and that, paradoxically, they show 
that the way to deal with complexity when detail matters, is to simplify. In chapter 2 we 
generate a model constructed around mortality functions which are currently unknowable. 
We cannot therefore populate our models with functions and parameters capturing the 
reality of specific parasite mortality schedules, with or without interventions, and we 
cannot realistically attempt to answer the question “what will happen?”. However, if we 
define the simplest result which can answer our original question, we merely need to know 
in which direction selection may push, and we need only consider the fact that 
interventions will increase worm mortality, not the details of the resultant mortality
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schedules. The question is “what may happen?” and to answer that question we don’t need 
to know any mortality functions or parameter values.
In chapter 3 we need a quantitative answer to whether LLAs can provide a combination of 
transmission control and resistance management. Although indicative values are available 
for some of the relevant life-history parameters, we lack not only well-defined parameter 
values, but also knowledge of the existence and/or significance of many aspects of the life- 
histories of mosquitoes, Plasmodium, and humans which might influence the precise 
number of infections transmitted by a mosquito, or the precise number of viable offspring 
it may produce. Here, again, we can simplify our question; rather than “what will happen if 
we change this” we ask “how much better or worse will things be if we change this?”. By 
formulating our results in comparative terms, we greatly reduce the significance of the 
unknown and unknowable aspects of the life-histories we are modelling, and remove the 
necessity of attempting to capture them in the model. Our sensitivity analysis confirms 
that, whilst the absolute calculated values for eggs laid and infectious bites given are very 
sensitive to some parameters, the comparative results remain robust to variations in 
parameters not directly related to the interventions we are assessing.
Simplicity also contributes to our evaluation of optimal virulence characteristics for fungal 
biopesticides. With an infinite range of possible survival curves, how do we produce 
generalisable results which can guide a practical process of strain selection? Elegant 
mathematical functions which replicate any curve are available, but the parameters which 
define such curves do not translate easily into biologically meaningful terms (Figure 67). 
Review of the basic biology leading to consideration of fungal entomopathogens as 
potential LLAs, the characteristic initial period of development prior to the onset of 
fungus-induced mortality, gave rise to the ‘simple virulence’ definition used in chapter 4 
which proved intuitive and easy to work with for this purpose (although tragically 
inelegant).
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Figure 67 Sample curves generated using the Weibull distribution
The curves generated by the Weibull distribution are defined by two parameters ‘s ’ and it \  which 
provide an elegant representation of almost any conceivable shape of survival curve, but do not give an 
obvious intuitive link to the biological parameters of interest.
t= 9 t= 12 t -  15t= 3 t= 6
s =
s =
s =-10
For the analysis based on experimental results in chapter 5, the whole process of deriving 
values useable in the model was one of simplification, supported by sensitivity analysis, to 
check that we hadn’t lost any crucial detail in the simplifying process.
In chapter 6, which is most explicitly about the importance of detail, it is nonetheless only 
by simplifying that we reached any meaningful conclusions. There are many differences 
between our age-structured vector PM model and the RM model. Only by eliminating as 
much of the complexity as possible could we establish that population overlap is a key 
driver of the dramatic difference in speed of spread of resistance alleles calculated by the 
two models.
Although we were able to address the specific questions which defined each of the above 
topics, and to reach conclusions based on our results, a number of other questions, beyond 
the scope of this text, are worth commenting on.
In section 3.6.6 we compare results calculated using two different population assumptions, 
either constant numbers of new adults joining the population in each period, or constant 
adult population size. It would be interesting to develop a new version of the model which 
could incorporate juvenile and adult density dependence, and ratios of offspring to 
breeding adults, so that the effects of various alternative assumptions could be assessed,
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such as seasonal variation in population size, and the effect of offspring numbers which 
change in line with the changing size of the adult population.
A potential mode of action for an LLA which cannot be evaluated by our model without 
further development is bioaccumulation, whereby repeated doses of a pesticide accumulate 
to reach a fatal dose. Assuming that coverage is less than 100% and/or the probability of 
feeding on a non-human host >0%, this would not be directly equivalent to any of the LLA 
types evaluated so far, and it may be interesting to explore the possibilities, either for novel 
chemistry, or as a novel mode of delivery for existing chemicals.
Although our numeric analysis justifies our conclusions in chapter 6, that population 
overlap is a key driver of the spread of rare recessive alleles, it would be pleasing to extend 
our mathematical result to illuminate why this appears to be true in all circumstance, not 
just for the initial conditions already identified.
Chapters 3, 4, and 5 all consider the use of novel insecticides within the existing 
framework of delivery in an indoor setting via IRS or ITNS. We explicitly define 
behavioural avoidance as a sub-category of resistance, and do not consider it as a separate 
issue. In terms of resistance management this seems a reasonable assumption. However, 
the evolution of outdoor biting behaviour [103,104] poses many questions about the 
sustainability of transmission control based on indoor delivery methods. No data is 
currently available about the fitness costs associated with changes to mosquito feeding 
patterns. Analysis of the effects of deflection by bed nets have focussed on the direct effect 
on disease control, usually by contrasting the effect of deflection with that of mosquito 
death in terms of preventing infectious bites, but have not attempted to quantify the fitness 
costs to the mosquito. To the best of our knowledge field data is not available regarding the 
fitness costs to the mosquito of deflection to alternative indoor hosts or to outdoor feeding. 
Since the widespread use of indoor insecticides and bed nets has not been seen to produce 
a rapid switch to outdoor biting, we must assume that there are either practical constraints
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which prevent this, or fitness costs which outweigh the costs of encountering insecticides 
during indoor feeding. Most Anopheles species preferentially feed indoors at night, biting 
sleeping hosts. There are many possible causes for this behaviour, for example, it may be 
safer to feed on humans when they are asleep, therefore vectors feed at night and indoors, 
because that’s when and where sleeping people are found. Alternatively, vectors may 
experience lower mortality by being active at night, and at night people are asleep and 
indoors, so that is where mosquitoes feed. If the former is the case, people choosing to 
sleep outdoors at any time of day would offer the best alternative hosts to people sleeping 
in buildings protected with IRS or ITNs. If the latter applies, then people outside at night 
would offer the most likely alternative hosts for mosquitoes avoiding indoor insecticides. 
Different fitness costs would be incurred in each case by mosquitoes switching strategies 
and without a proper understanding of such costs, intelligent management of this form of 
resistance cannot be confidently developed in theory, much less applied in practice. 
Whether as a problem to be resolved, or a process to be exploited, evolution must be taken 
into account when we make choices and design interventions. Ferguson et al [105] 
consider the possibility that public health interventions have already driven the evolution 
of malaria vectors on a grand scale, changing mosquito life-histories and consequently 
selecting for increased refractoriness to Plasmodium throughout Africa. In chapter 2 we 
discuss the idea of working with evolution, adjusting interventions not merely to avoid 
unwanted evolution, but to target desirable outcomes, Ferguson et al discuss this idea with 
respect to malaria vectors. At a time when it is still difficult to engage health professionals 
with the reality of resistance evolution as a pressing and immediate problem, it seems 
unlikely that they will be ready to respond to strategies designed to enlist evolution to act 
on their behalf. Can we stop seeing evolution generated by health interventions as 
inevitably threatening, and instead try to understand and direct it intelligently in directions 
which help us? Let’s hope so.
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S U M M A R Y
Infection caused by parasitic nematodes of humans and livestock can have significant health and economic costs. 
Treatments aimed at alleviating these costs, such as chemotherapy and vaccination, alter parasite survival and repro­
duction, the main selective pressures shaping life-history traits such as age to maturity, size and fecundity. Most authors 
have argued that the life-history evolution prompted by animal and public health programmes would be clinically 
beneficial, generating smaller, less fecund worms, and several mathematical models support this view. However, using 
mathematical models of long-lasting interventions, such as vaccination, and regularly repeated short interventions, such as 
drenching, we show here that the expected outcome actually depends on how mortality rates vary as a function of worm size 
and developmental status. Interventions which change mortality functions can exert selection pressure to either shorten 
or extend the time to maturity, and thus increase or decrease worm fecundity and size. The evolutionary trajectory 
depends critically on the details of the mortality functions with and without the intervention. Earlier optimism that health 
interventions would always prompt the evolution of smaller, less fecund and hence clinically less damaging worms is 
premature.
Key words: mortality rates, health interventions, maturation time, vaccination, chemotherapy, anthelminthic.
I N T R O D U C T I O N
Infections by parasitic nem atodes have a large impact 
on the health o f humans and dom estic livestock. T w o  
key life-history traits, fecundity and body size, are 
important determinants o f nem atode infectiousness 
and host damage (Skorping, Read and Keymer, 
1991; Stear, Strain and Bishop, 1999). Both are a 
consequence of the age at which nem atodes mature. 
A ll other things being equal, it takes longer to get 
bigger, and nem atode growth stops or rapidly de­
clines after reproduction begins. M oreover, bigger 
worms can produce more eggs (Skorping et al. 1991; 
M orand, 1996; G em m ill, Skorping and Read, 1999; 
Leignel and Cabaret, 2001; Sorci et al. 2003). 
Consequently, age at maturity m ust be subject to 
intense natural selection. Here we ask how health 
interventions, such as widespread vaccination and 
chemotherapy, m ight alter nem atode life history  
evolution. M ost previous work has show n that 
smaller, less fecund worm s are the likely outcom e 
(M edley, 1994; Poulin, 1998; but see Skorping and 
Read, 1998; G em m ill et al. 1999). In this paper we 
show that a variety o f evolutionary outcom es is
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possible, including the evolution of larger and hence 
more fecund and damaging worms.
Previous theoretical work on the evolution of  
parasitic nem atode life-histories has follow ed stan­
dard life history theory (Roff, 1992; Stearns, 1992) 
and assumed that mortality schedules are the 
major determinants o f selection (Skorping et al. 
1991; M orand and Sorci, 1998; G em m ill et al. 1999; 
Morand and Poulin, 2000; Sorci et al. 2003). W here 
chances o f survival are high, nem atodes should delay 
maturity to gain the fecundity benefits o f large size. 
H ow ever, w hen chances o f survival are low, worms 
should mature early in order to achieve som e repro­
duction before death, even if  this m eans they m ature 
at sm all size and hence have low fecundity. T hus, 
where daily survival rates are high, one m ight expect 
a life history like that o f Ascaris lumbricoides, for 
example, which reaches up to 30 cm  in length and 
produces 25 m illion eggs over a lifetim e. In contrast, 
where chances o f survival are low, natural selection  
should favour a life-history like that o f the pin  
worm , Enterobius vermicularis, which has a m axim um  
length o f 1 cm  and produces no more than 20000  
eggs. A  formal m odel o f this idea, together with  
experimental data on survival rates, explains about 
50 percent o f the cross-species variation in age 
to maturity o f parasitic nem atodes o f m ammals 
(G em m ill et al. 1999).
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T h e aim of animal and human health programmes 
like chem otherapy and vaccination is to reduce 
worm survival. T hus, nem atode life-histories could  
evolve in response to public and animal health pro­
grammes (M edley, 1994; Read and Skorping, 1995; 
Poulin, 1998; Skorping and Read, 1998; Leignel 
and Cabaret, 2001). T h is evolution may in principle 
occur in parallel w ith, or instead of, the evolution  
o f drug or vaccine resistance. There is no direct 
evidence yet o f such evolution, but it has not to our 
knowledge been looked for (for indirect evidence, see 
Leignel and Cabaret, 2001). In other contexts, where 
it has been looked for, life-history evolution in re­
sponse to anthropogenic alterations in mortality 
schedules has been demonstrated. For instance, 
size-selective harvesting of populations o f Atlantic 
silverside (M enidia menidia) changed size-dependent 
mortality schedules, and produced rapid evolution  
of slow growing, smaller fish in large-harvested 
populations and fast-grow ing, larger fish in sm all- 
harvested populations (Conover et al. 2005).
M ost previous theoretical work on the evolution  
o f nem atode age in response to m edical and veter­
inary intervention has suggested that the resulting  
life-history evolution would be beneficial from a 
disease control standpoint. T h e argument is that 
intervention-induced increases in mortality will 
mean that natural selection will always favour earlier 
maturation and thus result in smaller and less fecund  
worm s (M edley, 1994; Poulin, 1998; G em m ill et al.
1999). H ow ever, existing formal m odels o f this make 
fairly restrictive assum ptions about the nature of 
nem atode m ortality patterns, in particular assuming 
that m ortality rates are unaffected by age at maturity. 
Here we formally analyse earlier verbal suggestions 
(Read and Skorping, 1995; Skorping and Read, 
1998; G em m ill et al. 1999) that som e types o f stage- 
or size-specific mortality m ight generate clinically- 
detrimental life history evolution.
It seem s highly likely that mortality rates will 
vary w ith worm  size. Larger nem atodes presum ably 
provide m ore stim ulus to the im m une system , all else 
being equal, because they will secrete more antigens 
and have a larger surface area, and may do more 
damage. A lternatively, smaller nem atodes may be 
more vulnerable to im m une attack if they are less 
able to w ithstand damage from a given num ber of 
effector m olecules. T h e host im m une response can 
also alter worm  fecundity directly and indirectly via 
its effects on worm  size (W ilkes et al. 2004; V iney, 
Steer and W ilkes, 2006). M oreover, im m unity can 
differentially affect the survival o f different devel­
opmental stages o f parasites. For example, in 
Strongyloides ra tti different mortality rates were 
observed for larval and adult stages which are in 
different host tissues (Bell, Adams and Gerb, 1981). 
H ere w e consider the effects o f chem otherapy and 
vaccination allowing for these sort o f more com plex  
m ortality schedules. W e also consider the effects
both o f changes in mortality schedules which m ight 
be continuous (e.g. vaccination or, in the case of 
farm animals, artificially-selected resistant hosts) 
or those which would be pulsed (e.g. many chem o­
therapeutic regim es used in an agricultural context). 
W e show  that optim ism  em erging from previous 
m odels m ay be misplaced: in som e circumstances, 
animal and public health interventions may select for 
increased time to maturity, which would result in 
larger and more fecund worms.
M O D E L S
H ere w e consider the size-independent mortality 
m odel (henceforward “ S IM ” m odel) developed  
by G em m il et al. (1999), and introduce our new  
m odel, which incorporates size-dependent mortality 
(henceforward “ S D M ” m odel). W e then use these 
m odels to study the effect o f public and animal 
health interventions on worm  life-history evolution. 
In a subsequent section, we develop a m odel to 
study the effect o f size-dependent mortality when  
there are pulsed interventions like regular drenching 
o f farm animals w ith anthelm intics (henceforward 
“ S D M P ” m odel). A ll m odels assume that worm  
births are steady over time and the population is 
in equilibrium , hence lifetim e reproductive success 
(measured as lifetim e egg production) is an ap­
propriate measure o f fitness. Anderson and M ay 
(1985) provide evidence supporting this assumption. 
A nalysis of the epidem ic situation, where other fit­
ness measures are more appropriate, is beyond the 
scope o f this paper.
T hroughout, sym bols are as given in Table 1, 
and all mortality rates are instantaneous mortality 
rates -  the probability o f death at any particular point 
in time.
S ize  independent m ortality model
T h e assumptions o f this model are as follow s 
(G em m ill et al. 1999): (1). W orms grow throughout 
developm ent, but growth ceases at maturity. (2). Per 
unit tim e fecundity increases with worm  size and 
hence with maturation time a , according to the 
relationship fecundity =  ca^. (3). W ithin the host, 
parasites experience a constant juvenile mortality 
rate, M j ,  until maturation. (4). After the onset of 
reproduction, parasites experience a constant adult 
mortality rate, M a.
T h e probability o f survival to maturation at time 
a  is derived by treating the occurrence of death as 
a random variable with distribution Poisson(A) 
where X is the mortality rate, M j .  T hus, the average 
lifetim e fecundity for individuals maturing at a  is 
given by
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Table 1. Variables and Parameters for S IM , S D M  and S D M P  m odels. N ote all ages are measured  
from first infection of the mammalian host
a  Age at maturity
io(a) Fitness of worms maturing at a
c Constant relating age at maturity to worm fecundity
P Exponent of allometric relationship relating age at maturity to fecundity
Mj Within-host mortality rate for juvenile parasites
M a Within-host mortality rate for adult parasites
m(z) Mortality rate experienced by juvenile parasites at age z
d{a) Mortality rate experienced by adult parasites which matured at age a
cOf^ a) Fitness of worms maturing at a  in hosts experiencing a health intervention
Pi, Allometric exponent relating fecundity to age at maturity in hosts experiencing a health intervention acting
to reduce rate of increase of fecundity with age 
mh{z) Mortality rate experienced by juvenile parasites at age z  in hosts experiencing a health intervention acting
to increase juvenile parasite mortality 
dh{a) Mortality rate experienced by adult parasites which matured at age a  in hosts experiencing a health
intervention acting to increase adult parasite mortality 
Sj,{a*) Selection gradient at a* under an intervention
I  Time interval between doses; (7 > a )
H  Proportion of hosts dosed during dosing events
Dj Probability of juvenile parasites dying as a result of dosing event, if in dosed host
D m Probability of adult worms dying as a result of dosing event, if in dosed host
t Time from start of interval between dosing events; (0 <  t <  I)
0)p(a) Overall average fitness of parasites maturing at age a  under pulsed dosing
T h e model com prises three elem ents: c a the 
daily fecundity following maturity at a , e~M>a the 
probability o f survival to maturity with pre-patent 
period a , and the life expectancy post-m aturity  
(assum ing survival tim es are exponentially d is­
tributed).
T he age at maturity favoured by natural selection, 
a*, corresponds to the m aximum  of ft>(a), at which  
the derivative o/(a*) =  0, namely
M ; (2)
T h e same result can be derived from an explicitly  
epidem iological framework (Appendix A).
Size-dependent m ortality model
W e now extend the size-independent model 
(equation (1)) to include size-dependent mortality 
before and after maturation. In the next section, we 
use this framework to explore the effects o f health  
interventions on optim um  tim e to maturity.
T o  incorporate size-dependent mortality, we 
replace assumptions (3) and (4) above with the 
follow ing: (5). Pre-m aturity m ortality rate is deter­
m ined by size, and so changes during larval devel­
opm ent. It is given by the function m (z), where z  is 
the tim e (age) from arrival in host. (6). A dult para­
sites experience constant m ortality, determ ined by 
the size at which they matured, and given by the 
function d(a).
T h e size-dependent mortality m odel has a m or­
tality rate which varies with tim e, and so the occur­
rence o f death is a non-hom ogeneous Poisson  
process with distribution Poisson(w (2r)). T hus, the
probability that death will not occur before age z  is 
given by
1 - F { z )  =  e~ ^ z)
where
iu(z)- i ; m(u)du (z> 0)
Fitness is therefore given by
a>(a) = ca^ e~^ a)—^— 
d(a)
(3)
which reduces to equation (1) for constant mortality  
rates m (z)= M j  and d ( a ) = M a.
T he optimal value, a*, is again determ ined by the 
condition ta'ia*) — 0. T hus,
„ P d ' l a )
0 =  —  -   ~ m (a  )
a  d {a  )
(4)
with the additional requirem ent that, to ensure w {a) 
is maximal at a  =  c f , the second derivative m ust be 
negative.
A s illustrated in A ppendix B, m ultiple solutions 
may be possible for som e com binations o f mortality 
functions so that the theoretical global optim um  may 
not always be the value selected for.
T H E  E V O L U T I O N A R Y  C O N S E Q U E N C E S  O F  
P U B L I C  A N D  A N I M A L  H E A L T H  P R O G R A M M E S  
O N  N E M A T O D E  A G E  A T  M A T U R I T Y
Interventions like chem otherapy, vaccination and, in 
the case o f animal diseases, enhanced host resistance
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through selective breeding could affect many o f the 
key functions and variables w hich shape the selection  
pressures on nem atode age to maturity. For instance, 
enhanced host resistance or subcurative chem o­
therapy can reduce c, the absolute worm  fecundity  
(e.g. Crook and V iney, 2005; V iney et al. 2006). It 
follow s from equations (2) and (4) that this has 
no effect on the evolution o f age to maturity whether 
or not there is size-dependent mortality. Similarly, 
if  the adult mortality rate does not vary with age at 
maturity, then equation (4) reduces to equation (2) 
and changes to the absolute value o f the adult m or­
tality rate w ill also have no effect on selection for 
age at maturity. Otherwise, however, interventions 
w hich alter the juvenile mortality rate at a given age, 
m (z), the adult mortality rate for worm s maturing 
at a given age, d(a) or the rate at which fecundity  
increases w ith age at maturity, /S, will prom pt evol­
utionary change in age to maturity. For instance, host 
im m unity reduces the fecundity o f S . ra tti, by both  
reducing worm size and by reducing the fecundity 
o f worms o f a given size (Viney et al. 2006). It follow s 
from (4) that where such effects occur, disease con­
trol interventions like m ass vaccination w hich affect 
the im m une environm ent experienced by a worm  
population will im pose selection for altered age to 
maturity.
T o  understand the direction o f this new selection, 
we consider two types o f intervention. T h e first is 
where the entire natural life-span of the worm s can 
be expected to fall within a period where the inter­
vention is having an effect, as w ould be the case for 
im m unisation or enhanced resistance by selective 
breeding; for sim plicity we consider this under 
the general heading o f ‘ sustained interventions ’. T he  
second is where the intervention acts as series of 
brief, regularly spaced, discrete events against the 
background of the underlying mortality rates, as 
occurs with chem otherapy in an agricultural context, 
where animals are routinely drenched at particular 
intervals. W e refer to this as ‘pulsed interventions’. 
T h ese tw o situations need to be m odelled in different 
ways, so w e consider each in turn.
The effects of sustained interventions on optimum  
time to m aturity
W ith size-dependent m ortality, there is no general­
ised equation for a* analogous to equation (2). 
H ow ever, an indication of the immediate direction 
o f selection on age to maturity under an inter­
vention can be determ ined by the sign o f the selection  
gradient, the derivative o f the fitness function  
under the intervention, in the vicinity o f the pre­
intervention value o f a*. T h is corresponds to the 
sign of s*(a#) where
, fa dh (a ) , *ssi,(.a ) =  —  -  .  -  mA(a  )
a  d /fa  ) (5)
with one or m ore o f /J/,, d/,(a*) and m*(a*) affected by 
an intervention. W hen equation (5) is positive, the 
intervention is creating selection pressures that 
favour worm s which grow for longer before repro­
duction; when equation (5) is negative, natural 
selection favours shorter maturation periods. N ote  
that this selection gradient approach applies only in 
the im mediate region of the pre-intervention a*. 
W here m ultiple solutions are possible (e.g. A ppendix  
B), the overall direction o f evolutionary change may 
be different.
Inspection of equations (5) and (4) reveals the 
follow ing. All else being equal, a health intervention  
which changes the pre-maturity mortality function  
to m ifz), w ith greater mortality for a given size 
(m h (z)> m (z), for all relevant values of z )  w ill always 
favour reduced time to maturity. T h is is also true for 
size-independent mortality (equation (2); G em m ill 
et al. 1999). In both cases, this is because greater 
prematurational mortality selects for earlier repro­
duction, despite the fecundity costs, to ensure that 
worm s survive to reproduce at all. Similarly, an 
intervention which changes the rate o f increase o f 
fecundity w ith size, so that worm s are less fecund for 
a given size (i.e ft to such that <P)> will make 
Shift*) <  0, so that initial selection pressure will always 
favour a reduced time to maturity. T h is too is true for 
size independent mortality (equation (2); G em m ill 
et al. 1999), and is because the intervention is re­
ducing the fecundity gains which accrue through 
delayed reproduction. T hus, interventions which  
increase juvenile mortality or decrease the rate o f  
increase o f fecundity with worm  size w ill favour the 
evolution of an earlier age at maturity which will 
result in smaller and less fecund worm s, whether or 
not mortality rates are size-dependent. T hese effects 
are illustrated in Fig. 1.
A n intervention which affects m ortality rates of 
m ature worms has more com plex effects on the 
optim al age to maturity. Inspection of equations (5) 
and (4) shows that the direction o f selection under the 
intervention depends upon the difference between  
d'ia*)/dia*) and dh'{a*)ldh{a*), the proportionate 
rates o f change in mortality w ith size before and after 
im posing the intervention. T h is difference depends 
in turn upon the detail o f each function around a*. 
If the difference is positive, then the initial selec­
tion pressure will favour earlier maturing worm s 
(Fig. 2a-c). If  the difference is negative, as is always 
the case if  the slope of d&(a) is less than or equal to 
that o f d (a), then interventions to increase adult 
mortality will always favour worm s which delay 
maturation (Fig. 2 d -f  and g -i). If  age to maturity 
does not affect adult mortality, then the slopes o f d(a) 
and dhia )  w ill be zero, and the adult mortality rate 
im poses no selection on age to maturity (G em m ill 
et al. 1999).
T o  understand how changes in adult m ortality can 
have these contrasting effects on age to maturity, it is
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Fig. 1. Illustration of the effects of interventions which increase juvenile mortality or reduce fecundity. Panels (a) to (c) 
illustrate the effects on fitness of an intervention which increases the juvenile mortality rate from m(z) to m/t(z), and 
panels (d ) to ( /)  show the effect of an intervention which leaves the mortality rates unchanged but reduces the rate at 
which fecundity increases with age at maturity. In both cases the fitness function under the intervention reaches its 
maximum with a shorter time to maturity (a*,) than that without the intervention (a*). Continuous lines show functions 
without the intervention, dashed lines with the intervention.
helpful to consider the situation before the inter­
vention is im posed. A t the optim um  age to maturity, 
a*, there is the highest possible product from the 
three com ponents o f fitness: (i) chance of surviving  
to maturity, (ii) fecundity and (iii) duration o f re­
production (adult life expectancy). By definition, 
worms maturing earlier or later than the optim um  
age will not have maximum  fitness, so any associ­
ated im provem ent in one or m ore o f the fitness 
com ponents m ust be proportionately more than 
offset by a reduction in the other com ponent(s). For 
exam ple, worms beginning reproduction after the 
optim um  age will have a relative fitness benefit from  
increased fecundity, but this benefit m ust be out­
weighed by a proportionately greater reduction in 
the product o f their chance of surviving to maturity 
and their duration o f reproduction.
N ow  consider an intervention which changes 
adult mortality rates and hence duration of repro­
duction, w hilst the other tw o com ponents o f fit­
ness remain unchanged. T h e proportionate rate of 
change in the duration of reproduction with in ­
creasing age to maturity may (i) remain unchanged,
(ii) increase (adult life expectancy increasing more 
quickly, or decreasing more slow ly with size than 
w ithout the intervention), or (iii) reduce (increasing  
more slow ly or decreasing more rapidly with size 
than without the intervention). In case (i), the 
proportionate change in fitness costs and benefits 
for worm s maturing before or after a  will be
unchanged and the optim um  age at maturity w ill be 
unaffected by the intervention. In case (ii), worm s 
maturing after a* will enjoy a greater proportionate 
im provem ent in reproductive life than was the case 
with no intervention. Since the other com ponents 
o f fitness are unchanged, this means that increased  
fitness will now be achieved by worm s maturing 
som e time after a*, and such worms w ill be favoured  
by selection. In case (iii), the reverse occurs and 
selection will therefore favour earlier maturing 
worms.
A s an example, consider parasites evolved to 
mature at the optim um  age in hosts w hose im m une 
response increases in effectiveness w ith the size 
o f adult worms. A n intervention increasing adult 
mortality consistently for adult worm s o f all sizes 
would decrease the proportionate reduction in life 
expectancy for later maturing worms, whilst leaving  
unchanged the proportionate increase in fecundity, 
and reduction in chance o f reaching m aturity. T h is  
sort o f intervention would favour worm s with longer 
tim es to maturity.
T h e situation is further com plicated because the  
direction of initial selection pressure as given by  
the sign of equation (5) need not indicate the overall 
direction of selection in cases where m ultiple local 
optim a exist for the fitness function under an inter­
vention, (Df,(a). In such cases, one o f w hich is 
illustrated in Fig. 3, the slope of 03h{a) close to the 
original a* m ay not correspond to the change in a
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Fig. 2. Illustration of the effects of interventions increasing the adult mortality rate for parasites maturing at age a. 
Panels (a) to (c) show an intervention which increases the proportionate rate at which adult mortality rate changes with 
age at maturity, resulting in a reduction in optimum time to maturity. Panels (d) to (J) show an intervention which 
keeps the same rate of increase in mortality rate, so that, with higher absolute mortality, there is a reduced 
proportionate rate of increase and hence an increased optimum time to maturity. Panels (g) to (t) show an intervention 
with reduced rate of increase in mortality rate, and also reduced proportionate rate of increase in mortality, as might 
result if an intervention more easily resisted by larger worms outweighed the effects of an immune response more easily 
evaded by smaller worms, giving an increased optimum time to maturity. Continuous lines show functions without the 
intervention, and dashed lines with the intervention.
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Fig. 3. Illustration of the effects of an intervention changing adult mortality in an example with multiple optima for the 
fitness function. Panel (a) shows the assumed pre-maturity mortality function, panel (b) shows the assumed post 
maturity mortality functions with and without intervention, and panel (c) shows the fitness functions with and without 
the intervention. The slope of the post maturity mortality function under the intervention is always less than or equal to 
that without the intervention, so initial selection pressure will favour increased time to maturity. However, the overall 
optimum now falls on a different peak of the fitness function and selection will in fact favour a lower value of a. 
Continuous lines show functions without the intervention, and dashed lines with the intervention.
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required to give the m axim um  achievable fitness. 
O utcom es in such cases will be unpredictable, 
depending upon specifics o f starting conditions and 
the details o f the functions involved.
Size-dependent m ortality function with pulsed  
interventions
D rug treatments can arise as brief periodic events 
rather than on-going changes to mortality functions 
or fecundity parameters. Vaccine boosts (and som e 
natural im m unity processes) conceivably could do 
the same thing. T h e follow ing assum ptions and 
revised equations incorporate pulsed interventions, 
or interventions conferring transient changes in 
m ortality, w ithin the S D M  m odel: (7) D osing is 
periodic at a fixed interval, I .  (8) Parasites are 
assumed to infect hosts randomly at a constant rate, 
and are thus equally likely to arrive at any tim e point 
during the interval betw een dosing events. (9) T he  
proportion of parasites experiencing a second dose 
is assumed to be zero or very small for convenience  
of analysis. (Parameter values m ust be consistent 
with this assum ption.). (10) T h e effect o f the inter­
vention on any given parasite is assumed to vary only  
according to whether the parasite is immature or 
adult, irrespective of size or age. (11) Between dosing  
events, mortality rates are in accordance with those 
given by m (z) and d(a).
W orms infecting a host during interval I  can be 
divided into the follow ing four groups. (A) W orms 
which die before the dosing event, without reaching 
maturity. T hese worm s have zero fitness and thus 
do not contribute to the overall fitness function. (B) 
W orms which die before the dosing event, having 
reached maturity. T hese have fitness in accordance 
with the assum ptions o f the S D M  m odel, but the 
post-m aturity life expectancy m ust be the average 
for worms dying before I ,  not the overall post­
maturity life expectancy. Fitness for worms in this 
category, arriving in the host at time t, is m odelled  
by function f ( t) .  (C) W orm s which survive until 
the dosing event, and are mature at the time of the 
dosing event. T h ese worm s will reproduce from  
maturity to age I  - 1, and then will either die in the 
dosing event, or will survive the dosing event and 
subsequently die according to the post-maturity  
mortality function. F itness for worms in this cat­
egory, arriving in the host at time t, is m odelled  
by function g(t). (D ) W orms which survive until 
the dosing event and are immature at the time of  
the dosing event. T hese worms will either die in the 
dosing event before reproducing, or will survive 
to mature and reproduce in accordance with the 
SIM  and S D M  m odels. F itness for worms in this 
category arriving in the host at time t, is m odelled  
by function h(t).
U sing the sym bols given in Table 1, the aver­
age fitness for worm s in all categories arriving at
time t  is given by
cop(a) J o  af ( t ) d t+  Jg ° g(t)d t +  j j _ a h(t)dt
c a r e - ^  ( .  H (
D m  77-  baD .
d{a) H O d(a) ' ) )
(6)
T h e derivation o f this expression is given in  
A ppendix B.
In order to find the optim um  value o f a  under 
the pulsed intervention, a l ,  we require cop (ap) =  0,
COL ^
w hich, since ■ is non-zero, is equivalent to
< i« >
d'{ap)
d(a*p)2 - D j (7)
From this equation it is evident that, in addition  
to the detail o f the underlying mortality functions 
m (z) and d(a), all the parameters associated with  
the pulsed intervention — the effectiveness o f the 
treatment (D m, D j) ,  the proportion o f the host 
population treated (H ) and the interval betw een  
doses (7) -  have the potential to affect the evolution  
o f time to maturity.
A s for the S D M  m odel, it is not possible to derive 
an explicit solution for ap for the S D M P  m odel. 
H ow ever, again, the direction of the slope of the 
fitness function at a  , the optim um  value o f a  w ith­
out the intervention, will give the direction o f the 
initial selection pressure acting on tim e to m aturity 
under the intervention. S ince, from equation (4), 
A  — —m ( a )  =  0, and since y  ^ 0 ,  the sign o f the
selection gradient at a* corresponds to the sign of 
sp(a*), where
sf ( a ; = B „  ( ,  +  0 1  (a*  - 7 -  ^ ) )
d ' ( a )
d(a*)2
- D j (8 )
It is clear that the sign o f sp(a*) will depend upon  
the detail o f the mortality functions and the par­
ameters o f the pulsed intervention and hence that 
selection pressure may favour increased or decreased  
a  according to the specifics o f m (z) and d(a), and 
the values for the intervention parameters, D j,  D„t
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Fig. 4. Illustration of the effects of values for pulsed-dose model parameters on optimum time to maturity. From a given 
set of starting values, the direction of initial selection, for longer or shorter time to maturity can be changed by adjusting 
any of the three parameters, dosing interval, I, treatment mortality in immature parasites, Dj, and in mature parasites,
D m. Simple linear functions are assumed for m(z) and dia), with negative slope for d(a). Continuous lines show the fitness 
function without intervention, (o(a), dashed lines show the fitness function under pulsed intervention, ojp{a).
and I. G iven this, it is also clear that increasing the 
pre-maturity m ortality D j will always act to reduce 
the strength o f selection for increased tim e to 
maturity when sp(a*) >  0, and to increase the strength  
o f selection for reduced tim e to maturity when  
sp(a * )< 0 .
For exam ple, Fig. 4 illustrates that the optim um  
age to maturity under a pulsed intervention may 
be either longer or shorter than that w ithout inter­
vention, depending upon the relative and absolute 
values o f the parameters Dj, D m and I. T hus, within  
a given range of values for any tw o o f these par­
ameters, the direction of initial selection can be de­
term ined by the value o f the third parameter. For 
instance, w ithin a suitable range o f values for I  and 
D m, changing the parameter Dj  alone can change 
the direction of initial selection pressure. In each 
case, a lim it m ay exist beyond which given values for 
one or m ore of these parameters fixes the direction of 
initial selection irrespective o f the value o f the others.
T he proportion o f hosts dosed, H,  does not 
influence the direction of initial selection pressure. 
However, it does help to determ ine the size o f the 
change from a* to ap, and can contribute to the
Fitness for parasites maturing at a
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«
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Fig. 5. Effect of H, proportion hosts dosed, on selection 
for time to maturity. In this example with multiple 
optima for the fitness function, although the selection 
gradient around a  is positive and initial selection favours 
increased time to maturity, increasing the value of H  
moves the global optimum to the earlier peak, giving 
overall selection in favour of a reduced time to maturity.
overall direction of selection pressure in cases with  
m ultiple solutions as illustrated in Fig. 5, where 
increasing H  for a particular intervention produces 
very small changes in the values o f a  at which the 
peaks o f the fitness function fall, but ultim ately  
causes the optim um  value o f a  to m ove from the
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second to the first peak. In practice, the outcom e of  
such a change would depend inter alia  upon there 
being sufficient variation in a  within the parasite 
population to allow the transition between the two  
optima, given that m ost intervening values o f a  
would be selected against.
D I S C U S S I O N
Nem atode life history traits respond readily to  
selection (e.g. Paterson and Barber, 2007). C onse­
quently, animal and human health programmes 
which alter nematode mortality schedules (almost 
always the aim of such programmes) can drive life- 
history evolution. For nematode age at maturity, a 
key life-history trait with important fitness conse­
quences, we found that the resulting evolution  
could have variable outcom es. In som e cases clin i­
cally beneficial evolution giving smaller, less fecund 
worm s is likely. But in som e cases, evolution  
prom pted by animal and human health programmes 
could generate nem atode life-histories which would  
be clinically detrimental: larger worms producing  
m ore eggs.
T h e sim plest trade-off m odel o f nem atode age to 
maturity (G em m ill et al. 1999; Morand and Poulin,
2000), assumes size-independent m ortality (SIM  
m odel above), and predicts that selection on age at 
maturity is primarily driven by juvenile mortality  
rates. Consequently, selection will always favour 
earlier maturity under interventions which increase 
mortality or reduce the fecundity gains associated  
with increased size. H owever, the m odels developed  
here show  that when adult mortality rate changes 
with parasite size, then both adult and juvenile  
mortality rates influence the evolution o f age at 
maturity. Critically, and unlike juvenile mortality, 
the effect o f adult mortality on optim al age to 
maturity is not unidirectional. Analysis of equations 
(4), and (5) shows that enhanced adult mortality can 
select for earlier or later age to maturity. T h u s it is 
possible for animal or public health interventions like 
im m unisation programmes or widespread chem o­
therapy to prom ote either smaller less fecund worms 
or larger m ore fecund worms.
W hich of these possible outcom es occurs will 
depend upon the biology of the parasite, the biology  
of the interactions between parasite and host im mune 
system , and on the specifics o f the health intervention  
applied. Predicting the outcom e for any particular 
case requires knowledge o f the pre- and post­
maturity mortality functions, with and without the 
intervention. T hese are currently not known for any 
worm , and indeed they would be difficult to deter­
m ine even where direct experim entation is possible. 
Furthermore, for pulsed interventions, the interval 
between doses, the proportion o f hosts dosed, and 
juvenile and adult parasite mortality rates resulting 
from the treatment all also help to determine whether
selection will favour earlier or later maturing worms 
under the intervention. There are no sim ple gen­
eralities and indeed, given current levels o f under­
standing, it is not even easy to speculate on which  
evolutionary outcom es are more likely.
N onetheless, the com plexity of this issue does 
not make it go away. H um an interventions which  
change mortality schedules will exert selection  
pressure. In many cases, the resulting evolution in  
life-history traits will have little clinical significance, 
or will result in increased animal or public health. 
H ow ever, where, for exam ple, the larval stage is 
m uch more pathogenic than the adult parasite, 
prolonging the tim e taken to reach adulthood may 
have undesirable clinical consequences. In such  
instances it would be important to take account 
of whether a given intervention strategy m ight be 
expected to select for a longer duration o f larval stage, 
and plan accordingly.
In som e instances, it m ay even be possible to 
avoid undesirable evolution. Often the selection  
pressures im posed by an intervention cannot be 
readily adjusted as, for example, with vaccine- 
induced im m unity, although even here, the likely 
effects o f stage or tissue-specific im m unity could  
be investigated where there are several vaccine can­
didates being evaluated. For pulsed interventions, 
som e elem ents, such as the time interval between  
doses, can readily be adjusted. W here such control is 
possible, rather than sim ply ameliorating selection  
for unwanted changes, it m ight be possible to specify  
an intervention to intentionally exert selection  
pressure in favour o f a desirable change.
D etailed m odels developed to analyse specific 
cases could extend our m odels in a num ber o f ways. 
For example, contrary to our assum ption 11, worms 
which survive a dosing event may be damaged in 
som e way and experience higher m ortality rates, 
or have lower fecundity, than w ould otherwise be 
the case. T h is and other circum stances, such as 
seasonal life-cycles and dosing patterns m ight mean  
that worms are more likely to enter hosts early or late 
in the dosing cycle, contrary to our assum ption 8. 
Certain com binations o f dosing strategy and life- 
history may mean that a significant proportion of  
worms survive more than one dosing event, violating  
our assumption 9. A lternatively, density effects 
may mean that worms surviving a dosing event, or 
arriving in a host shortly after a dosing event, may 
experience lower mortality or higher fecundity  
than would otherwise be the case. W e doubt that 
such com plexities would alter our general conclusion  
that som e interventions can select for clinically- 
detrimental worm evolution, but they m ight none­
theless be important considerations for evaluating  
the m agnitudes o f any such evolution in particular 
cases.
T h e relationship between mortality rate and age 
at maturity suggests that in an environm ent where
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mortality rate showed variation, as w ould be 
expected within a normal host population, there 
would be benefits to the parasite in adjusting the 
age of maturity according to the m ortality rate 
actually experienced or predicted in its individual 
host, provided the benefits o f such flexibility out­
weighed the costs o f achieving it. Such flexibility 
has been demonstrated experim entally for at least 
two nematode species (G uinnee et al. 2003). T h is  
may provide a m eans o f testing our conclusions, by 
exam ining whether the changes flexibly adopted by 
worms under different mortality schedules, a system  
which should have evolved to m axim ise worm  fit­
ness, are consistent with the responses predicted by  
the m odels.
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Table 2. Equivalence o f parameters used in the m odels discussed in A ppendix A . A  and M  is from  
A nderson and M ay (1985), M  and P, M orand and Poulin (2000) and S IM  is the m odel o f G em m ill et al. 
(1999) described in the current paper
A and M Parameter Description M and P SIM
k Parameter summarising aggregation of parasites 
within host population
not explicitly included n/a
s Proportion of females in parasite population not explicitly included n/a
O Mating function not explicitly included n/a
P Transmission co-efficient between host and 
infective stages
P n/a
di Proportion of parasites entering host which 
survive to maturity
not explicitly included n/a
<h Proportion of output transmission stages surviving 
to infective stage
assumed immediately 
infective
n/a
N Host density H n/a
P In-host parasite mortality rate arising from host death b part of M j and M a
Pi In-host parasite mortality rate arising from other causes immature 
mature f.ip
part of Mj 
part of M a
Pi Free-living parasite mortality rate Pw n/a
X Fecundity/eggs per day X = a ° c caP
A P P E N D I X  a : M O R A N D  A N D  P O U L I N  M O D E L
M orand and Poulin (2000) derived an alternative 
m odel for the relationship between parasite mortality 
rate and optimal time to maturity using R 0, the basic 
reproductive rate, based on explicit epidem iology, 
as follow s;
R 0 =
(aaYPH
aifiv+ptDQ+b+ftJlb+ftJ
giving
( c a - \ ) ( f t L +  b)
(9)
(10)
with sym bols as in T able 2. Equation (10) differs 
from equation (2). H ow ever, we show  here that the 
tw o m odels give an equivalent solution for optimal 
age to maturity.
T he derivation of equation (9) is based on a m odel 
by Anderson and M ay (1985),
Ro =
ksQfidtdtNX
(fi+fiJifc+PN)
which separates the parasite mortality rate into 
two com ponents, mortality o f parasites within a 
living host, and parasite mortality through host 
death. T h e Anderson and M ay model also reflects a 
period of larval developm ent outside the host prior 
to infectiousness, and a subsequent period o f v i­
ability in the environm ent during which infective 
larvae may contact and infect hosts. Morand and 
Poulin (2000) ignored aggregation and im plicitly  
assumed that all worms are hermaphrodite, so the 
parameters k, s, and 4> in the Anderson and M ay  
m odel can be ignored.
M orand and Poulin (2000) give the proportion
o f larvae infecting hosts which ultim ately becom e
adults within the host as X ^—tt-. T h is seem s “ (PL + b+i)
to be replicating the Anderson and M ay formula 
for the proportion o f eggs produced which u lti­
m ately infect hosts, given by the probability o f  
survival to infective stage x life expectancy o f in ­
fective larvae in the environm ent x  per diem  trans­
m ission rate. H ow ever, this is not an appropriate 
representation o f the process of in -host maturity 
where the transition from juvenile to adult occurs 
at age a  for all larvae surviving to age a , not ran­
domly at a given rate after age a  has been reached. 
In addition, the use o f 1 /a  as the rate at which  
immature parasites becom e mature is inappro­
priate, since maturation does not happen randomly 
across all ages o f immature parasites, but only to 
the proportion which have survived to age a , and 
this would only be 1 /a  in the case where the in­
host mortality rate among immature parasites was 
zero.
U sin g  the parameters o f the M orand and Poulin
m odel, the amended formula for the proportion
o f immature parasites which survive a period of a
days from arrival in-host to reach maturity is 
e- ( ^  + 6)a_
Incorporating this means that equation (9) 
becom es
Ro = a acpH
giving
( P l  +  b)
(11)
(12)
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Fig. 6. Illustrations of multiple maxima for the fitness function (equation (3)). Mortality rates as a function of age 
for juveniles (left panels) and of age at maturity for adults (middle panels) generate the fitness functions shown in the 
right hand panels. The adult mortality function shown could arise if, for example, bigger worms are harder to kill and 
smaller worms are harder to detect. For (c), multiple local optima are found, with the global optimum falling on the 
later peak at a2. In (e), there are also multiple local optima, but the global optimum falls at ai, on the first peak. In this 
case, in the absence of lower limits on the time needed to physically achieve maturity, selection would favour maturity 
at a!. If minimum achievable time to maturity is between ax and tx, selection will favour maturity at the minimum 
achievable age, and if the minimum achievable time to maturity is greater than tx, then selection will favour maturity 
at a2.
Since («z, +  6) is the total mortality rate for im ­
mature parasites, equivalent to M j  in the S IM  m odel, 
and ca is equivalent to /J in the S IM  m odel, equations
(12) and (2) are equivalent.
A P P E N D I X  B:  I L L U S T R A T I O N  O F  M U L T I P L E  
M A X I M A  F O R  F I T N E S S  F U N C T I O N
Fig. 6 gives exam ples o f situations in which there 
can be more than one age to m aturity associated with  
fitness maxima.
A P P E N D I X  c: D E R I V A T I O N  O F  P U L S E D  
I N T E R V E N T I O N  M O D E L
In this A ppendix we derive expressions for the 
functions f ( t) ,  g(t) and h(t) introduced in section 3.2, 
and hence show that fitness is given by equation (6). 
For 0 < t ^ ( I —a), we have
/ ( f )  =  probability o f survival from t  to t  +  a
x (1 — probability o f survival from t +  a  to I)  
x  average life expectancy for worms 
dying between t +  a  and I  
x  fecundity for worm s maturing at age a
T h e average life expectancy post-m aturity for 
w orm s born at tim e t  which survive to tim e t +  a
and die before tim e I ,  can be calculated from the 
definite integral on age q, measured from maturity, 
from 0 to (I  -  t -  a)  o f the proportion of such worms 
surviving to age q less the proportion which will 
survive to I.
T h u s the average life expectancy post maturity, 
for worm s born at time t  which die betw een t +  a  
and I  is
1
1 — e - d ( a ) ( I - t - a )
x e- ^ ) ‘i d q - { I - t - a ) e - d(a){I- t - a'^
1 (I - t - a ) e - dia)<-I ~a- t)
~  d (a )  1 — e —d(a)(I—t —a)
So
/ ( f )
/  1 ( I - t - a ) e ~ d^ I - a- t)\
X  V <f(a) \ - e ~ d ( a ) { I - t - a )  J
= cape -^
/ I  — p - d ( a ) ( I - a - t )  \
x (— m -------
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F org(t), we obtain, for 0 < t ^ ( I — a) 
g(t) =  probability o f survival from t to I
x ((probability in undosed host +  probability 
in dosed host but survives) 
x (average life expectancy from I ) + I —a  — t) 
x fecundity for worms maturing at age a  
giving
g{t) = cafie-fi(a)e-d(a)(I-a-t)
13
d(a)
For the function h (t) we find, with (I —a ) < t < I  
h(t) =  probability of survival from t  to a
X (probability in undosed host +  probability 
in dosed host but survives) 
x average life expectancy from a  
x fecundity for worm s maturing at age a  
which yields
d(a)
T h e definite integrals o f these functions over the 
relevant ranges for t give the fo llow ing;
I
, ca^ e-^ a) 
f ( t ) d t=  2 
d{a)
( ( d { a ) { I - a )  +  2)<
- 2  +  d ( a ) { I - a )
rJ- a ca^e~^a)
I .................................. »... ( (2 ~ H D m)d(ct)
] '
J l —a
h{t)d t =
c a . f i —HDj) 
d(a)
T hese functions are then com bined to give the 
overall fitness function
1 (  c a . f i (  r \
<M«) =  j  ( d{a)i  ^ (r f (g ) ( /-a )  +  2j<
\  coP b f
— 2 +  d (a ) ( I —a ) J  +  ■ ^ ( ( 2 - H D m)
+  (d (a )(a  - I ) + H D m -  2) 
cafi+1e~M(a)( l —HDj)
+ d(a)
T h is can be rearranged to give 
, N cafie
/  H /  l _ e - d ( a ) ( I - a )
* (  / (  d (a )  + a A
which is equation (6).
(13)
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How to Make Evolution-Proof 
Insecticides for Malaria Control
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Summary
Insecticides a re  o n e  o f th e  c h e ap es t, 
m o s t effective, an d  b e s t p roven  m e th o d s  
o f con tro lling  m alaria, b u t m o sq u ito es  
can  rapidly evo lve resistance. Such 
evo lu tion , first s een  in th e  1950s in 
a rea s  of w id esp read  DDT use, is a 
m ajor ch a llen g e  b ec a u se  a t te m p ts  to  
com prehensively  con tro l a n d  even  
elim ina te  m alaria rely heavily on  in doo r 
h o u se  spraying  an d  in sec tic ide -trea ted  
b ed  nets. C u rren t s tra teg ie s  for d ea ling  
w ith  res is tance  evo lu tion  a re  expensive  
an d  o p e n  e n d e d , a n d  th e ir  sustainab ility  
has yet to  b e  d em o n s tra te d . H ere w e 
show  th a t if insectic ides ta rg e te d  old 
m osq u ito es , a n d  ideally old m alaria- 
in fec ted  m osqu itoes , th e y  cou ld  p rov ide  
effec tive m alaria con tro l w hile  only 
w eakly se lec ting  for resistance . This 
a lone  w ould  g rea tly  e n h a n c e  th e  useful 
life span  o f an  insecticide. H owever, 
such  w eak  se lec tion  fo r res is tance  can 
easily  b e  o v erw helm ed  if res is tance  is 
asso c ia ted  w ith fitness costs . In th a t  case, 
la te-life-ac ting  insectic ides w ould  never 
b e  u n d e rm in ed  by  m o sq u ito  evo lu tion . 
W e discuss a n u m b e r o f practica l w ays 
to  ach ieve  this, inc luding  d iffe ren t 
u se  o f ex isting  chem ical insecticides, 
b iopestic ides, a n d  novel chem istry . D one 
right, a one-o ff  in v e stm en t in a single 
insec tic ide  w ould  so lve th e  p ro b lem  o f 
m o sq u ito  res is tance  forever.
ndoor residual spraying (IRS) 
with insecticides continues to be a 
mainstay of malaria control, having 
been responsible for often spectacular 
reductions in disease incidence during 
the 20th century, including elimination 
of malaria from many countries [1-4]. 
More recently, insecticide-treated bed 
nets (ITNs) have become a leading 
tool for malaria control [4,5], Major 
international efforts are currently 
underway to comprehensively control 
and even globally eradicate malaria, 
and these involve enormous up­
scaling of IRS and ITN use [6-10]. As 
in the last century, one of the major 
challenges to these new efforts is the 
evolution of insecticide resistance 
in Anopheles populations [1,2,11- 
18]. IRS spraying for malaria was 
responsible for resistance evolution 
in countries as diverse as Greece,
Java, Haiti, and Sudan [17,19-21]. 
Insecticide-resistant mosquitoes were 
one of the main hurdles faced by 
the ultimately unsuccessful Global 
Malaria Eradication plan in the middle 
of last century [1,2,11,13,14,17,22], 
Contemporary experience is that 
nothing has changed. For instance, a 
surge in malaria cases from 600/m onih 
to 2,000/m onth in KwaZulu-Natal, 
South Africa, at the end of last century' 
was associated with pyrethroid-resistant 
An. funestus [23,24]. In a recent 
24-village trial in Mexico, the frequency 
of pyrethoid-resistant Anopheles went 
from effectively zero to 20% after three 
years of IRS (Box 1) [25], There are 
also serious concerns [16-18,26-31] 
and increasing evidence [32-34] that 
insecticides on bed nets trill similarly 
drive resistance evolution.
Once a “resistance crisis” [26] 
occurs, where disease control fails 
because mosquito evolution has 
rendered an insecticide ineffective, 
options are few, not least because of 
the very limited insecticide arsenal 
available. Insecticides recommended 
for malaria control by the World 
Health Organization (WHO) represent 
just four classes of compound for IRS 
and just one class of compounds for 
ITNs [13,15]. Consequendy, there 
is an increasing focus on resistance 
management strategies, whereby 
efforts are made to use existing 
insecticides in ways which can 
maximize the time period for which 
they provide useful disease control 
(what we hereafter refer to as the 
“useful lifespan” of a compound). 
Resistance management strategies
include the use of diverse insecticides 
in space and time (rotations and 
mosaics), insecticide mixtures, and 
restricting use to specific risk periods 
and locations [13,25,26,31,35-38], 
Resistance management requires 
on-going surveillance [14,17] and 
a level of application management 
that is frequently problematic in 
regions where the malaria challenge 
is most severe. Moreover, techniques 
such as rotations and mixtures can 
be underm ined by issues of cross 
resistance [13]. Indeed, given current 
restrictions on approved chemicals, 
there are virtually no options for 
resistance management for ITNs.
Consequently, there is now a 
concerted effort to identify new 
insecticidal compounds for use in 
malaria control [36,39]. On the face of 
it, this is desirable, but novel chemistry 
does not, in itself, provide a sustainable 
answer. All existing insecticides were 
“new” at some point, and there is
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the very real danger that, as with the 
antimalarial drug treadmill [40], the 
search for products can become open 
ended as the efficacy of successful 
new compounds is, in turn, eroded 
by the evolution of resistance. Here 
we show that the natural history of 
the Anopheles-Plasmodium interaction 
makes possible an alternative strategy 
to deal with insecticide resistance: 
the development of insecdcides with 
properties that retard and even entirely 
prevent the spread of resistance. An 
“evoluUon-proof” compound would 
provide sustainable control, render 
convendonal resistance management 
strategies unnecessary, and completely 
avoid an insecticide treadmill.
The Proposition
All current insecticides approved for 
ITNs or IRS kill extremely rapidly after 
contact, and some are also irritants 
that cause the mosquito to move away 
from the net or house and search for 
blood meals elsewhere. Where coverage 
is high (a requirement for effective 
control), insecticides greatly reduce 
malaria transmission, but their high 
lethality or interference with blood 
feeding also imposes intense selection 
for resistance. It is our contention that 
effective transmission reduction can be 
achieved while minimizing selection 
for resistance. To simplify the following 
discussion, we initially consider only the 
lethal effects o f insecticides; we return 
to the irritant (excito-repellency) 
effects at the end.
Our argument derives from the 
following observations. First, female 
mosquitoes convert a blood meal 
into eggs and oviposit in appropriate 
water bodies before seeking the next 
blood meal. This gonotrophic cycle 
takes 2-4 d [41,42]. Females contact 
insecticides on bed nets during feeding 
attempts, or on house walls while resting 
immediately after the feed. Second, 
extrinsic mortality rates for the key 
vector species, even in the absence of 
any public health measures, are very 
high—on the order of 10% per day or 
20-40% per gonotrophic cycle [41,42]. 
The consequence is that most females 
go through only a few gonotrophic 
cycles before they die. Third, after 
infecting mosquitoes, malaria parasites 
go through various developmental 
stages and very many replicative cycles 
before migrating to the salivary glands, 
from where they can be transmitted to
humans. The duration of this process 
(the sporogonic or extrinsic incubation 
period) depends on host, parasite, and 
environmental factors, but it is in the 
order of 10-14 d or 2-6 gonotrophic 
cycles in areas of high malaria 
transmission [41,42]. These facts 
together lead to one of the great ironies 
of malaria: most mosquitoes do not live 
long enough to transmit the disease.
These facts also mean that the 
majority of eggs a female will produce 
in her lifetime are laid in the window 
before malaria-infected mosquitoes can 
become dangerous to humans. Thus, 
in principle at least, public health 
advances can be achieved with minimal 
selection for resistance by an insecticide 
that kills after the majority of mosquito 
reproduction has occurred but before 
malaria parasites are infectious. Unlike 
in agriculture, the aim here is disease 
control, not necessarily insect control.
Below we consider how insecticides 
could be designed so as to kill only 
older mosquitoes, but we first compare 
the transmission control potential 
and the evolutionary properties of 
our proposed late-life-acting (LLA) 
insecticides with compounds like 
dichloro-diphenyl-trichloroe thane 
(DDT), pyrethroids, and others 
currently in use (“conventional”’ 
insecticides). The first key question 
is whether LLA insecticides can offer 
significant reductions in malaria 
transmission.
Control
To assess the malaria control potential 
of LLA insecticides, we followed 
others [42-44] in developing a 
simple feeding cycle model (FCM) 
that deterministically tracks discrete 
cohorts of mosquitoes through their 
gonotrophic cycles, where mosquitoes 
have fixed probabilities o f becoming 
infected with malaria parasites and, 
in our case, exposed to insecticides.
The background mosquito mortality 
rates and durations o f sporogony used 
to parameterize the baseline model 
are the average o f four Plasmodium 
falciparum-endemic sites, two in 
Nigeria, one in Tanzania, and one in 
Papua New Guinea [42]. These sites are 
intense foci of malaria transmission.
An LLA insecticide could 
disproportionately kill older 
mosquitoes in two ways. First, it might 
work some time after first exposure 
(a time-dependent killer), as might
be the case for an infectious agent. 
Second, the insecticide might be 
disproportionately effective against 
older mosquitoes, irrespective of time 
since contact (age-dependent killer), 
as might be the case if older insects 
are more physiologically vulnerable. In 
the following analysis, we consider this 
latter type of LLA insecticide, but our 
conclusions are unaltered in either case 
(Table SI).
The evolution of insecticide 
resistance is a practical problem only 
where insecticide coverage is high, 
which we take here to be 80%, a 
minimum target for coverage with 
IRS or ITNs [10]. For computational 
simplicity, we also assume that LLA 
insecticides have no impact on 
either total mosquito densities or 
the proportion of humans that are 
infectious. With these assumptions (and 
others, see Materials and Methods), 
we calculate that LLA insecticides 
killing mosquitoes that have reached 
2 or more gonotrophic cycles will 
reduce the number o f infectious bites 
by 99.2%. The corresponding figures 
for 3- and 4-cycle killers are 97.9% and 
94.2%, respectively. These figures are 
highly encouraging, especially as they 
are minimum estimates: reductions in 
the number of infectious human cases 
following intervention will further 
reduce the number of infectious 
mosquitoes, as would higher or more- 
effective insecticide coverage and any 
effects on mosquito densities (more 
likely the earlier-acting the insecticide).
Evolution
While fast-acting conventional 
insecticides can produce even more 
effective initial control (in our analysis, 
a 99.8% reduction in the number 
of infectious bites), they impose 
enormous selection for resistance 
by killing young female adults. The 
consequence is that spectacular initial 
mosquito control can last as little as 
a few years, thus providing very poor 
medium- to long-term disease control, 
as history has shown [22]. To analyze 
the evolutionary sustainability of 
LLA insecticides, we used fecundities 
calculated in our feeding cycle model 
as input into a discrete-time analog of 
standard population genetics models 
to track the spread o f single-allele 
resistance through the population. 
Frequency of resistance in a population 
was calculated by assuming that
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(%)
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fitness of 
resistant 
mosquitoes 
when 
insecticide 
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conventional 84.6 6.49
2  cycle LLA 54.2 2.18
3 cycle LLA 34.5 1.53
4  cycle LLA 21.8 1.28
5 cycle LLA 13.4 1.15
6 cycle LLA 8.4 1.09
doi:10.1371/journal.pbio.1000058.g001
Figure 1. Evolutionary C onsequences o f Insecticides That Are Highly Lethal Im m ediately 
after First Contact (Conventional Insecticides, like DDT and Pyrethroids, Con) and 
H ypothetical LLA Insecticides That Kill M osquitoes from Their Second th rough  Sixth 
G onotrophic Cycles (C2-C6)
(A) Frequency of resistant mosquitoes through time. (B) Impact of insecticides on fitness of 
susceptible mosquitoes, and relative fitness of resistant mosquitoes in presence of insecticides, 
assuming no costs of resistance. LLA insecticides are a substantially less potent driver of the 
evolution of resistance than are conventional insecticides because of their substantially  smaller 
impact on mosquito fitness. Note tha t when first deployed, four-cycle LLAs reduce the  number 
of infectious bites by 94.2%. Two- and three-cycle killers remove more, but at cost of increased 
selection for resistance. We assume the control offered by five- and six-cycle killers, 76.6% and 
57.1 % of infectious bites removed, is too low to  make them  practicable (although absolute levels 
of control required will depend on local epidemiological context and the availability of other 
disease m anagem ent tools). For model details and param eter values, see Materials and Methods.
resistance is dominant and ablates 
the mortality effects o f the insecticide 
in question. We discuss the effect of 
relaxing the dominance assumption, 
and other assumptions, in Text SI.
With parameters as above, resistance 
spreads considerably more slowly for 
LLA insecticides than for conventional 
insecticides (Figure 1). This is because 
insecticides that kill on first contact will 
reduce mosquito lifetime reproductive 
success by about 85%. In contrast, 
insecticides that kill mosquitoes that 
have reached at least their fourth 
gonotrophic cycle eliminate just 22% of 
progeny (Figure 1). Thus, all else being 
equal, the fitness of a mutant resistant 
to conventional insecticides is 6.5 times
that o f the susceptible wild type; the 
corresponding advantage for a four­
cycle killer is just 1.28.
The evolution of resistance to LLA 
insecticides could be slowed even 
further if they were disproportionately 
effective against malaria-infected 
mosquitoes. This is because insecticides 
that are less likely to kill uninfected 
mosquitoes further relax selection for 
resistance without any loss o f control. 
For instance, if we leave the probability 
that a four-cycle LLA insecticide would 
kill infectious mosquitoes unaltered 
but halve its likelihood of killing 
uninfected mosquitoes, the time taken 
for resistance to reach 50% frequency 
would increase by about half as much
again. A potentially useful side effect 
of disproportionate killing of malaria- 
infected mosquitoes would be to 
increase the selection pressure favoring 
malaria-resistant mosquitoes [45,46].
Importantly, resistance to LLA 
insecticides will not spread at all if there 
are nontrivial fitness costs to insecticide 
resistance. Reduced fitness of resistant 
insects in the absence o f insecticides 
is frequently reported [47-49]. For 
Anopheles, costs of resistance have 
been seen in the laboratory [50,51] 
and, in the field, unexpectedly low 
frequencies of resistant homozygotes 
(e.g., [52]), and declines in resistance 
after withdrawal o f causal insecticide 
(e.g., [18,25]) (see Box 1) point 
to substantial fitness costs. Costs of 
resistance have little impact on the 
evolution of resistance to conventional 
insecticides where the benefits o f  
resistance are so high. The situation 
is, however, very different for LLA 
insecticides, where the fitness benefits 
of resistance (Figure 1) are very much 
lower. For LLA insecticides, resistance 
costs can outweigh resistance benefits, 
preventing resistance spreading at all, 
even when resistance alleles are present.
This argument follows from the 
evolutionary theory of aging [53-57]. 
The strength of selection declines 
with age. Beneficial genes that act late 
in life can fail to spread if they are 
associated with fitness costs earlier in 
life. This is because all individuals pay 
these costs, whereas only those few that 
survive to old age benefit The theory 
of aging is well verified, not least in 
insects [58]. Senescence does occur in 
mosquito populations, and in Anopheles 
is detectable around the age at which 
mosquitoes can first become infectious 
to humans [59-62]. Thus, natural 
selection has not been strong enough 
to favor beneficial alleles that would 
act around the same time as would a 
putative resistance allele against a late- 
life insecticide.
The inclusion o f even modest 
costs of resistance substantially slows 
the rate at which resistance to LLA 
insecticides spreads in a population, 
thus considerably prolonging the 
effectiveness of malaria control (Figure
2). Importantly, it is also possible to 
maintain the initial levels o f control 
forever. For the particular parameter 
values used here, costs of resistance, 
which accrue as an additional 
daily mortality rate o f 3.4%, would
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time since start of intervention
F ig u r e  2 .  Evolutionary C onsequences and  Control Effectiveness o f Insecticide W here There 
Are No Costs o f Resistance (+0%) o r W here th e  Costs of Resistance Accrue as Additional Daily 
Mortality Rates as Shown
(A) Frequency of resistant mosquitoes through time. (B) Control effectiveness through time, w here 
0% effectiveness is the situation prior to  the insecticide application, and 100% is com plete absence 
of infectious bites. Plotted values are for a conventional insecticide (Con) or an LLA insecticide that 
kills mosquitoes on contact during or after their fourth gonotrophic cycle (a 4C LLA in Figure 1). 
Beyond the  duration of our simulations, th e  LLA insecticide eventually fails even for a 2% cost of 
resistance (green line); for the param eter values used here, complete evolution-proofing occurs at 
3.4%. For model details and param eter values, see Materials and Methods.
render a four-cycle LLA insecticide 
completely evolution proof: this is 
the point at which the fitness gains of 
resistance, which benefit only a few, 
are outweighed by the fitness costs of 
resistance, which are paid by all. Thus, 
in principle at least, it is possible to 
create an insecticide that would provide 
effective malaria control yet never 
be undermined by the evolution of 
resistant mosquitoes.
The cost o f resistance required 
to get evolution proofing is lowered 
for LLA insecticides which are 
disproportionately effective against 
malaria-infected mosquitoes (Figure
3). For instance, a four-cycle LLA 
insecticide, which is half as likely to 
kill uninfected mosquitoes, requires 
a cost of resistance o f just 2.3% to be 
completely evolution proof. Strikingly, 
if its effectiveness against uninfected 
mosquitoes was just 10% of what it was 
against infected mosquitoes, complete 
evolution proofing would occur at 
a resistance cost of just 0.9%, a cost 
which would be barely measurable. An 
LLA insecticide that kills only malaria- 
infected mosquitoes is completely 
evolution proof for vanishingly small 
costs o f resistance (0.43%).
We are aware of only one quantitative 
estimate o f the relative fitness of
resistant mosquitoes in the field. This 
comes from the non-malarial vector 
Culex pipiens, following 40 years of 
organophosphorous (OP) insecticide 
spraying in Southern France [48,63], 
There, the fitness of individuals 
homozygous for a resistance mutation 
relative to sensitive homozygotes is
0.63-0.72 (discussed further in Text 
SI). Using our model to calculate 
lifetime fecundity of mosquitoes 
experiencing various mortality 
costs o f resistance in the absence of 
treatment, we find that the relative 
fitness associated with the highest cost 
of resistance required to get complete 
evolution proofing, 3.4% additional 
mortality, is 0.78; the corresponding 
figures for the 2.3% and 0.9% 
additional mortality described above 
are 0.84 and 0.93, respectively. Similar 
figures are obtained if we assume the 
costs o f resistance accrue as reduced 
fecundity rather than reduced adult 
survival (unpublished data). Thus, the 
costs of resistance required to achieve 
complete evolution proofing are not 
out o f line with those seen in nature.
Product Options
The foregoing analysis argues 
that new insecticides for malaria 
control should minimize impact
on mosquito lifetime reproductive 
output while also minimizing the 
number of infectious mosquitoes.
The achievement of this goal ideally 
requires insecticides that kill late in life, 
that are disproportionately effective 
against malaria-infected mosquitoes, 
and for which resistance carries fitness 
costs. This approach, which will 
retard the spread of resistance alleles 
(possibly forever) even when they 
are already present in a population, 
should complement or even replace 
strategies aimed solely at delaying the 
initial origin o f resistance, since these 
latter strategies often have no effect 
when resistance eventually becomes 
established in a population.
We are unaware of any attempts to 
evaluate potential insecticides for these 
properties, but it is possible to imagine 
a range o f approaches or modes of 
action that would achieve late-life 
killing. For example, cumulative 
exposure to ordinarily sublethal doses 
of an insecticide over multiple feeding 
cycles could result in the death of older 
mosquitoes. Alternatively, formulation 
techniques such as microencapsulation 
could provide a means for slow release 
of an insecticide over time. Similarly, 
age-dependent mortality could be 
achieved by exploiting the fact that 
in Anopheles, metabolic detoxification 
activity declines with age [29,64]. This 
decline may be a natural consequence 
of senescence and explain why 
Anopheles become more susceptible to 
DDT, malathion, and pyre thro ids with 
increasing age [64-68]. It is also easy 
to imagine compounds that would act 
disproportionately on mosquitoes with 
advanced malaria infections. Malaria 
parasites impose large metabolic costs 
on mosquitoes [69-73], either directly 
via competition for resources, or 
indirectly by prompting costly immune 
responses. These costs are likely to 
increase as the malaria infection 
progresses, both as a consequence 
of the increasing parasite burdens as 
replication proceeds, and as blood 
and other meals become progressively 
less successful as the mouthparts 
become blocked with sporozoites [74]. 
Metabolically stressed insects should be 
more vulnerable to normally sublethal 
doses or compounds.
An even more radical possibility 
is that there may be formulations 
or deployment strategies that would 
convert existing insecticides into
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F ig u r e  3 .  F i t n e s s  o f  R e s is t a n t  M o s q u i t o e s  R e la t iv e  t o  S u s c e p t i b l e s  f o r  a n  LLA I n s e c t ic id e  
f o r  V a r io u s  C o s t s  o f  R e s is t a n c e  a n d  D if f e r e n t ia l  E ff ic a c y  a g a i n s t  M a la r ia - I n fe c t e d  
M o s q u it o e s
When relative fitness is greater than 1, resistance spreads, when relative fitness is less than 1, 
resistance can never spread, even when present in a population (complete evolution-proofing). 
Plotted values are for an LLA insecticide which kills mosquitoes on contact during or after their 
fourth gonotrophic cycle; these remove 94.2% of infectious mosquitoes when first deployed. 
Differential mortality is the proportionate reduction in mortality for uninfected mosquitoes 
compared to  malaria-infected mosquitoes. Costs of resistance accrue as additional daily mortality 
rates. Relative fitness for conventional insecticides is 6.5 (Figure 1), which is little affected by costs 
resistance (see text). For model details and param eter values, see Materials and Methods.
evolution-proof LLA insecticides. As 
noted above, DDT, pyrethroids, and 
malathion are disproportionately 
efficacious against mosquitoes that 
are old enough to transmit malaria 
[64-68]. Doses lower than those 
currently recommended may therefore 
be insufficient to kill younger 
mosquitoes but fatal to older, near- 
infecdous mosquitoes. If so, existing 
insecticides could be evolution-proofed 
by changing concentrations delivered 
in the field, even where resistance is 
currently spreading in a population.
The evolutionary benefits o f an LLA 
insecticide apply irrespective of the 
resistance mechanism involved, but the 
greatest benefits accrue for compounds 
against which resistance is the most 
costly. Resistance to conventional 
insecticides involves target site 
alterations, metabolic detoxification, 
and behavioral avoidance [2,12,13].
It seems highly likely that the fitness 
costs o f resistance will depend on 
the mechanisms involved. In other 
insects, there is evidence that fitness 
costs depend on the insecticide, and 
for some but importantly not all, 
die costs can clearly be negligible or 
degrade through time as modifiers 
spread [63,75]. Explicit deployment of 
compounds against which resistance is 
costly would be a novel approach and 
would also assist traditional resistance 
management strategies.
There may also be ways of achieving 
evolution-proof insecticides by means 
other than chemicals. For example, 
fungal biopesticides are already 
known to generate the required 
phenotypes. These insecticides are 
based on oil-formulated spores of 
entomopathogenic fungi applied to 
surfaces on which adult mosquitoes 
will rest after blood feeding [46,76,77]. 
Although still at a research stage, they 
have proven to be very effective malaria 
transmission blockers in the laboratory 
[76] and can be delivered in African 
houses [77]. Fungal biopesticides 
work as time-dependent late-life 
insecticides, killing die insect 7-14 d 
post-contact [46,76-79]. They are also 
disproportionately effective against 
malaria-infected mosquitoes [76]. Other 
biocontrol agents such as Wolbachia [80] 
and densoviruses [81] have a similar 
potential to disproportionately target 
older mosquitoes [82], and hence are 
potentially immune to the evolution of 
host resistance.
Moreover, nothing in our arguments 
actually requires compounds that 
kill mosquitoes. Critical is that older, 
infectious mosquitoes be prevented 
from biting humans. Killing them is 
one way of doing this, but analogous 
arguments would apply to products 
which, late in life, have other 
transmission-blocking effects, such 
as interference with host-seeking 
behavior, flight, or blood feeding 
propensity. Sublethal effects like 
these must have pronounced fitness 
consequences for mosquitoes but, as 
with lethality, these need not result in 
strong selection for resistance so long 
as they impact in later life. Fungal 
biopesticides reduce feeding propensity 
as infection progresses [76,83].
Irritancy is an important feature of the 
protection offered by some existing 
chemical insecticides like pyrethroids, 
because it drives mosquitoes out of 
houses and in search of other hosts 
[33]. For highly anthrophilic species, 
like An. gambiae, evolution-proofing 
an irritant would require that it be 
selectively excito-repellent to older 
mosquitoes. For vector species that 
are not particularly anthrophilic, an 
insecticide that achieved irritancy 
without lethality would impose 
negligible selection for resistance at 
any age if the fecundity and survival 
of mosquitoes feeding on nonhuman 
hosts was no lower.
Complications and Possible 
Downsides
Exploiting the ideas advocated above 
requires that criteria used to evaluate 
insecticides for malaria control be 
broadened beyond those currently 
now in use. Current minimum target 
product profiles required by the WHO 
Pesticide Evaluation Scheme for Phase 
1 (laboratory) testing of insecticides 
for ITN and IRS use are 80% mortality 
up to 24 h post-exposure in young 
(2-5 d post-emergence) adult female 
Anopheles [84,85]. These thresholds, 
little changed since the 1960s [86], are 
used by the WHO to determine which 
insecticides to recommend to national 
authorities, and consequently by others 
to determine candidate compounds 
for inclusion in product development 
portfolios (for example, the Innovative 
Vector Control Consortium; 
h ttp: /  / www.ivcc. com/workwi thus/ 
application_process/irs.htm; accessed 
4 March 2009). However, these “young- 
kill” criteria will result in the use of 
insecticides that impose near maximal 
selection for resistance. Minimizing that 
selection while still providing malaria 
control requires the use of insecticides 
and application protocols that impose 
marked reductions in transmission 
potential while simultaneously 
minimizing reductions in mosquito 
fitness. Assessing that requires exposing
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Box 1. A Contemporary Example o f the Selection of Insecticide Resistance by Indoor Residual Spraying
S om e o f th e  b e s t d a ta  on  th e  im pact 
o f m alaria con tro l insec tic ides on  
res is tan ce  in Anopheles  co m e from  
th e  Pacific C oast o f  Chiapas, M exico 
[25,92,93]. In th is  reg ion , agricultura l 
u se  o f insectic ides a ro u n d  m o sq u ito  
b reed in g  sites to g e th e r  w ith  indoo r 
residual sp ray ing  o f DDT for m alaria 
con tro l resu lted  in h igh  levels of 
res is tance  to  o rganoch lo rines , 
o rg a n o p h o sp h a te s , ca rb a m a te s , an d  
py re th ro id s  by th e  e n d  o f  th e  1970s.
In th e  1980s a n d  '90s, DDT co n tin u ed  
to  b e  u sed  fo r m alaria con tro l, an d  
DDT res is tance  rem ain ed  a t  high 
levels. H ow ever, th e  ag ricu ltu ra l u se  o f 
insectic ides dec lin ed  m arkedly, so  th a t 
by th e  m id-1990s, res is tan ce  to  all o th e r  
classes o f insec tic ides h ad  reg ressed  
to  th e  p o in t w h e re  it w as barely  
d e te c ta b le  in s ta n d a rd  WHO b ioassays 
[93]. G enetic  a n d  b iochem ical analyses 
confirm ed  th a t, n o n e th e le ss , several 
know n res is tance  alleles rem a in ed  in th e se  
p opu la tions .
In th e  la tte r half o f  th e  1990s, a  24-village IRS trial w as c o n d u c ted , a im ed  a t ev a luating  th e  e ffec t o f  con tras tin g  resistance  
m a n a g e m e n t s tra teg ie s  on  th e  ev o lu tion  o f  res is tance  [25,92,93]. This trial w as p ro m p te d  by rising concerns  th a t  th e  p rac tice  o f using  
insectic ides until re s is ta n ce  b e c a m e  a lim iting fac to r w as rapidly e ro d in g  th e  n u m b e r  o f insectic ides availab le  fo r m alaria contro l. 
Villages w ere  ass ig n ed  to  o n e  o f  fo u r tre a tm e n ts  o f re p e a te d  cycles o f house-sp ray ing : (i) tw o  sp ray  ap p lica tions  p e r  yea r o f DDT, or 
th re e  ap p lica tions  p er yea r o f (ii) a p y re th ro id , (iii) a spatial m osaic o f an  o rg a n o p h o s p h a te  a n d  a pyre th ro id , o r (iv) an  ann u a l ro ta tion  
o f an  o rg a n o p h o s p h a te , a pyre th ro id , a n d  a ca rb am ate .
O ver th e  th re e  years o f  th e  trial, p y re th ro id  res is tance  inc reased  m arked ly  in th e  m o sq u ito  p o p u la tio n s  in all villages, irrespec tive  of 
insec tic ide t r e a tm e n t (Figure 4). Thus, sp ray  ca m p a ig n s  ta rg e tin g  m o sq u ito es  in an  a g e -in d e p e n d e n t m a n n e r  can  very rapidly drive 
res is tan ce  ev o lu tion  w h en  re lev an t alleles a re  p re se n t in a p o p u la tio n . P resum ably, th e  m ajority  o f m o sq u ito es  in all villages w ould  
hav e  b ee n  res is tan t h ad  th e  trial co n tin u e d  a few  m o re  years. This trial w as well reso u rced  an d  m on ito red , so  th a t th e  insectic ide 
co v e ra g e  a ch ieved  w as likely to  b e  as h igh  is practically  possib le , a n d  th u s  rep resen ta tiv e  o f an  IRS cam p aig n  confering  m axim al 
possib le  m alaria con tro l.
R esistance m e asu res  b ase d  on  forcefully ex posing  m o sq u ito e s  to  insecticide, such  th e  WHO bioassays u sed  to  g e n e ra te  th e  d a ta  
in th e  figure, likely u n d e r  es tim a te  ep idem io log ica lly  re lev an t res is tance  b ec au se  th e y  can  n o t a ssay  im p o rtan t fo rm s o f resistance 
such  as behav io ra l av o id an ce . M oreover, ev e n  res is tance  to  d irec t e x p o su re  can b e  d u e  to  m any  d iffe ren t m echan ism s an d  th e re  
can  b e  m any  g e n e tic  varian ts  in any  o n e  b iochem ical pathw ay . Thus, th e  c o n trib u tio n  o f an y  particu lar allele to  overall resistance  
varies substan tially . In th is  trial, levels o f cy to ch ro m e P450, a m ajo r d e te rm in a n t of res is tance  to  py reth ro ids, w ere  m a in ta in ed  a t h igh  
levels on ly  in villages sp ray ed  solely w ith  py re th ro ids. In villages sp ray ed  w ith DDT o r su b jec t to  th e  ro ta tio n  sch em e, cy to ch ro m e P450 
levels d ec lin ed  below  d e tec ta b ility  [25]. This su g g es ts  th a t  cy to ch ro m e P450-m e d ia ted  res is tance  can  b e  m a n a g e d  by sw itching  to  a 
d iffe ren t insec tic ide  class, b u t also  th a t such  sw itches n ee d  n o t lim it res is tance  a t th e  w ho le-in sect level (Figure 4). It is o u r co n ten tio n  
th a t evo lu tion -p roo fing  is possib le  fo r all res is tance  m echan ism s, ev e n  w h e re  th e y  a lready  exist in a popu la tio n , by ta rg e tin g  o lde r 
m osqu itoes .
%
Anopheles 
albimanus 20 
resistant to 
pyrethroids
□ DDT 
Pyretmoia
□  Mosaic
□  R o ta tio n
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Figure 4. Evolution of Insecticide Resistance over Three Years of Indoor Residual Spraying in 
Coastal Southern Mexico.
Pyrethroid resistance was assessed using WHO susceptibility bioassays before intervention (year 0) 
and over three years of different insecticide spraying regimes. Redrawn from [25],
cohorts of young and old mosquitoes to 
insecticides, and analyzing life-long life 
tables, propensity to blood feed and, 
critically, fecundity, all ideally done 
with malaria-infected mosquitoes going 
through regular gonotropic cycles.
Such experiments are not technically 
demanding, but they are logistically 
challenging, so that it would be 
impractical to do such tests for 
thousands of candidate compounds. 
However, for a limited num ber of
promising candidates, such tests are 
feasible [46,76-79]. Candidates could 
be chosen in a num ber of ways. First, 
highly lethal compounds already at 
an advanced stage of development 
(or even registered) could be tested 
at lower concentrations for LLA 
properties. Second, known compounds, 
possibly rejected in previous screens 
because of slow speed of kill, could 
be revisited. Third, other product 
evaluation criteria such as likely cost,
environmental safety, and potential 
for cross resistance could be used 
to preselect candidates for LLA 
testing from among the thousands 
of compounds currently tested in 
standard protocols. With lower 
lethality as a requirement, many more 
compounds might become feasible 
public health tools. We note that when 
it costs >US$175 million to bring a 
new compound into use [10], even 
substantially higher initial development
PLoS Biology | w w w .plosbiology.org 0006 April 2009 | Volume 7 | Issue 4 | e l 000058
costs for one LLA product look good 
against the costs of having to develop 
a second and third conventional 
insecticide (potentially ad infinitum 
if malaria can not be eradicated or 
controlled some other way). They 
also look good against the indefinite 
implementation costs and logistic 
constraints o f resistance management 
strategies such as rotations or mosaics, 
which are currently being investigated 
as a means to prolong the life of 
existing, fast-acting insecticides once 
resistance is present (Box 1).
One side effect of the highly lethal 
insecticides currently in use for malaria 
control is that they also kill nontargets, 
such as nuisance mosquitoes and 
bedbugs. This side-effect is believed 
to help with householder compliance 
and uptake [3,37,87], at least before 
the nontargets also evolve resistance. 
LLA insecticides would not have these 
immediately beneficial side effects 
(although a product with differential 
impact against primary targets and 
secondary targets is a possibility). As 
such, LLA insecticides would essentially 
be community-level interventions, 
like transmission-blocking vaccines, 
with the associated issues of user 
take-up. Accordingly, it maybe that 
LLA insecticides will require delivery 
mechanisms that provide some degree 
of personal protection against nuisance 
insects, like bed nets, or imaginative, 
culturally-sensitive delivery systems 
and education programs that facilitate 
adoption irrespective of immediate 
personal relief from biting insects.
The late-life killing insecticides we 
are proposing here work because of 
die time Plasmodium takes to develop 
in mosquitoes. Could these insecticides 
select more rapidly developing 
parasites [82,88]? They might, but the 
short lives of mosquitoes must already 
be imposing intense natural selection 
for shorter extrinsic incubation 
periods, a selection pressure that must 
be further exacerbated by conventional 
insecticides. The apparent lack of 
response to this selection implies that 
significant fitness gains result from 
prolonged development [46,89], gains 
which presumably accrue through 
increased infectiousness [74], It 
might be that LLA insecticides would 
add sufficient additional selection to 
offset these, but if it did, the resulting 
evolution would presumably generate 
substantially less-fit malaria parasites.
Further investigation of this possibility 
is certainly warranted; in the meantime 
we note that the hypothetical 
evolution of significantly less-infectious 
parasites must be of less public health 
significance than the observed failure 
of existing insecticides in the face of 
resistance evolution.
For equivalent levels o f coverage (at 
least lower than 100%), conventional 
insecticides will always give better 
control initially, before any resistance 
evolution. This disparity widens as 
coverage drops (unpublished data). 
Indeed, if only poor coverage can be 
achieved, the control benefits of LLA 
insecticides may be negligible. However, 
in that case, the need for them is 
also negligible, because resistance 
evolution is much less of a problem at 
low coverage, where insecticides of any 
type will impose weaker selection for 
resistance. LLA insecticides come into 
their own when coverage is high, an 
explicit aim of ITN and IRS programs, 
particularly in intense transmission 
areas. At high coverages, sustained 
reductions in transmission of ~95% 
by an LLA insecticide will quickly out 
weigh the even higher reductions that 
are initially possible with conventional 
insecticides once resistance against 
the latter inevitably spreads. Even 
LLA insecticides which fall short of 
being completely evolution-proof will 
minimize the evolutionary pressures 
that otherwise rapidly erode the efficacy 
of conventional insecticides. Very much 
slower rates o f increase of resistance 
give more time for surveillance to 
detect resistance problems (or less 
frequent surveillance to provide the 
same warning), and more time to 
react. Lower selection pressures can 
also translate into many decades of 
additional effective control, which from 
a practical control perspective may be 
essentially infinite.
Concluding Remarks
Somewhat ironically, given that all 
the insecticides currently in use in 
the public health sector derive from 
products developed for the agricultural 
sector, the long-term sustainability 
of LLA insecticides could be further 
enhanced precisely because they are 
likely to have little utility in agriculture. 
The linkage between public health and 
agricultural use of insecticides plagues 
public health use of insecticides like 
DDT and pyrethroids, where agricultural
applications are one of the major drivers 
of resistance in vector populations 
[13,17,90]. This linkage could be broken 
by choosing LLA insecticides which 
could not be profitably reformulated 
for agricultural use, and for which 
there is no cross-resistance with existing 
agricultural pesticides. Moreover, 
restricted to the much smaller public 
health arena, any environmental 
impact of LLA insecticides would also 
be substantially reduced. However, an 
insecticide exclusive to public health 
would be unable to exploit die financial 
drivers promoting investment in 
agricultural insecticides, and so would 
need an artificially constructed market 
of the sort necessary to encourage the 
pharmaceutical industry to invest in 
malaria vaccines.
Our argument that public health 
insecticides can be evolution-proofed 
will not generalize to all vector-bome 
diseases, but it may be applicable to 
others with extrinsic incubation periods 
that approach the life spans o f their 
vectors. Such diseases may include 
dengue, filariasis, West Nile virus, 
Japanese encephalitis, onchocercaisis, 
and Chagas disease. Novel technologies 
directed against a variety o f disease 
vectors, such as those exploiting 
genetic modification of mosquitoes 
and selfish genetic elements, could also 
be immune to the evolution of host 
resistance if they are late-life acting.
The Global Malaria Action Plan 
(GMAP) [10] has laudable ambitions of 
spraying 172 million houses annually, 
and distributing 730 million insecticide- 
impregnated bed nets by the year 
2010. If implemented with existing 
insecticides, this program will impose 
unprecedented selection for resistance. 
The historical record [22], and theory 
(e.g., Figure 1) shows that the medium- 
term prognosis for the insecticides 
currently in use is inescapably poor. 
Transitioning to an LLA insecticide 
strategy could see the benefits o f the 
massive GMAP effort sustained, and 
could maintain for the long term the 
contribution of several key vector 
control tools to the goal o f eradication. 
Failure to address evolution now runs 
the risk of replaying history [22]: 
operational disaster and a derailing o f 
the whole malaria control agenda.
Materials and Methods
The aim is to compare the relative 
effects o f various hypothetical
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insecticides on (i) malaria 
transmission and (ii) evolution of 
resistance. Age-structured models of 
vector-bome diseases are notoriously 
difficult to parameterize, but because 
our aim is comparison of insecticides 
(our aim is theoretical proof-of- 
principle), and not absolute rates or 
amounts, considerable simplification 
is possible.
Our analysis consists of two parts: 
a static deterministic feeding cycle 
model (FCM) similar to those used 
by others [42-44], and a population 
genetics model (PGM). The FCM 
tracks, for each gonotrophic cycle over 
the lifetime of a mosquito (up to a 
maximum of ten cycles), probabilities 
of survival, contact with insecticides, 
frequency and ages o f malaria 
infections, and the number of eggs laid. 
Incorporation of relevant mortality 
assumptions allows the FCM to assess 
the impact o f a particular insecticide 
on the average lifetime number of 
infectious bites per mosquito and the 
average fecundity per mosquito. The 
PGM then uses the survival, infectious 
bite, and fecundity figures from the 
FCM for each class of mosquito to 
calculate, for the population as a whole, 
the relative frequency of resistant 
mosquitoes (our measure o f resistance 
evolution) and the average number 
of infectious bites per mosquito (our 
measure of control), over a series of 
time periods (each equivalent to the 
length of one gonotrophic cycle), 
using standard population genetics 
approaches.
The FCM makes the following 
assumptions.
1. Mosquitoes bite humans randomly 
and uniformly.
2. Malaria-infected mosquitoes never 
become uninfected.
3. The proportion of humans who are 
infectious is constant.
4. A variety o f parameters do not 
change over successive gonotrophic 
cycles: (i) the background mosquito 
mortality rate (what Smith and 
McKenzie [44] call “force of 
mortality”), which is considered as a 
constant per-capita daily death rate 
(i.e. there is no senescence), (ii) the 
probability o f taking a blood meal 
and (iii) the probability of feeding 
on a human.
5. Conventional insecticides are instant 
kill.
LLA insecticides are envisaged to 
kill in either of two ways: (i) when they 
contact a mosquito after she has been 
through a fixed number of gonotrophic 
cycles, e.g., a four-cycle age-dependent 
insecticide (ADI) kills mosquitoes 
that have been through four or more 
cycles; or (ii) a fixed number of cycles 
after first contact, as might be the case 
for an infectious agent, e.g., a four­
cycle time-delay insecticide (TDI) kills 
mosquitoes four cycles after initial 
contact. We have modeled both; the 
values we report are for ADIs. In Table 
SI, we show that ADIs and TDIs have 
equivalent effects. [Note that a mode of 
action for an LLA insecticide could also 
be via bioaccumulation, where lethal 
concentrations of an insecticide are 
finally achieved after repeated contacts 
over course of a mosquito’s life. We 
have not explicitly modeled that mode 
of action].
The non-mathematical description 
of the model, considering ADIs only, 
is as follows. Female mosquitoes are 
followed from successful emergence 
through ten gonotrophic cycles. In 
each cycle, the probabilities of survival 
are tracked through the processes of 
host seeking, feeding, resting, finding 
an oviposition site, and laying. For each 
cycle, the proportion of mosquitoes 
that acquire a malaria infection, bite 
whilst infectious for malaria, and 
successfully lay eggs is also recorded. 
The mosquito may die whilst searching 
for a host, with a probability arising 
from the time spent searching and 
the background mortality rate. If she 
survives searching, she then attempts 
to feed on a human with a given 
probability, and on a nonhuman with 
one minus that probability. She may die 
whilst attacking the host immediately 
before or immediately after feeding, 
with probabilities calculated from 
the underlying risk of death when 
attacking a host, and the probability 
of encountering an insecticide 
(conventional or ADI) that kills on 
contact Of those that successfully feed 
on a human host, females carrying 
a mature malaria infection give an 
infectious bite, whilst those so far 
uninfected may become infected, with 
a fixed probability. Those that survive 
feeding may then die during resting 
with a probability calculated from the 
time spent resting, and the background 
mortality rate. Those surviving resting 
may die whilst searching for a resting
site, again depending on time and 
relevant mortality rates, and survivors 
may then die whilst attempting to lay, 
either before or after laying, with fixed 
probabilities. The tracked values give 
the proportion o f mosquitoes surviving, 
biting, and laying in each cycle.
The variables and parameters used 
in the FCM to generate the figures 
reported in the paper are given in 
Table S2 with equations in Protocol 
SI. Differential mortality of malaria- 
infected and uninfected mosquitoes 
was calculated by applying only a 
proportion of the mortality associated 
with a given treatment to individuals 
not infected with malaria. The full 
mortality is applied to malaria- 
infected individuals. The model was 
implemented in Microsoft Excel [91].
The PGM makes the following 
assumptions:
1. Adult mosquito population size is 
constant.
2. Mosquitoes do not complete more 
than ten gonotrophic cycles.
3. The genetic make-up of mating 
males in any cycle is the same as 
that calculated for newly hatched 
mosquitoes in that cycle.
4. Males of all resistant/susceptibility 
genotypes are equally likely to mate 
successfully.
5. Females mate once only, in their 
first cycle, as is the norm [45].
6. Number of eggs produced per 
laying female is unaffected by egg 
paternal genotype.
7. Genotypes o f emerging adults 
joining the population are in the 
same proportions as the genotypes 
of the generation of eggs from 
which they hatch.
8. Resistance is dominant, as can be 
the case [52].
9. Costs o f resistance are dominant.
10. The proportion o f infectious 
humans is constant.
Variables and parameter values 
for the PGM are given in Table S3 
and associated equations are given 
in Protocol S2. The model uses 
survival probabilities from the FCM 
to calculate the initial age structure 
within the susceptible phenotypes in 
the population. The resistant allele 
is assumed initially to be present in 
heterozygotes, forming a very small 
proportion of the population, as 
detailed in Table S3. Subsequent
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spread of the allele reflects the 
age-linked survival probabilities for 
susceptible mosquitoes in the presence 
of the treatment and for resistant 
individuals, as well as the age-linked 
fecundity of each, all calculated in 
the FCM. The model, implemented 
in Microsoft Excel [91], analyses the 
changing status of the population for 
1,290 sequential discrete time periods, 
each equivalent to the length o f one 
feeding cycle.
Further discussion of model 
assumptions and sensitivity analyses 
are given in Text SI, together with 
additional analysis o f the merits o f the 
approach.
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Prospective malaria control using 
entom opathogenic fungi: comparative evaluation 
of impact on transmission and selection for 
resistance
Background: Chemical insecticides against adult mosquitoes are a key elem ent in m ost malaria m anagem ent 
programmes, but their efficacy is threatened by the evolution of insecticide-resistant mosquitoes. By killing only 
older mosquitoes, entom opathogenic fungi can in principle significantly impact parasite transmission while 
imposing much less selection for resistance. Here an assessment is m ade as to  which of the  wide range of possible 
virulence characteristics for fungal biopesticides best realise this potential.
Methods: With mathematical models that capture relevant timings and survival probabilities within successive 
feeding cycles, transmission and resistance-management metrics are used to  com pare susceptible and resistant 
mosquitoes exposed to  no intervention, to  conventional instant-kill interventions, and to  delayed-action 
biopesticides with a wide range of virulence characteristics.
Results: Fungal biopesticides that generate high rates of mortality at around the  tim e mosquitoes first becom e 
able to  transmit the malaria parasite offer potential for large reductions in transmission while imposing low fitness 
costs. The best combinations of control and resistance m anagem ent are generally accessed at high levels of 
coverage. Strains which have high virulence in malaria-infected mosquitoes but lower virulence in malaria-free 
m osquitoes offer the  ultimate benefit in terms of minimizing selection pressure whilst maximizing impact on 
transmission. Exploiting this phenotype should be a target for product development. For indoor residual spray 
programmes, biopesticides may offer substantial advantages over the  widely used pyrethroid-based insecticides.
Not only do  fungal biopesticides provide substantial resistance m anagem ent gains in the  long term, they may also 
provide greater reductions in transmission before resistance has evolved. This is because fungal spores do  not have 
contact irritancy, reducing the chances that a blood-fed m osquito can survive an encounter and thus live long 
enough to transmit malaria.
Conclusions: Delayed-action products, such as fungal biopesticides, have the potential to  achieve reductions in 
transmission comparable with those achieved with existing instant-kill insecticides, and to  sustain this control for 
substantially longer once resistant alleles arise. Given the current insecticide resistance crisis, efforts should continue 
to  fully explore the operational feasibility of this alternative approach.
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Background
The impressive reductions in global malaria burden 
achieved this century by chemical insecticides against 
adult mosquitoes could be eroded by insecticide- 
resistant mosquitoes [1-6], just as they were last century
[7]. In principle, the evolution of insecticide resistance 
could be considerably slowed and perhaps prevented 
altogether by vector control aimed at killing only older 
mosquitoes, so-called late-life action (LLA) [8]. Malaria 
parasites in a mosquito host take at least nine days to 
develop to a stage which can be transmitted to a human 
via an infectious bite [9]. Since mortality in wild m os­
quito populations is high, the majority o f eggs are pro­
duced by young mosquitoes. Thus, a vector-control 
treatment which kills only older mosquitoes could re­
move infected mosquitoes before they can transmit mal­
aria whilst only impacting the reproductive success of 
only the relatively few mosquitoes that survive to old 
age. This would dramatically reduce transmission while 
exerting only weak selection for resistance.
One option for an LLA vector-control measure is 
entomopathogenic fungi [10]. Naturally occurring strains 
of two fungi, Beauveria bassiana and Metarhizium  
anisopliae, are already in commercial use for agricultural 
applications and have been shown to infect and kill m os­
quitoes in laboratory and field settings. Fungal spores 
can be picked up by mosquitoes following contact with 
treated surfaces, and so could be used against mosqui­
toes in indoor residual spray (IRS) programmes, or deliv­
ered via traps, curtains or netting [11-16].
A wide variety of mortality schedules can be induced 
in Anopheles by entomopathogenic fungi [17]. In some 
cases, all mosquitoes can be killed within a few days; in 
others, background mortality rates can be barely altered. 
This virulence variation depends on isolate [11], dose 
[18] and malaria-infection status [15,18], see also [19]. 
Lethality can also be increased by genetically modifying 
fungal isolates [20-22].
If fungal entomopathogens are to realize the potential 
of the LLA approach to sustainable malaria control, can­
didate biopesticides need to be chosen which balance 
reductions in parasite transmission (maximized by high 
fungal virulence) with resistance management (maxi­
mized by low fungal virulence). Here a mathematical 
model is used to ask which virulence phenotypes best 
achieve this balance. The intention is to guide the devel­
opment of target product profiles. The possible efficacy 
of fungal biopesticides in IRS campaigns is compared 
with that of pyrethroid-based insecticides now in wide­
spread use. Pyrethroids are highly lethal if contacted by 
a mosquito, but they also have a strong excito-repellency 
effect, which can drive away mosquitoes before they re­
ceive a lethal dose [23-25]. There is evidence that fungal 
spores do not repel mosquitoes [26], raising the prospect
that, for IRS, fungal biopesticides might more effectively 
reduce transmission than pyrethroid-based technologies 
currently in use.
Methods
T h e  m o d e l
Many malaria transmission models already exist [27], 
but most do not capture the detailed timings and prob­
abilities of infection, infectiousness, reproduction and 
mortality over the mosquito lifespan which are key to 
assessing whether LLAs can provide a useful balance of 
transmission control and low selection for resistance. In 
order to encompass these elements, a model has been 
developed with two separate components, a markovian, 
deterministic, feeding cycle model (FCM) which calcu­
lates survival, egg-laying and infectious bite values dur­
ing the lifetime of an adult mosquito, and a population 
model (PM) which tracks the population-level spread of 
resistance alleles and corresponding loss of transmission 
control. The model is a development of a simpler ver­
sion previously used to evaluate putative chemical LLAs
[8]. Other modelling frameworks used to assess the LLA 
approach are heuristically useful but lack sufficient detail 
to define target virulence schedules [28-30].
T h e  f e e d i n g  c y c l e  m o d e l
The FCM calculates survival, egg-laying and infectious 
bite values across a series of discrete adult age classes 
for a specified type of mosquito (e.g., susceptible) sub­
jected to a given intervention (e.g., a particular fungal 
biopesticide at a particular coverage). Each sequential 
age class is defined as lasting for the average length of 
one gonotrophic cycle. Use o f the mosquito feeding 
cycle as the basis for age-structured analyses of m os­
quito populations is well established [31-34],
The FCM tracks possible states and transitions 
through each age class (/), applying survival, exposure 
and infection probabilities (Figure 1). Infection status for 
a biopesticide (/) or malaria (m), is zero for no infection, 
otherwise equal to the age of the infection. State changes 
depend on the preceding state, the passage of time, mor­
tality rates and the probabilities o f certain events, such 
as contacting a biopesticide when resting after a human 
blood meal. For example, for a case analysing the effects 
of a fungal biopesticide, a mosquito commencing its 
fourth cycle with an infectious, three-cycle-old malaria 
infection, and no fungal infection, will spend a defined 
period of time searching for a host, with an associated 
probability of dying from background mortality while it 
does so. It will then attack a host, with a given probabil­
ity that the selected host will be a non-infectious human, 
a malaria-infectious human, or non-human, and a given 
probability of being killed whilst attacking the host be­
fore biting. If it survives to bite, and if the host is
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Figure 1 FCM model structure for one feeding cycle. Calculation of possible outcomes for feeding cycle /+1 of the model, assuming status 
when commencing cycle /+1 is age = i, malaria status = m,, fungal infection status = 4, with /0=0 and m0=0. Each arrow represents a probability 
calculated by the model. If the malaria infection status (number of cycles since infection) of a mosquito when biting is greater than the 
development time of the malaria parasite in the mosquito, then 'bites host' after attacking a human host is recorded as an infectious bite.
human, this is recorded as an infectious bite. There is 
then a given probability that it is killed by the host after 
biting. If it is not killed, it begins a period of resting, dur­
ing which, if the chosen host was human, it has a fixed 
probability of encountering and being infected by the 
fungus, as well as a given probability of dying from back­
ground mortality before leaving to search for an egg- 
laying site. During the search for an egg-laying site there 
is a given probability that the mosquito may die from 
background mortality, or from the effects of its newly 
acquired fungal infection. If it survives searching for an 
egg-laying site it may die before or after laying with 
given probabilities. If still alive at the end of the cycle, it
begins its fifth cycle with an infectious, four-cycle-old 
malaria infection, and a one-cycle-old fungal infection. 
For a case analysing the effects of a conventional 
instant-kill chemical pesticide, the analysis would in­
clude a probability of contacting the pesticide after bit­
ing the host, and a probability of death, assumed to be 
instant, resulting from that contact, with zero probability 
of contacting a biopesticide.
Both conventional instant-kill and delayed-action bio­
pesticides offer public health benefits by reducing the 
numbers of mosquitoes that survive to give infectious 
bites in a treated population. Clearly the extent to which a 
reduction in infectious bites maps to reduced transmission
Lynch et al. Malaria Journal 2012,11:383
http://www.malariajournal.eom/content/11/1/383
Page 4 of 15
and reduced numbers or severity o f malaria cases in a 
human host population involves many complex, context- 
specific factors. For comparative purposes, however, it is 
assumed that in a given context, a given reduction in in­
fectious bites will generate the same reduction in malaria 
transmission and malaria morbidity and mortality irre­
spective of the type of intervention from which it results. 
For generality, therefore, the comparative public health 
benefits of the insecticides considered in this analysis are 
all evaluated based on the reduction in infectious bites 
which they provide. This is quantified in the FCM for a 
given phenotype by calculating RAIB, the proportionate 
reduction in the average number of infectious bites per 
mosquito per lifetime (AIB), defined as
RAIB =  1 -
AIB with treatment 
AIB without treatment
can potentially offer rates of infection equivalent to the 
rates of mortality generated by conventional insecticides. 
The latter assumption is supported by field trials show­
ing >86% infection of mosquitoes entering outdoor bait 
boxes [36], 76% infection in experimental huts with 
fungus-impregnated eave curtains [13], and laboratory 
trials showing >95% infection from treated clay pots [14] 
or exposure to treated clay tiles [11].
The average number of eggs laid in a given cycle, by mos­
quitoes surviving to the start of that cycle, Fit is calculated as
Ft
^  j ^  ' j i.mjVj.m.l
0 /= 0____
v,-
Assuming that the rate at which newly maturing adults 
join a population is constant through time, and that the 
size of the human host population is unaffected by the 
intervention being assessed, RAIB is equal to the pro­
portionate reduction in the entomological inoculation 
rate (EIR), the number of infectious bites experienced 
per person per unit of time.
To evaluate mosquito fitness, the average number of eggs 
produced per mosquito per lifetime is used as a proxy for 
lifetime reproductive success (LRS). The selection coeffi­
cient, the proportionate fitness benefit of resistance to a 
given intervention, is calculated as Selection Coefficient =  
LRS for specified mosquito type with intervention ■ 
LRS for susceptible mosquitoes without intervention 
A selection coefficient of zero means no selection pressure 
in favour of resistance, with higher selection coefficients in­
dicating increasingly strong selection for resistance.
Formulating these key variables in relative terms mini­
mizes the sensitivity o f the conclusions to parameter 
values that are independent of the vector-control treat­
ment or mosquito phenotype being evaluated.
The primary definitions of the FCM are given in 
Table 1, and its main features are detailed below. A  
detailed derivation of the FCM is given in Additional file 
1: Appendix A. Baseline parameter values used in the 
analysis are summarized in Table 2.
The probability that a mosquito contacts and is 
affected (killed or infected) by a conventional or bio­
logical insecticide after biting a human host is input as a 
single ‘coverage’ value, incorporating the probabilities of 
being in a treated property, o f contacting the pesticide, 
and of being affected by the pesticide during contact. It 
is assumed that physical constraints on the proportion 
of surfaces and internal areas treated will apply equally 
to conventional and fungal insecticides, and that for 
mosquitoes contacting treated surfaces, biopesticides
This provides the basis for the evaluation of relative 
fitness using a comparison of values for <p, lifetime egg
A
production, representing LRS, 0  =  E m ,-
i= 1
Comparative levels of transmission control are 
assessed using u, the average number of infectious bites 
A
per mosquito lifetime, u =
(=i
The average number of infectious bites during cycle i 
per mosquito surviving to the beginning of cycle i, is 
calculated as
i—i  i - i
E E/i = -£i=°------ --------------i>D
The average probability of survival from start of cycle i 
to start of cycle (i + 1) is S,-, with
Si =
i - l  z - iy y M m j
m = 0 1=0
Vi
T h e  p o p u l a t i o n  m o d e l
The PM tracks susceptible and resistant phenotypes over a 
sequence of time periods for a population subject to a given 
vector-control treatment. The key outputs, calculated for 
each time period, are the proportion of the population with 
resistant and susceptible phenotypes and the overall reduc­
tion in infectious bites across the population compared to a 
susceptible population with no vector-control treatment
The variables and parameters for the PM are described 
in Table 3, and baseline values used in the analysis are 
summarized in Table 4.
A detailed derivation of the model is given in Additional 
file 2: Appendix B. In brief, the PM works in discrete time 
periods, each equivalent to the length of one gonotrophic 
cycle, with recruitment of newly emerged adult mosquitoes
Lynch et al. Malaria Journal 2012,11:383
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T a b l e  1 V a r ia b le s  a n d  p a r a m e t e r s  f o r  t h e  f e e d i n g  c y c l e  m o d e l
Variable or Parameter Symbol Comments and Constraints
Time, measured in whole units equal to average length of sporogonic cycle, from infection 
of mosquito by malaria to cycle from which mosquito gives infectious bites
D input 0< D
Number of age classes included in analysis A
Cycle number (identifies specific cycle in the A cycles over which probabilities are tracked in the FCM) i 0< /  <A
Malaria status, the number of whole or partial cycles since infection with malaria m 0< m <X, m = 0 means not infected
Biopesticide infection status, the number of whole or partial cycles since infection with biopesticide I 0< l< A, / =  0 means not infected
Average number of eggs laid in cycle i by mosquitoes surviving to the start of cycle i F,
Average lifetime number of eggs laid per mosquito <t>
Average number of eggs laid in cycle i, by mosquitoes starting cycle /' with malaria status m and 
biopesticide status /
Si.nl m<i l<i
Average probability of survival from start of cycle i to start of cycle /+1 St
Average probability that a mosquito starting cycle / with malaria status m and biopesticide status /, 
will survive to start of cycle i+1
st,n l m<i l<i
Average probability of a mosquito being alive at start of cycle /. V,
Average probability of a mosquito being alive, with malaria status m and biopesticide status /, at 
start of period /.
Vl.nl m<i l<i
Probability that a mosquito alive at start of cycle i with malaria status m and biopesticide status /, 
survives and bites host type h in cycle i
riUnlM m<i l<i
Type of host attacked h h= 1, non-human
h=2, non-infectious human
h=3, infectious human
Average number of infectious bites in cycle / per mosquito alive at the start of cycle i It
Average lifetime number of infectious bites per mosquito u
treated as occurring at the start of each time period. For 
each sequential time period, the proportion of the popula­
tion comprised by each genotype in each age class is calcu­
lated, reflecting the genotypes of new adult recruits and 
the survival of adults in each age class from the preceding 
period. This is then used to calculate the proportion of the 
total population in time period n with homozygous reces­
sive (G3i„) and heterozygous (G^J genotypes, from which 
R„ is calculated, the proportion of the population with a re­
sistant phenotype in period «, with R„ = G3,„ + G^rfi. 
Dominance is actioned by the value of d, which is 0 when 
resistance is assumed recessive, and 1 when it is assumed 
to be dominant 
Results from the FCM are used by the PM to calculate 
the average number of infectious bites per mosquito 
in the population during each time period. From this 
Q„, the number of infectious bites given by the popula­
tion as a whole relative to those given by an untreated 
population, can be calculated for each time period as
A s s u m p t i o n s
The model does not attempt to capture the effects of mu­
tational processes or stochastic demographic effects on 
the origin and initial spread of very low numbers of
resistance alleles, and so it is assumed that resistant phe­
notypes are already established at a low frequency in the 
population at the start of the analysis. Resistance involves 
a single gene and a simple dominant/recessive process. 
Moreover, it is assumed that the size and age structure of 
the population at the start o f the PM analysis is that 
achieved after sustained use in a susceptible population of 
the insecticide being evaluated, that there is no immigra­
tion or emigration, and the proportion of each genotype 
in the new adults joining the population matches that in 
the eggs from which they originate. Density dependence is 
assumed to occur at the mosquito larval stage and the 
number of adult mosquitoes recruited to the population 
per unit of time remains constant.
All model parameters are age-independent, apart from 
background mortality rates and the action of age-linked 
pesticides, with incremental mortality from fungal bio­
pesticide infection varying according to the number of 
days since infection. Conventional insecticides affecting 
a susceptible individual are assumed to be instantly fatal. 
Mosquitoes choose human hosts at random, and the 
model does not capture feedback between numbers of 
infectious bites and the proportion of human hosts with 
infectious malaria. Malaria-infected mosquitoes never 
become uninfected. All feeding cycles are of equal dur­
ation and mosquitoes bite once in each cycle. All eggs
Lynch et al. Malaria Journal 2012,11:383
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T a b l e  2  V a l u e s  u s e d  in  F C M  f o r  t h i s  a n a ly s i s
Variable or Parameter Symbol Value units
Background instantaneous mortality rate for mosquito age /' rB,i 11.75% ’ per day
Length of gonotrophic cycle w 2.85 1 days
Time spent host searching and feeding during a cycle b 1.26 5 days
Time spent finding oviposition site and laying during a cycle 4> 1.26 s days
Length of resting period (days) >) 0.32 s days
Proportion human population infectious for malaria4 P 4.28% 1
Probability attacks non-human host H 0.17 1
Probability killed when attacking host before biting ai .05 6
Probability killed when attacking host after biting (excluding mortality from 
insecticide treatments)
a2 .05®
Probability becomes infected with malaria when biting infectious human host4 M 1.00
Number of eggs laid per successfully laying mosquito per cycle L 100 2 eggs
Time, measured in whole units equal to length of gonotrophic cycle, from 
infection of mosquito to cycle from which mosquito gives infectious bites
D 3 3 Based on 10.78 ' days cycles
Baseline probability that mosquito contacts and is killed by conventional instant-kill 
chemical insecticide (CC) whilst resting after biting human host
k 0 for cases not assessing use of CC 
0.8 for cases assessing use of CC
Baseline probability that mosquito contacts and is affected by delayed action 
pesticide whilst resting after biting human host
X 0 for cases not assessing use of 
delayed action pesticide
0.8 for cases assessing use of delayed 
action pesticide
Number of age classes included in analysis X 10 cycles
1 Averages taken from four geographic locations [31]. Results using individual geographic data sets are expected to give qualitatively equivalent results. Limited 
sensitivity analysis was consistent with this assumption, so use o f the average figures was considered adequate for the present analysis.
2Since we are only interested in comparative values, the absolute value for the number o f eggs per lay is immaterial, 100 has been used as a convenient normalised 
value.
3.The number of cycles assumed for sporogonic development is calculated from the average number o f days for sporogonic development and the average number of 
days per gonotrophic cycle, rounded down to give a whole number o f cycles. This is a  conservative assumption with respect to the amount o f EIR reduction calculated 
for given fungal virulence parameters.
4.The data set used provides a total probability o f acquiring a malaria infection when biting a human host This has been used as the value for parameter p, with 
M=1.00, to give the appropriate combined probability, Mp.
5. Assumes c l  1.1% o f every cycle is spent resting (8 hours in a  72 hour cycle), with the rest o f the gonotrophic cycle divided equally between laying and feeding.
6. Estimated 10% mortality per feeding attempt [351, divided equally between pre- and post-bite.
laid are o f equal quality and viability. The analysis assumes 
that malaria infection produces no effects on behaviour, 
background mortality or fecundity in infected mosquitoes, 
and fungus-infected mosquitoes that survive and lay eggs 
are assumed to lay as many eggs at each laying event as 
uninfected individuals.
Mosquitoes are assumed to contact the chemical or 
biopesticide when resting after biting a human host, 
reflecting an application method essentially consistent 
with IRS. Avoidance behaviour such as outdoor feeding 
and outdoor resting is not reflected in the coverage 
values for susceptible mosquitoes since it comprises a 
method of resistance.
A n a ly s i s
A number of fungal strains have now been tested in la­
boratory mosquito populations, and a wide range of 
mortality characteristics have been observed around the 
basic pattern of initial fungal growth and development 
followed by an increase in observable mosquito
mortality [11,15,16,18,37]. This suggests that most viru­
lence profiles are potentially available, and in a search 
for generalizable results this analysis therefore uses 
highly simplified virulence mortality characteristics, 
defined by two parameters, ‘initiation day] the time from 
infection to the onset of fungus-induced mortality, and 
the daily mortality rate from that point (Figure 2).
Fungal biopesticides can also impact mosquito feeding 
propensity and flight capacity in the days before mos­
quito death [11]. A mosquito which no longer attempts 
to feed or to lay eggs is effectively dead from the per­
spectives of fitness and disease transmission. For the 
purpose of the model therefore, ‘mortality’ encompasses 
cessation of feeding and reproduction, as well as actual 
death.
Results
C o v e r a g e  a n d  v i r u l e n c e
The proportionate reduction in EIR generated by use of a 
biopesticide is affected by fungal virulence and coverage
Lynch e t al. Malaria Journal 2012 ,1 1 :383 
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Variable or Parameter Symbol Comments & 
Constraints
Period number (periods over which the population is tracked)* n 0 <n
Dominance of resistance allele d dominant d = 1 
recessive d = 0
Genotype (normal allele s, resistant allele r) S (s,s) g = 1 
for) g = 2 
for) g = 3
Proportion of total population having genotype g at start of period n G&n
Proportion of the population resistant at start of period n Rn
Average number of infectious bites per mosquito in population in period n M „
Size of initial population (susceptibles in the presence of treatment) as proportion of base population (susceptibles 
without treatment)
J value from FCM
Population size in period n as proportion of initial population size Wn
Average infectious bites during one time period from an untreated population 4 value from FCM
Number of infectious bites from treated population during time period n, expressed as a % of the number of Qn Chosen measure of
infectious bites during one time period from a susceptible population without treatment, control
Number of periods between egg-laying and adult emergence 0 Input
'As for the FCM, the duration o f one gonotrophic cycle is used as a unit o f time. For convenience we use ‘cycles' to refer to mosquito age and 'periods' to refer to the 
sequential time periods for which values are calculated in the PM.
(Figure 3). For a given level of coverage, similar levels of 
EIR reduction are achieved by various combinations of the 
two parameters used to summarize virulence (initiation 
day and mortality rate (Figure 2)). Unsurprisingly, the 
longer a fungus takes to initiate mortality, the greater the 
subsequent mortality rate has to be to maintain a given 
level of reduction in EIR. There are limits to the EIR 
reductions that can be achieved at low virulence and/or 
low coverage.
For equivalent reductions in EIR, selection for resist­
ance is best minimized by high coverage with late initi­
ation day, high mortality rate biopesticides. For example, 
the lowest selection coefficient associated with a 90% 
RAIB at 80% coverage is 21%, with day 9 initiation and 
a 91% mortality rate. At 50% coverage the lowest selec­
tion coefficient available in combination with 90% RAIB 
is 40%.
T a b l e  4  V a l u e s  u s e d  in  t h e  p o p u l a t i o n  m o d e l  f o r  t h i s
a n a ly s i s
Variable or Parameter Symbol Value
Proportion of total population 
having genotype g at start 
of period 1
G&t
C}  
C)
 
II 
II 
II 
° 
£
Dominance of resistance allele 
(0=recessive, l=dominant)
d d =  1
Number of periods between egg-laying 
and adult emergence
0 3
Fitness factor for males with genotype g fg f,=f2=f3=1.00
All other input values use results calculated by the FCM.
The temporal dynamics of EIR reduction and resist­
ance evolution are shown in Figure 4. Predictably, more 
virulent biopesticides give better population-level reduc­
tions in EIR to begin with, but they then drive the evolu­
tion of resistance more rapidly. The speed of resistance 
evolution is more sensitive to the timing of mortality 
onset than to the incremental mortality rate.
The evolutionary dynamics and resulting pattern of 
control failure differ markedly for different insecticides 
even when they give identical reductions in EIR in the 
pre-evolutionary phase (Figure 5). Conventional instant- 
kill chemical insecticide (with coverage adjusted to 
achieve the same initial control) fails first. The longest 
time to product failure is offered by a fungal biopesticide 
with relatively late mortality initiation, which then kills 
at a very high rate (Figure 5).
Clearly, the probability that a mosquito contacts and 
is affected by a vector-control treatment has a significant 
impact on both the reduction in EIR and reproductive 
success. Reductions in EIR improve as coverage is 
increased, but the strength of selection for resistance 
also increases (Figure 6, left panels). This illustrates 
the predictable trade-off between the best transmission 
control, obtained at high coverage, and the best resist­
ance management, obtained at low coverage. When 
compared to the currently available alternative, a con­
ventional instant-kill chemical insecticide, however, the 
relative values for EIR reduction and resistance manage­
ment with the biopesticides are maximized at the high 
coverage values which correspond to the best transmis­
sion control and the strongest selection pressures for
Lynch et al. Malaria Journal 2012,11:383
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Figure 2 Illustrative survival curves for a range of simple virulence mortality assumptions. Survival curves illustrating mortalities defined by 
two simple virulence parameters. For each illustrated pair of values, mortality is zero until the specified initiation day, and is thereafter maintained 
at the indicated fixed daily mortality rate. Initiation day and mortality rate are the two parameters used to define the assumed incremental 
mortality generated by a given biopesticide infection.
Biopesticide coverage 80% Biopesticide coverage 50%
50% RAIB
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
initiation day initiation day
Figure 3 Comparison of virulence characteristics and fitness costs associated with given reductions in EIR. Top panels show different
combinations of values for initiation day (x-axis) and daily mortality rate (y-axis) which achieve the denoted reductions in EIR (RAIB). The mortality 
rate required to achieve a given RAIB increases for later initiation days, up to an initiation day beyond which the target RAIB cannot be achieved, 
at which point the plots stop. With 50% biopesticide coverage, no virulence parameter combinations achieve 99% RAIB. Bottom panels show the 
selection coefficients corresponding to the same set of virulence parameter values, eg, the 99% RAIB value plotted for initiation day 2 gives the 
fitness cost for susceptibility to a biopesticide with initiation day 2 combined with the mortality rate required to achieve a 99% RAIB. Higher 
selection coefficients indicate stronger selection pressure for resistance.
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Figure 4 Population level infectious bite rate and proportion resistant for populations exposed to different biopesticides. Top panels
time
show the population reduction in infectious bites per unit of time for each of five different virulence combinations, and the change in this value 
over time with the spread of resistance to the treatments, shown in bottom panels. 80% coverage assumed throughout.
resistance (Figure 6, right panels). Even a biopesticide 
with sufficiently high virulence to match the initial 
EIR reduction of instant-kill insecticides at the same 
coverage levels offers some benefit in terms of useful
life (Figure 7). This is because fungus-infected mosqui­
toes are still able to achieve some reproduction before 
being killed, thus somewhat reducing the selection 
for resistance.
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(ii) 50% day 3
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Figure 5 Comparison of four interventions providing a 90% initial reduction in infectious bites. Plots show the change over time in the 
proportion of resistant individuals (bottom panel) and the percentage reduction in population level infectious bites (top panel) for a mosquito 
population consistently exposed to one of four vector control treatments, all chosen to give the same 90% initial reduction in EIR.
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Figure 6 Comparison of conventional instant-kill chemical insecticide and four biopesticides across a range of coverage values.
Lifetime reproductive success with interventions as a proportion of LRS for untreated mosquitoes (top left panel) and as a proportion of LRS for 
mosquitoes treated with an instant-kill insecticide (top right panel). Reduction in average infectious bites per mosquito lifetime with interventions, 
compared to the value for untreated mosquitoes (bottom left panel), 0 = no reduction in infectious bites, 1.00 = no infectious bites. Reduction in 
infectious bites with interventions vs untreated mosquitoes, compared to the reduction achieved using a conventional instant kill insecticide 
(bottom right panel), 1.00 means reduction equal to that achieved by instant-kill insecticide.
R e p e l l e n c y
One of the most commonly used classes of conventional 
insecticides, pyrethroids, have high contact irritancy 
(also called excito-repellency), causing approximately 
50% of mosquitoes contacting treated surfaces to be re­
pelled without acquiring a harmful dose [23-25,38]. 
There is no indication of any repellency effects for the 
fungal biopesticides [26]. For IRS, if 50% of mosquitoes 
contacting the instant-kill insecticide are unaffected by 
it, then, for equivalent spray coverage, fungal biopesti­
cides offer better reductions in EIR at all coverage levels, 
whilst maintaining selection benefits for all but the most 
virulent strain at the lowest coverage (Figure 8).
M a la r ia  i n t e r a c t i o n s
Some fungal strains have been shown to have higher viru­
lence in malaria-infected mosquitoes than in those without 
malaria infection [15]. The trade-off between reducing EIR 
and resistance management is greatly reduced where fungal 
virulence is lower in malaria-free mosquitoes, with selection 
for resistance virtually eliminated if the fungus induces mor­
tality exclusively in malaria-infected mosquitoes (Figure 9).
Discussion
Variation in the virulence characteristics of potential bio­
pesticides offers scope for selecting strains targeted to
provide desirable combinations o f reduced transmission 
and resistance management A number of virulence phe­
notypes can provide equivalent levels of EIR reduction 
(Figure 3), and in general high biopesticide-induced mor­
tality rates commencing as late as possible offer better re­
sistance management for a given level of EIR reduction 
(Figures 3 and 5). There is nonetheless a trade-off between 
extending the time taken for resistance evolution to 
undermine efficacy of a pesticide, and the initial reduc­
tions in transmission (Figure 4). In general terms, more 
virulent fungal strains better reduce transmission initially, 
but at the cost of stronger selection for resistance, and 
consequently a shorter useful life (Figure 10).
Although high coverage offers scope to use less viru­
lent fungal strains to reduce EIR, for given virulence 
parameters, higher levels of coverage also generate 
stronger selection for resistance, for both conventional 
and biopesticide interventions. Remembering that the 
biopesticides must be considered in relation to the best 
currently used approaches, it is interesting to note that 
in relative terms, the benefits o f biopesticides versus 
conventional instant-kill insecticides are maximized at 
high coverage for both transmission control and resist­
ance management (Figure 6).
The relative importance of initial control versus prod­
uct lifespan depends on a large number of factors,
Lynch et al. Malaria Journal 2012,11:383
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Figure 7 Comparison of resistance spread and consequent increases in infectious bites with instant-kili and fungal biopesticides.
Biopesticide virulence selected to give pre-resistance EIR reduction matching instant-kill pesticides at 80% or 30% coverage. Plots show the 
proportion of the population with resistant phenotypes, and the corresponding values for population-level reduction in infectious bites per unit 
of time compared to an untreated population.
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Figure 8 Comparison between biopesticides and instant-kill insecticide with 50% contact irritancy, across range of coverage values.
Lifetime reproductive success with interventions as a proportion of LRS for untreated mosquitoes (top left panel) and as a proportion of LRS for mosquitoes 
treated with an instant-kill insecticide with 50% contact irritancy (top right panel). Reduction in average infectious bites per mosquito lifetimewith 
interventions, compared to the value for untreated mosquitoes (bottom left panel), 0 = no reduction in infectious bites, 1.00 = no infectious bites.
Reduction in infectious bites with interventions vs untreated mosquitoes, compared to the reduction achieved using a conventional instant kill insecticide 
with 50% contact irritancy (bottom right panel), 1.00 means reduction in AIB equal to that achieved by instant-kill insecticide with 50% contact irritancy.
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Figure 9 Differential mortality in malaria-infected and malaria-free mosquitoes. Comparison of speed of spread of resistance and 
consequent loss of transmission control for populations treated with one of five fungal biopesticides with differential mortality rates in malaria- 
infected mosquitoes. Plots show the proportion of the population with resistant phenotypes, and the corresponding values for population-level 
reductions in infectious bites per unit of time compared to an untreated population. The biopesticides all have day 3 initiation of a 72% daily 
mortality rate for malaria infected mosquitoes, giving an initial 99% reduction in infectious bites per time period.
including the availability of alternative replacement 
treatments, the meaning in terms of human morbidity 
and mortality of a smaller reduction in EIR at the outset, 
and the realities of public budgets and other resources. 
The relative costs and benefits also change if the biopes­
ticide is being considered for use as part of a combin­
ation treatment with other interventions [34,39,40]. 
There is, therefore, no simple mathematical optimum  
for the many possible virulence schedules; the many 
possibilities need to be considered in context. In so far 
as it can be done without compromising transmission
control, however, it is clearly beneficial to choose the 
biopesticide that generates the lowest selection for re­
sistance in a particular context. For resistance manage­
ment, the aim should be to achieve high levels of 
coverage, allowing less virulent fungal strains to achieve 
a given level of control, and maximizing their resistance 
management benefits over instant-kill insecticides.
Even strains sufficiendy virulent to match the transmission- 
reducing characteristics of conventional instant-kill chemical 
insecticides at matching coverage levels still offer a small 
benefit in terms of the rate of spread of resistance (Figure 7).
100%
Cost of using 
less virulent 
strain
Benefit of 
using less 
virulent 
straino% .
time
Figure 10 Schematic illustration of the trade-off between initial levels of control and product useful life. The green and red areas 
highlight the differences in infectious bites resulting from a choice between a high-virulence intervention with high initial infectious bite 
reduction and high selection for resistance versus a lower-virulence intervention with lower initial benefits and lower selection for resistance. The 
red area highlights the additional infectious bites associated with choosing the lower virulence option, before resistance spreads. The green area 
shows the additional infectious bites associated with choosing the high-virulence option in the long term once resistance spreads.
Lynch et al. Malaria Journal 2012,11:383
http://www.malariajoumal.eom/content/11/1/383
Page 13 of 15
Such a resistance management gain would be enhanced by 
any fitness costs associated with resistance [8].
The conclusions presented here are independent of 
the method of resistance (e.g., metabolic or behavioural), 
provided resistance is genetically determined. It is 
assumed however that resistance is a binary quality, with 
mosquitoes either experiencing the full effects of a con­
trol measure, or remaining completely unaffected by i t  
The analysis of the speed of spread of resistance here 
thus assumes that susceptible mosquitoes experience 
infections with the specified virulence characteristics, 
and that resistant mosquitoes have no fungal mortality. 
In reality, it is more probable that a resistance/tolerance 
process would operate, with resistant mosquitoes still 
becoming infected, but experiencing a lower mortality 
rate than fully susceptible individuals. The spread of re­
sistance would therefore effectively comprise a reduction 
in fungal virulence, rather than a complete loss of con­
trol. Considering the results presented in Figure 4, for 
example, this would mean that the spread of resistance 
to the highest virulence biopesticides, rather than com­
prising a steep function to complete resistance and total 
loss of transmission control, would move to the curves 
calculated for sequentially less virulent strains, as resist­
ance converts high virulence strains to low virulence 
strains, offering even more beneficial resistance manage­
ment possibilities. Future analyses could explore the im­
pact of hypothetical resistance mechanisms that might 
operate with respect to conventional and fungal pesti­
cides. The analyses presented here could also be 
extended to evaluate the impact o f malaria infection on 
mosquito survival, fecundity and behaviour and variation 
in fecundity with mosquito age.
Certain widely used pyrethroid insecticides have high 
contact repellency, with studies suggesting that around 
50% of mosquitoes landing on treated surfaces may leave 
before acquiring a fatal dose [23-25,38]. Whilst this po­
tentially enhances the impact of pyrethroid-treated bed 
nets on transmission by deflecting mosquitoes away 
from protected humans before they bite, for IRS it 
results in mosquitoes surviving to potentially transmit 
malaria in later feeding cycles [24]. Thus, for this group 
of conventional insecticides, the composite ‘coverage’ 
value at a given level of spray cover, would be half that 
for biopesticides, and could never be greater than 50%. 
Comparing biopesticide performance with that of a con­
ventional insecticide, and assuming 50% contact repel­
lency (Figure 8) across a full range of coverage values, 
fungi better reduce transmission than pyrethroid IRS, 
while still maintaining some resistance management 
benefits. This suggests that, for all spray coverage values, 
suitably virulent fungal strains might provide a better 
option for IRS-based vector interventions than contact- 
repellent pyrethroids. If only low levels of spray coverage
are achievable, replacing repellent pyrethroids with high- 
virulence fungal treatments could significantly improve 
the achievable EIR reduction, without significantly in­
creasing selection for resistance, which is in any case 
relatively weak at low coverage (Figure 8). Where high 
spray coverage is achievable, replacing pyrethroids with 
relatively low-virulence fungal treatments could give 
improvements in both transmission control and resist­
ance management, since the relative fitness of suscep­
tible mosquitoes would be potentially doubled.
The analysis shows that in all cases, having higher 
fungal-induced mortality in malaria-infected mosquitoes 
than in uninfected mosquitoes minimizes the fitness 
costs associated with a given reduction in transmission 
(Figure 9). The ideal biopesticide from the resistance 
management perspective would be one that had little or 
no impact on mosquitoes not infected with malaria, but 
was strongly virulent in malaria-infected individuals. 
This might be possible since malaria infection can im­
pose significant metabolic and immunological challenges 
to mosquitoes [41-44]. There is only a minimal trade-off 
between transmission control and resistance manage­
ment in malaria-linked incremental biopesticide mortal­
ity. By changing the fitness cost to the mosquito of 
malaria infection, pesticides working in this way might 
also exert selection in favour of vector resistance to mal­
aria, further enhancing the transmission-control benefits 
from the intervention. Strain selection or genetic modifi­
cation should ideally target this trait. A further develop­
ment of this principle would be fungal strains which 
specifically block development of the malaria parasite in 
the mosquito, or simply act as a delivery mechanism for 
anti-malaria interventions in the mosquito host (‘para- 
transgenesis’ [10,37]), with minimum survival or fecund­
ity costs to the mosquito. It must be noted, however, 
that this potentially moves selection for resistance from 
the mosquito to the malaria parasite, which has so far 
proved extraordinarily adept at evolving its way out of 
trouble.
Conclusions
This analysis shows that fungal biopesticides have the 
potential to significantly reduce EIR while imposing only 
weak selection for resistance. There is always a trade-off 
between the magnitude of the initial reductions in trans­
mission and maintaining those reductions in the longer 
term. Given the severe human and economic conse­
quences of malaria transmission, choosing an interven­
tion which does not maximally reduce transmission at 
the outset requires very careful justification. However, 
the analyses presented here show that fungal biopesti­
cides can offer equivalent or better reductions in trans­
mission than existing interventions in both the short 
and long term. This is especially true where existing
Lynch et al. Malaria Journal 2012,11:383
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conventional chemical pesticides have high contact irri­
tancy or resistance to them has already begun to spread. 
The theoretical analyses presented here should help define 
the vector mortality profiles required to maximize the sus­
tained malaria control potential of fungal biopesticides, or 
indeed other novel biological or chemical insecticides.
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